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ABSTRACT 
Hypotheses. i) Atypical exposure to measles virus is a factor in the aetiology of 
inflammatory bowel disease (IBD). ii) Measles, mumps and rubella (MMR) 
vaccination is a factor in the aetiology of autistic enteropathy. 
Aims. i) To compare a range of molecular techniques for measles RNA 
amplification. ii) To develop a sensitive and robust method for the detection of 
measles RNA. iii) To analyse clinical samples from IBD patients for the 
presence of measles RNA. iv) To analyse clinical samples from autistic 
enteropathy patients for the presence of measles, mumps and rubella RNA. 
Methods development. Three RNA amplification methods were compared in 
terms of their sensitivity and fidelity for the detection of measles RNA and 
nucleic acid sequence-based amplification (NASBA) was found to be the most 
sensitive. In a preliminary study, NASBA did not detect any measles RNA in a 
coded series of IBD and control intestinal tissues. 
In order to improve the detection sensitivity, the use of hybrid capture, using 
measles-specific oligonucleotides linked to paramagnetic solid phase supports, 
was investigated. Hybrid capture was found to increase the measles RNA 
detection sensitivity 100-fold when followed by RT-PCR. An internal modified 
transcript was developed which could be co-amplified with measles RNA as an 
internal positive control. 
IBD samples. Resection samples from 20 IBD and control patients were used for 
measles hybrid capture followed by RT-PCR, in addition to peripheral blood 
mononuclear cells (PBMCs) from 13 IBD and control patients. 
Autistic enteropathy samples. Biopsies, PBMCs and Vero/PBMC cocultures 
were analysed from 22 patients with autistic enteropathy and 6 controls. 
Results. Hybrid capture and RT-PCR could detect 104 molecules of a measles 
RNA transcript added to control tissue homogenates. The fidelity of NASBA, in 
terms of its nucleic acid error rate, was found to be comparable with that of RT- 
PCR. All samples were found to be positive for a housekeeping RNA species 
and internal modified positive control RNA. None of the samples tested positive 
for measles, mumps or rubella RNA, although viral RNA was successfully 
amplified in positive control samples. 
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Conclusion. The results do not support previous data implicating persistent 
measles virus infection with the aetiology of IBD or autistic enteropathy. 
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GENERAL INTRODUCTION 
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases 
(IBD) of unknown aetiology. It is widely believed that IBD results from either a 
normal immune response to a particular infectious agent, or an abnormal 
immune response to enteric flora. 
One hypothesis is that a persistent measles virus infection, originating from 
early or atypical exposure to measles virus, may be involved with the 
development of IBD - particularly Crohn's disease. Several epidemiological 
studies by our group and others have shown early measles infection and measles 
vaccination to be risk factors for the development of IBD. Furthermore, several 
electron microscopy and immunohistochemical studies by our group and others 
have provided evidence of measles virus in areas of granulomatous 
inflammation within IBD tissue. However, such evidence remains controversial 
and ongoing research by our group aims at resolving this matter. 
In order to confirm results from electron microscopy and immunohistochemical 
studies, it is essential to detect measles virus RNA in IBD tissue using highly 
sensitive molecular biology techniques, such as nucleic acid amplification. 
Given that previous studies have failed to detect measles RNA in IBD clinical 
samples, the aims of the studies described in this thesis were to develop a highly 
sensitive method capable of detecting low copy-number measles RNA in clinical 
samples. This could then be applied to the detection of measles RNA in clinical 
samples from IBD patients in order to provide evidence for or against the 
involvement of measles virus in the disease aetiology. 
Research at the Royal Free Hospital has focused on early exposure to measles 
virus as a factor in the aetiology of IBD, particularly Crohn's disease and 
therefore, the molecular studies described in this thesis concentrate primarily on 
measles virus and Crohn's disease. 
In addition, a group of paediatric patients, presenting with ileo-colonic lymphoid 
hyperplasia, chronic colitis and developmental disorder (autistic enteropathy) - 
temporally associated with measles, mumps and rubella (MMR) vaccination - 
Js )1 aýe' been recently described in a study at the Royal Free Hospital. These 
patients may represent cases of early-onset IBD and therefore experiments 
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described in this thesis, concerning the detection of measles RNA (in addition to 
mumps and rubella RNA) in clinical samples from these patients, may provide 
further evidence for or against the involvement of measles virus in the disease 
aetiology. 
The first chapter of this thesis gives a background to IBD, discussing the 
evidence for an infectious aetiology and the role of granulomatous vasculitis in 
the pathogenesis of Crohn's disease. The second chapter summarises the 
evidence for and against the involvement of measles virus in the aetiology of 
IBD and autistic enteropathy. The third chapter describes measles virus, diseases 
associated with measles virus, and methods used to detect measles virus RNA. 
Following the materials and methods chapter (Chapter 4) and the results 
chapters (Chapters 5-10), the implications of the findings of this study, with 
regard to measles virus, IBD, and autistic enteropathy, are discussed in detail 
(Chapter 11). 
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Chapter 1 
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Chapter 1: INFLAMMATORY BOWEL DISEASE 
Evidence that ulcerative colitis was first recognised as a disease entity in the mid 
19th century exists in several case reports, although a definitive clinical 
description of the disease was not given until 1921 in a Guy's Hospital report by 
Sir Arthur Hurst. 
Inflammation of the terminal ileum was described by the Scottish surgeon, 
Kennedy Dalziel in 1913, but it was Burrill Crohn et al. who presented a report 
on the clinical and pathological features of regional ileitis to the American 
Medical Association in 1932 (Crohn et al. 1932). Although Ginsberg and 
Oppenheimer contributed equally to the work, Crohn appeared as first author on 
the paper published by the Journal of the American Medical Association by 
virtue of the journals' alphabetical listing of authors and thus "terminal ileitis" or 
"regional ileitis" subsequently became known as "Crohn's disease". 
IBD usually occurs in early adulthood and is characterised clinically by 
abdominal pain, weight loss and diarrhoea (containing blood and mucus), and 
often requires long-term anti-inflammatory therapy (steroid and/or non-steroid 
drugs; reviewed by Jewell, 1990; Rhodes and Mayberry, 1990). Wide variations 
occur between patients with IBD in terms of the site and clinical course of 
disease. It is thought by some that ulcerative colitis and Crohn's disease may 
represent different ends of an IBD spectrum (with cases of indeterminate colitis 
possessing features of both diseases), although there are important differences 
between classical Crohn's disease and ulcerative colitis in terms of their 
epidemiology, pathology and clinical course. 
Periods of remission and relapse are a feature of both diseases, and surgery is 
often required to remove sections of affected gut if the disease becomes 
unresponsive to steroid or other immunosuppressive therapy. Although surgical 
intervention may prevent further disease in patients with ulcerative colitis, it 
often does not prevent future disease relapse in patients with Crohn's disease. 
Moreover, surgical intervention often leads to absorption and nutritional 
problems associated with short bowel syndrome. 
In recent years the incidence of IBD has increased dramatically, particularly in 
childhood, without many significant improvements in disease treatment, posing 
19 
a major health problem to western societies. 
Regarding the aetiology of IBD, much early work focused on a psychosomatic 
origin of the disease, and the possibility that IBD was a stress-related disorder 
was popular for a long time. More recently, several aetiological factors have 
been proposed, ranging from genetic factors responsible for gut immune 
regulation, to infectious agents such as Mycobacteria paratuberculosis and 
measles virus. However, decades after the first descriptions of IBD, the relative 
merits of many proposed aetiological factors remain widely debated and the 
huge volume of research into IBD has not led to a foreseeable discovery of a 
cause or cure. 
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I. I. THE EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE 
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I. I. I. Prevalence and Incidence 
Incidence. Several studies have shown that the incidence of IBD is increasing in 
developed countries (reviewed by Langman (1990) and Sandler (1994)). In 
general, early reports showed a higher incidence of ulcerative colitis compared 
to Crohn's disease whereas more recent reports have shown a higher incidence of 
Crohn's disease. 
Figure 1.1: The increasing incidence of Crohn's disease. 
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se in incidence of Crohn's disease (a) compared to the relatively steady 
incidence of ulcerative colitis (b) reported in several studies. The y axis 
represents incidence per 100,000 population. Data was taken from a review by 
an (1990) with permission from Churchill Livinstone Press. 
It is possible that these trends may, in part, be artifactual. However, the large 
number of studies performed on different populations support the phenomenon 
of increasing incidence an prevalence of IBD, and it is therefore unlikely that 
artifactual data alone are responsible for this trend. 
Mayberry et al. (1979) reported a dramatic increase in the incidence of Crohn's 
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disease in a population in Cardiff, UK, from 0.18 to 4.8 cases per 100,000 per 
annum between 1934 and 1977 (see Figure 1.1. a. ). Of particular interest in this 
study, the authors demonstrated that neither disease mis-diagnosis, nor changes 
in diagnostic practice, alone were likely to be responsible for this rise in 
incidence by following up reported cases and showing that disease 
reclassification did not alter the original findings. 
Prevalence. In general, recent studies have shown much higher prevalence rates 
for IBD than early studies (Sandler 1994). For instance, Loftus et al. (1997), 
observed high prevalence rates of Crohn's disease and ulcerative colitis (104 and 
116 cases per 100,000 respectively) in a US population, and an epidemiological 
study of Crohn's disease in Finland between 1986 and 1991 reported a three-fold 
increase in disease prevalence from approximately 20 to 60 cases per 100,000 
population (Nuutinen et al. 1997). 
In England, early studies have shown prevalences of 65 per 100,000 for Crohn's 
disease in a population-based study of the Nottingham area in 1973 (Keighley et 
al. 1976), and approximately 70 per 100,000 for ulcerative colitis in a 
population-based study of the Oxford area in 1960 (Evans and Acheson, 1965). 
A study from the Royal Free Hospital, based on members of the 1970 British 
Cohort Study (BCS70) revealed high prevalence rates for IBD (Montgomery et 
al. 1998). Almost 10,000 individuals born in the UK during a week in 1970 
replied to a questionnaire concerning IBD diagnosis. The overall prevalence of 
IBD in this population was found to be 520 per 100,000, with the prevalences of 
306 and 214 per 100,000 for Crohn's disease and ulcerative colitis, respectively. 
These prevalence rates represent a dramatic increase compared to those 
previously found in English populations, and since the members of the BCS70 
cohort were only 26 years of age at the time of study, it is likely that prevalence 
rate will further increase as the cohort ages. The increasing prevalence of 
Crohn's disease is represented in Figure 1.2. 
The dramatic increase in the incidence of IBD, particularly Crohn's disease, 
argues against a strong genetic component in the aetiology of this disease since 
such a genetic factor could not become so widespread in a period of decades. 
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Figure 1.2: The increasing prevalence of Crohn's disease. 
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The increasing prevalence of Crohn's disease over time with boxes representing 
the results of published prevalence studies. MRC represents the prevalence rate 
in the study by Thompson et al. (1995a) and BCS70 represents the prevalence 
rate in the study by Montgomery et al. (1998). Data supplied by Dr. A 
IBD in Childhood. The incidence of childhood IBD, in particular Crohn's, has 
increased since the mid 1970's (Barton et al. 1993; Cosgrove et al. 1996), again 
indicating the importance of environmental risk factors. Candidate 
environmental factors include the measles vaccination program which began in 
1969 and evidence for this will be discussed later. 
In 1996 Cosgrove et al. reported a 2.5-fold increase in the incidence of Crohn's 
disease in the UK during an 11 year period, contrasting with a constant 
incidence rate for ulcerative colitis. The corresponding IBD prevalence rate at 
the end of the study period was 16.6 cases per 100,000 with Crohn's disease 
accounting for 83% of these cases, emphasising the emergence of' Crohn's 
disease in childhood . 
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1.1.2. Age 
The peak age of onset of IBD has been shown to be between approximately 15 
and 25 years (Sandler et al. 1994) although the disease can develop at any age. 
This delayed onset of disease is unlikely to be solely due to genetic factors and 
three possible mechanisms for this delay are outlined below: 
i) A genetic susceptibility to IBD may require an environmental trigger later in 
life for the development of disease. 
ii) Exposure to an environmental agent early in life may require a second 
exposure for disease development. For instance a persistent microbial infection 
early in life may require an acute or sub-clinical infection with the same or 
similar agent later in life to induce a chronic inflammatory response to the 
persistent infection. 
iii) Exposure to an environmental agent early in life may induce a dysregulation 
of the host immune system which only manifests itself following an infection of, 
or physical damage to, the intestine later in life. 
Several studies have demonstrated a bimodal age distribution of IBD incidence, 
with a second peak in elderly age groups and it has been suggested that this 
second peak could be due to a persistent environmental agent which is activated 
in later life (Sandler, 1994). Alternatively, increased susceptibility to vascular 
disease with age may account for this second peak if chronic granulomatous 
vasculitis plays a role in the early pathogenesis of Crohn's disease, as has been 
suggested (Wakefield et al. 1991 a). 
1.1.3. Sex and Social Class 
Several studies have shown that females may be more at risk of developing 
Crohn's disease, and males more at risk of developing ulcerative colitis and an 
increased incidence of IBD in higher socio-economic groups has also been 
reported (reviewed by Langman, 1990). However, a more recent study from our 
group found no association between sex or socio-economic class and the 
prevalence of IBD (Montgomery et al. 1998), indicating that these factors have 
become less important risks for development of 11313 over the past five decades, 
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and that the incidence of IBD is increasing throughout society. Therefore, any 
genetic components involved with the development of IBD via sex and social 
class have become overshadowed by the dramatic increase in the incidence of 
IBD in both sexes and all social classes. 
One explanation for this is that there may previously have been differences 
between sexes and social classes, in terms of susceptibility to an infectious agent 
involved with the aetiology of IBD. As living standards improved, it may be 
assumed that exposure to such an agent was reduced leading to a reduction IBD 
incidence. However, if vaccination for such an agent is also involved with 
disease aetiology, then universal vaccination may lead to an increase in IBD 
incidence in all areas of society as the epidemiological data suggests. 
1.1.4. Distribution 
IBD is predominantly a disease of developed societies and has generally been 
reported to be more common in urban versus rural areas (Kyle, 1971a; Ekbom et 
al. 1991 a). This may be due to a lower level of domestic hygiene in urban areas 
due to a greater population density, leading in urban areas to an altered pattern 
of exposure of an infectious agents. For instance, an infectious agent which may 
be involved with the aetiology of IBD may spread rapidly through an urban 
community leading to the infection of many individuals early in life -a factor 
which may be important in IBD aetiology. In rural communities however, such 
an infection may not spread as rapidly and therefore individuals may become 
infected later in life. 
This mechanism has been supported by Gent et al. (1994) who described an 
association between childhood domestic hygiene and the development of IBD. 
1.1.5. Perinatal risk factors 
Several studies have shown events early in childhood to be important for the 
later development of IBD. Ekbom et al. (1990), studying a Swedish population, 
showed that patients with IBD, or their mothers, were more likely to have had a 
recorded health event during or after their pregnancy compared to controls (odds 
ratio = 4.4). Another study by the same research group (Ekbom et al. 1991b) 
found evidence for clustering of IBD in terms of birth place and time, and 
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seasonal peaks in the incidence of ulcerative colitis (but not Crohn's disease). 
These results imply that exposure to an environmental agent(s) during or after 
pregnancy may be involved with the development of IBD. Other studies have 
confirmed that perinatal factors are important in the development of IBD (Gent 
et al. 1994; Thompson et al. 1995a; Montgomery et al. 1997), further arguing 
against a strong genetic component in this disease. 
1.1.6. Childhood Factors 
Domestic Hygiene. In a 1994 UK study, Gent et al. (1994) demonstrated a 
correlation between childhood domestic hygiene and the later development of 
Crohn's disease. Children whose first house contained a hot water tap (used in 
this study as a marker for domestic hygiene) were found to be at a greater risk of 
developing Crohn's disease than those whose first house did not. The authors 
argued that improved domestic hygiene could lead to a decreased exposure to 
certain infectious agents early in life. The authors also suggested that delayed 
exposure to enteric infections could trigger an abnormal immune response, 
leading to chronic inflammation. This study found no association between 
childhood domestic hygiene and the development of ulcerative colitis, indicating 
that different aetiologies may be responsible for the two diseases, or that 
different patterns of exposure to an infectious agent may lead to the 
development of different IBD phenotypes. 
There are interesting parallels with regard to age of exposure to infectious agents 
and the development of IBD. Delayed exposure to Epstein-Barr virus (EBV) has 
been shown to be a risk factor for the development of Hodgkin's disease, a 
malignant lymphoma. In 1981, Gutensohn and Cole identified a number of risk 
factors for the development of Hodgkin's disease. It was shown that risk 
increased with age of exposure to infectious agents since patients with the 
disease generally had less contact with children of the same age group than 
controls. From this data, the authors suggested that delayed exposure to EBV 
may be responsible for the associated cases of Hodgkin's disease. 
Another example of delayed exposure to a virus leading to complications later in 
life is that of polio virus. Poliomyelitis, a complication following acute infection 
occurs in approximately 1% of infected individuals and it has been shown that 
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the severity of this complication increases with age of exposure with severe 
paralysis occurring in some individuals (Gutensohn and Cole, 1977). 
Interestingly, several studies have reported the occurrence of poliomyelitis 
following vaccination (Smith and Wherry, 1978; Strebel et al. 1994), providing 
a possible parallel for measles vaccination and the development of Crohn's 
disease. There are striking similarities between Gutersohn and Cole's studies on 
Hodgkin's disease and poliomyelitis, and age of virus exposure, and that of Gent 
et al. which supports the hypothesis that delayed exposure to an infectious agent 
may be involved with the aetiology of Crohn's disease. 
Infant mortality. In study at the Royal Free Hospital, Montgomery e1 al. (1997) 
showed an inverse relationship between infant mortality and incidence of' 1131) 
throughout Europe, with Portugal having the highest rate of infant mortality and 
the lowest incidence of IBD, and countries such as The Netherlands having the 
lowest rate of infant mortality and the highest incidence of IBD. These results 
have been supported by a study of the incidence of IBD in Iceland from 1915 to 
1984, showing a relative risk of 17 for the development of Crohn's disease at the 
time of lowest infant mortality compared with the time for highest infant 
mortality (Montgomery, S. M., personal communication). 
Figure 1.3: Infant mortality and Crohn's disease. 
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27 
CU 9U bU tlU IUU 
However, this relationship was not as strong in ulcerative colitis. The authors 
argued that in the case of Crohn's disease, an environmental aetiological agent 
may be present which is fatal during times of high infant mortality (Montgomery 
et al. 1997). Therefore, as living standards improve, more infants survive early 
infection to develop persistent infection associated with Crohn's disease. This 
may explain the findings of Gent et al. in as much as there is an inverse 
relationship between levels of childhood domestic hygiene and infant mortality. 
Improvements in living conditions may have altered the pattern of exposure to 
such an infectious agent leading to an increased frequency of persistence, and 
the development of IBD. Alternatively, an environmental actiological agent 
which has become more prominent as living conditions have improved could 
also account for this phenomenon. 
1.1.7. Adult factors 
Smoking and Crohn's disease. Studies have shown relative risks I'Or tile 
development of Crohn's disease among current smokers to range between 1.2 
and 3.9, and several studies have found smoking to have a potentiating effect on 
Crohn's disease (reviewed by Sandler 1994), suggesting that smoking is 
involved with both the development and potentiation of Crohn's disease. 
Smoking has been shown to induce endothelial cell injury, leading to the 
formation of microthrombi, and enhanced platelet aggregation (Pittilo et al. 
1990; Krupski 1991). 
It has been suggested that granulomatous vasculitis plays an early role in the 
pathogenesis of Crohn's disease, leading to ischaemia and chronic inflammation 
(Wakefield et al. 1991a). The effect of cigarette smoking on the vascular 
endothelium and the increased risk of smokers developing Crohn's disease 
supports this hypothesis. 
Smoking and ulcerative colitis. Interestingly, data from several studies have 
shown smoking to be protective for the development of' ulcerative colitis. For 
example, Lindberg et al. (1988) reported a relative risk of' 0.7 fier the 
development of ulcerative colitis among smokers compared to non-smokers, and 
a relative risk of 12.2 for the development of ulcerative colitis in Iormer smokers 
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compared to smokers has been shown (Thornton et al. 1985), confirming the 
protective effect of smoking in ulcerative colitis. In addition, several studies 
have shown that smoking protects against disease relapse in ulcerative colitis in 
a dose-dependent manner (Franceschi et al. 1987; Lindberg et al. 1988) 
indicating a protective role in disease pathogenesis. 
Colonic mucus composition and production in patients with ulcerative colitis 
has been shown to be abnormal (Podolsky and Isselbacher, 1983; Cope et al. 
1986) and may be involved with disease/pathogenesis. As proposed by Rhodes 
(1989), abnormal colonic mucus secretion could expose the colonic epithelium 
to invasive bacteria, eliciting an inflammatory immune response. Nicotine has 
been shown to increase colonic mucus production (Finnie et al. 1996) and it has 
been suggested that the effects of cigarette smoking may compensate for 
abnormal mucus secretion in individuals susceptible to ulcerative colitis leading 
to disease remission in these patients (Thomas et al. 1996). Therefore, removal 
of this compensatory mucus secretion may then lead to the development of 
ulcerative colitis or disease relapse. 
Such studies on smoking and IBD indicate that different aetiological and 
pathological mechanisms may be involved with the development of these 
diseases. Alternatively, it is possible that a chemical in tobacco such as nicotine 
may modulate the immune response in different ways, leading to an up- 
regulation of the host inflammatory response in Crohn's disease and a down- 
regulation in ulcerative colitis. 
Oral contraceptives and IBD. Women taking oestrogen-containing oral 
contraceptives have a higher risk of developing IBD (Boyko et al. 1994). Oral 
contraceptives have been shown to have prothrombotic properties (Beller and 
Ebert, 1985) and it has been proposed that these thrombotic effects of the pill 
lead to the occlusion of intestinal submucosal blood vessels in susceptible 
individuals which, in turn leads to the pathological events of Crohn's disease 
(Wakefield et al. 199lb). 
1.1.8. Conclusions 
Recent studies have shown a dramatic increase over time in the prevalence of 
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IBD, particularly Crohn's disease, compared to previous studies, indicating that 
environmental factors are important in disease development. A number of 
childhood factors, among them childhood domestic hygiene and infant 
mortality, have been shown to influence the incidence of IBD. In addition, 
studies by Ekbom and his co-workers have indicated that childhood infections 
are important in the development of IBD. 
Significant differences between Crohn's disease and ulcerative colitis, in terms 
of risk factors, suggest that either different aetiologies are responsible for the 
development these diseases, or that a changing pattern of exposure to a common 
aetiological agent determines the phenotype of disease. 
Taken together, epidemiological studies argue against a strong genetic 
component in the aetiology of IBD and suggest that infectious agents, and 
particularly altered exposure to such agents may be important in disease 
development. 
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1.2. THE IMMUNOGENETICS OF INFLAMMATORY BOWEL 
DISEASE 
Epidemiological studies have shown a higher incidence of IBD among 
Caucasians, especially Jewish populations, than other racial groups and a high 
incidence of IBD among Jews in different geographical areas has been shown 
(Reviewed by Yang and Rotter 1994). In the light of such evidence, there is little 
doubt that genetic factors are involved with susceptibility to IBD. However, the 
high prevalence of IBD in Jewish populations may be confounded by factors 
such as socio-economic status and infant mortality, and the size of the genetic 
contribution is debatable. The mode of inheritance of such a genetic factor is 
unlikely to be simply Mendelian, and the observed heterogeneity of IBD in 
terms of clinical course and severity indicates that a complex combination of 
genetic elements in addition to environmental factors are involved in both 
disease susceptibility and clinical course. 
1.2.1. Familial studies 
Several studies have shown an increased risk of the development of IBD in the 
relatives of individuals with IBD (Mayberry et al. 1980; Fielding, 1986). Such 
increased risks may represent a common exposure to an environmental agent or 
transmission of agents from mother to child, rather that a strong genetic 
component to the disease. 
Several studies have reported families with multiple individuals affected with 
IBD (Kirsner, 1973; van Kruiningen et al. 1993). van Kruiningen et al. (1993) 
reported two French families with multiple affected individuals with Crohn's 
disease. Development of disease appeared to have occurred in 7-13 month time 
periods and the authors concluded that an infectious micro-organism, rather than 
inheritance of susceptibility genes, was the most likely cause for these particular 
cases. 
No increase in the incidence of IBD has been observed in spouses of individuals 
with IBD compared to the general population (Mayberry et al. 1980; Weterman 
and Pena, 1984), arguing against a rapid infectious aetiology for IBD, and 
suggesting the involvement of genetic factors and/or early environmental factors 
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in disease development. 
1.2.2. Twin studies 
Twin studies represent a valuable source of date for determining the contribution 
of genetic elements to the development of IBD. Differences between 
monozygotic and dizygotic twins pairs, in terms of whether either one or both 
twin is affected, enables the extent of the genetic contribution of IBD to be 
determined, since twins have presumably been exposed to very similar 
environmental factors. Differences in disease concordance between affected twin 
pairs enables the differences in inheritability between Crohn's disease and 
ulcerative colitis to be analysed. 
Tysk et al. (1988), in a study of 80 affected twin pairs in the Swedish twin 
registry reported a higher rate of disease concordance among monozygotic twins 
(one of 16 twins for ulcerative colitis, and 8 of 18 twins for Crohn's disease) 
than dizygotic twins, indicating that genetic factors are important in the 
development of IBD, particularly in Crohn's disease and possibly accounting for 
the observed familial aggregation of IBD. However, in a similar study at the 
Royal Free Hospital, Thompson et al. (1996) reported IBD concordance in 11 of 
63 identical twin pairs and 4 of 81 non-identical twin pairs. Although 
significant, the small difference in disease concordance between identical and 
non-identical twins in this study indicates that environmental factors are more 
important than genetic factors for the development of IBD. 
Results from such twin studies have shown the coefficient of inheritability of 
Crohn's disease to be in the same range as the inheritability of diseases which 
are thought to be partly genetically determined such as diabetes and 
schizophrenia. 
1.2.3. Genetic markers 
Linkage analysis. Linkage analysis studies have shown several genetic loci to be 
involved with the inheritance of IBD and its clinical course (Jewell, 1997). 
Many of these studies have focused on genes involved with the regulation of the 
immune system (such as human leukocyte antigen (HLA) complex genes) on the 
assumption that immune dysregulation is involved with both the susceptibility 
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and phenotypic expression of IBD. 
However, the weakness of the association between these genes and disease 
susceptibility suggest that other non-HLA genes are also involved with disease 
susceptibility. It is possible that combinations of several genetic loci, involved 
with factors such as gut barrier function, immune regulation and repair of 
intestinal tissue following inflammation, may be involved with the development 
of IBD. In this manner, different combinations of many genetic susceptibility 
loci may lead to the development of a number of phenotypically similar 
inflammatory bowel diseases in certain individuals. Such a mechanism has 
recently been reviewed by Jewell (1997). These diseases are then clinically 
classified as ulcerative colitis, indeterminate colitis or Crohn's disease. The 
classification and characterisation of subsets of inflammatory bowel diseases 
(e. g. colonic Crohn's disease) may aid the discovery of genes conferring a 
significant susceptibility to the development of IBD. 
Antineutrophil cZoplasmic antibodies (ANCAs). ANCAs have been 
demonstrated to be involved with diseases associated with vasculitis, for 
instance in Wegener's granulomatosis. Saxon et al. (1990) demonstrated the 
presence of ANCAs in the sera of 84% of patients with ulcerative colitis and a 
subsequent study (Hertervig et al. 1995) demonstrated a higher prevalence of 
perinuclear ANCA (pANCA) in the sera of patients with colonic Crohn's 
disease (36%) than in those without colonic disease (18%). The target of these 
antibodies has not yet been determined and their significance in ulcerative colitis 
and colonic Crohn's disease remains unclear although the association with 
vascular disease is intriguing given the involvement of vasculitis in Crohn's 
disease (Wakefield et al. 1991 a). 
1.2.4. Bacteria 
Recent work has shown that monocytes in the lamina propria of patients with 
IBD, but not in the lamina propria of control patients, express the bacterial 
lipopolysacharide receptor CD14 (Grimm et al. 1995). The responsiveness of 
these cells to luminal bacterial antigens may be involved with the perpetuation 
of chronic intestinal inflammation. 
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It has been observed that in animal models susceptible to colitis (e. g. the 
interleukin (IL)-10 knockout mice), growth in germ-free conditions does not 
lead to the development of chronic colitis (Kuhn et al. 1993), indicating that 
bacterial luminal antigens are involved with the propagation of a chronic 
inflammatory response in these models. Jung et al. (1995) have shown that 
epithelial cells produce a range of proinflammatory cytokines in response to 
bacterial invasion in vitro, leading to the hypothesis that increased permeability 
of the gut may lead to invasion of epithelial cells by luminal bacteria and thus 
production of pro-inflammatory cytokines, giving rise to chronic inflammation. 
Such an increase in gut permeability may be genetically determined or may arise 
from previous damage caused by an infectious agent. 
Hermiston and Gordon (1995) elegantly demonstrated the importance of gut 
barrier function in IBD using a dominant negative N-cadherin mouse model. N- 
cadherin is involved with cell adhesion and areas of the gut which did not 
express N-cadherin were found to be susceptible to inflammation due to the 
influx of luminal bacteria. 
1.2.5. Immune dysfunction 
IBD is an immune-mediated condition. Dysfunction of the gut immune system 
is thought to play an important role in IBD, both in terms of disease 
susceptibility and propagation of chronic inflammation and evidence for this has 
come from animal studies. Several rodent models - either transgenic or knockout 
for particular cytokine genes - develop colitis (reviewed by Elson et al., 1995). 
In addition to cytokines themselves, mutations in, or altered expression of, 
cytokine receptors and proteins involved with cytokine intracellular signalling 
pathways may also lead to chronic inflammation. 
A host of factors, including cytokines, chemokines, T and B cell costimulatory 
molecules, and molecules involved with T cell activation-induced apoptosis are 
involved with immune regulation and disruption of any one, or combinations of 
these factors may be important in the development of chronic inflammation. 
Crohn's disease is immunologically characterised by cell mediated response to 
an unidentified antigen or set of antigens. During active inflammation, T-cells 
are recruited from peripheral blood via the production of endothelial cell 
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adhesion molecules. The different range of cytokines produced by peripheral 
blood T-cells compared to lamina propria T-cells may play a role in the 
propagation of chronic inflammation (Targan et al. 1995). 
It has been shown that stimulation of peripheral T cells, but not lamina propria 
T-cells induces the production of the cytokines IL-2, IL-4, interferon gamma 
(IFN-y) and tumour necrosis factor alpha (TNF-a) (Targan et al. 1995). Such 
cytokines are thought to play an important role in disturbing the immunological 
homeostasis of the gut in IBD. 
In view of these findings, it is reasonable to assume that intestinal microvascular 
endothelial cells play a key role in the generation and propagation of chronic 
inflammation in IBD. 
Thl/Th2 cvtokine profiles. Disruption to the homeostasis of the gut immune 
system is thought to play a major role in both the aetiology and pathogenesis of 
IBD. Studies on cytokine profiles in IBD are complicated by the fact that most 
have looked at end-stage disease tissue samples (e. g. Niessner and Volk, 1995) 
which may contain abnormal levels of cytokines produced as a consequence of 
chronic inflammation rather than being involved with the development of colitis. 
The normal intestine is in a state of chronic low-level inflammation due to the 
array of bacterial, food and viral antigens constantly encountered in the gut 
lumen and the host response to these antigens is thought to involve a balance 
between Thl and Th2 cytokines (Mosmann and Coffman, 1989). 
Thl cytokines (including IL-2, TNF-a and IFN-y) are predominantly pro- 
inflammatory, inducing a cell-mediated response, i. e. macrophage activation and 
cell-mediated cytotoxicity, while Th2 cytokines (including IL-4, IL-5, IL-6 and 
IL-10) are generally protective, leading to macrophage deactivation and 
stimulation of a humoral response (Neurath and Meyer zum Buschenfelde, 
1996). 
Powrie et al. (1994) have studied the relationship between Thl cells, Th2 cells 
and chronic colitis by reconstituting severe combined immunodeficient (SCID) 
mice with Thl and Th2 cell populations (Powrie et al. 1994). This work showed 
that, in mice, Thl cells are responsible for the development of a colitis which 
can be prevented by the presence of Th2 cells. Subsequent work identified 
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transforming growth factor ß as the cytokine secreted by Th2 cells suppressing 
the Thl cell-mediated inflammatory response in this model (Powrie et al. 
1996). Such work on animal models of colitis has highlighted the importance of 
Thl and Th2 responses in the development of chronic colitis. 
IL-12, a cytokine produced by dendritic cells, is thought to mediate 
differentiation of ThO cells to Thl cells (Palmer and van Seventer, 1997) and 
may therefore be involved with the establishment of chronic inflammation. 
Bacterial infection of dendritic cells has been shown to induce IL-12 (Heufler et 
al. 1996) production and this may lead to the propagation of chronic 
inflammation following bacterial invasion of lymphoid tissue. 
1.2.6. Oligoclonal T cell response 
In an elegant approach to determine the nature of antigens responsible of the 
inflammatory response in IBD, Chott et al. (1996) analysed the T cell receptor 
(TCR) gene region of lamina propria CD4+ and CD8+ cells, using PCR. Lamina 
propria T cells from control tissue showed a wide range of amplification 
products indicating that no amplification of a specific T cell clone had occurred. 
However, cells from ulcerative colitis patients produced a smaller range of PCR 
products, indicating the expansion of certain T cell clones. The TCR binding site 
peptide sequences of these expanded T cell clones were found to be similar both 
within and among patients, indicating an oligoclonal response to a common 
antigen. Similar results using T cells isolated from patients with Crohn's disease 
are currently underway. These experiments raise the possibility that a single 
antigen, or a group of closely related antigens, are the focus of a chronic 
inflammatory response in patients with IBD. 
1.2.7. Conclusions 
Genetic studies have shown that polygenic inheritance is involved in IBD 
susceptibility and clinical course. Such genes have not as yet been characterised 
but are likely to be involved with regulation of the intestinal immune system and 
gut barrier function. However the weak associations reported, together with the 
data from twin studies, indicate that environmental factors are more important in 
determining IBD susceptibility. 
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Immunological evidence points to an immune dysregulation in IBD in 
conjunction with a oligoclonal T cell response, possibly to a single antigen, 
leading to the propagation of chronic intestinal inflammation. The imbalance 
between Thl- and Th2-type T cells may be due to infection of cells involved 
with ThO cell differentiation, for instance dendritic cells, and may disrupt 
intestinal homeostasis, leading to chronic intestinal inflammation. 
It is likely that an infectious agent (or group of agents) is involved with the 
initial damage to the gut barrier required to generate an inflammatory response. 
Susceptibility to infection, failure to repair damaged intestinal tissue, and failure 
to downregulate the inflammatory response in some individuals may lead to the 
establishment of chronic inflammation. 
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1.3. GRANULOMATOUS VASCULITIS AND CROHN'S DISEASE 
1.3.1. Pathology of IBD 
Crohn's disease. Crohn's disease can affect any part of the gastrointestinal tract 
from the mouth to the anus (although the terminal ileum is more commonly 
affected) and involves patchy inflammation of intestine (skip lesions; 
Whitehead, 1975). Crohn's disease, is characterised histologically by transmural 
inflammation, often involving granulomas, principally in a submucosal or 
serosal location (Jewell, 1990). Fissuring and fibrosis lead to complications such 
as fistula and stricture formation, often requiring surgical intervention. 
Ulcerative colitis. Ulcerative colitis is a disease of the large bowel, involving the 
rectum and to a variable extent, the colon in a contiguous fashion. Ulcerative 
colitis, is characterised histologically by crypt abscesses, goblet cell depletion, 
and distorted microvillus architecture (Rhodes and Mayberry, 1990). 
Complications include toxic colonic dilation with perforation and a risk of 
colorectal neoplasia. There is some evidence to suggest that ulcerative colitis 
may have a vascular origin, as the extent of colitis has been shown to be 
dependent upon the territory of the mesenteric artery (Hamilton et al. 1995). 
In both diseases, inflammatory cell infiltrates consist of lymphocytes, 
macrophages and plasma cells. 
1.3.2. Granulomatous vasculitis and Crohn's disease 
A study by Wakefield et al. (1989) set out to investigate the vascular lesion in 
Crohn's disease by examining perfusion-fixed resection tissue from 15 patients. 
The authors showed evidence for a sequence of events beginning with vascular 
injury and leading to fibrin deposition, vascular occlusion and 
neovascularisation. These data implied that vascular injury may be involved 
with the early pathogenesis of Crohn's disease. 
Subsequent work by the same group used perfusion-fixed resection tissue to 
show that submucosal granulomas may be involved with vascular injury in the 
majority of tissues from patients with Crohn's disease (Wakefield et al. 1991a). 
A total of 485 granulomas were analysed in 24 perfusion-fixed resection 
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specimens of patients with Crohn's disease. A large proportion of these 
granulomas were found in the submucosa and the majority were identified as 
being involved with vascular injury. A subsequent study by Sankey et ul. (1993) 
demonstrated that damage to the mucosal microvasculature occurred prior to 
infiltration of inflammatory cells, supporting the idea that vasculitis is an early 
feature of chronic intestinal ulceration rather than a secondary phenomenon. 
Figure 1.4: Granulomatous vasculitis in Crohn's disease. 
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Electron micrograph of a perfusion-fixed sub mucosal blood vessel from a 
patient with Crohn's disease containing a granuloma. Original electron 
micrograph supplied by Dr A. Wakefield (personal communication). 
Contrary to these data, Matson et al. (1995) identified only a minority of 
granulomas associated with blood vessels in patients with Crohn's disease. 
However, the tissue analysed in this study was not pertüsion-fixed, and theretiorc 
the presence of granulomas occluding submucosal blood vessels may not have 
been recognised. Moreover, only a small number of local blood vessel-occluding 
granulomas may be required to cause widespread ischaemia, inf-hurction and 
chronic inflammation. 
The involvement of granulomatous vasculitis in Crohn's disease has been 
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supported by case reports (Motte et al. 1992; Weiss et al. 1995) and by 
experiments using an animal model of intestinal vasculitis to show that ferret 
mesenteric arteries injected with albumin microspheres develop submucosal 
vasculitis followed by discontinuous transmural inflammation (Osborne et al. 
1993; Hudson et al. 1994). 
Homeostatic changes. Evidence of active coagulation in blood vessels of 
Crohn's disease lesions has supported a role for granulomatous vasculitis in the 
early pathogenesis of Crohn's disease. A study at the Royal Free Hospital 
showed elevated concentrations of prothrombin fragments in patients with 
Crohn's disease at times of both active and inactive disease (Hudson et al. 1992), 
implicating thrombosis in the early stages of disease pathogenesis. Further work 
showed higher levels of markers for active coagulation (factor VII, lipoprotein a, 
fibrinogen) in the sera of patients with Crohn's disease compared with controls 
(Hudson et al. 1996). Additionally, low levels of factor XIIIa, the active subunit 
of factor VIII, in the sera of patients with active disease combined with strong 
immunostaining of mucosal microthrombi for factor XIIIa in the same patients, 
support the view that active coagulation is occurring in diseased tissue. Several 
independent studies by other research groups have also shown evidence for 
activation of coagulation in Crohn's disease (Chamouard et al. 1995; Smith et al. 
1996; Chiarantini et al. 1996) and it has been shown that individuals with blood 
clotting abnormalities, such as haemophiliacs, are at a reduced risk of 
developing Crohn's disease (Thompson et al. 1995c). 
Furthermore, epidemiological data shows that smoking and the oral 
contraceptive are risk factors for the development of Crohn's disease. The 
prothrombotic nature of these substances may exacerbate microvascular 
thrombosis in Crohn's disease 
1.3.3. Conclusions 
Crohn's disease is characterised histologically by granulomatous vasculitis and 
patients with Crohn's disease have increased plasma levels of prothrombotic risk 
factors and evidence of ongoing coagulation (Wakefield, 1995). As coagulation 
(leading to vasculitis and ischaemia) may play such an important role in the 
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early pathogenesis of Crohn's disease, it is likely that components of the 
intestinal submucosal microvasculature, for instance antigens expressed on 
microvascular endothelial cells, may lead to the aggregation of lymphocytes, 
leading to ischemia and producing discontinuous inflammation, ulceration and 
fibrosis. This is an attractive hypothesis since a vascular origin of Crohn's 
disease would explain the characteristic skip lesions observed. 
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1.4. BACTERIA AND CROHN'S DISEASE 
There is little doubt that bacteria are involved with the pathogenesis of IBD: the 
possibility that a bacterial agent(s) is involved in the aetiology of IBD (in 
particular Crohn's disease) has received much attention ever since the first 
descriptions of the disease. The clinical benefits following metronidazole 
treatment in patients with Crohn's disease underlines the involvement of bacteria 
in the disease pathogenesis (Blichfeldt et al. 1978) as does the results of a recent 
study concerned with antibiotic therapy and Crohn's disease (Gui et al. 1997). 
1.4.1. Mycobacteria 
In 1913, Dalzeil first recognised the similarities between Crohn's disease and 
Johnne's disease, a chronic granulomatous enterocolitis of cattle known to be 
caused by Mycobacteria paratuberculosis infection (Dalziel, 1913). Although 
no comparable amounts of Mycobacteria have been observed in Crohn's disease 
tissue, much work has been carried out into the possibility that a low copy 
number, persistent Mycobacterial infection may be involved with the aetiology 
of Crohn's disease (reviewed by Sanderson and Hermon-Taylor, 1992). 
Different strains of Mycobacteria are often found in the lumen and tissues of 
healthy individuals but may be pathogenic in immunocompromised hosts 
(Hermon-Taylor et al. 1990). It is possible that individuals with an innate or 
acquired immune dysfunction could be susceptible to a persistent myc/obacterial 
infection, leading to chronic granulomatous inflammation. 
Bacterial culture. In 1984, van Kruiningen's group cultured a Mycobacteria 
(Chiodini et al. 1984a and b) which was later identified as M. paratuberculosis 
(Thayer, Jr. et al. 1984) from two patients with Crohn's disease, providing the 
first evidence for the presence of this organism in Crohn's disease. Subsequent 
work by the same group used infant goats injected with M. paratuberculosis 
isolated from a patient with Crohn's disease (van Kruiningen et al. 1986) to 
show the development of colitis without the microscopic presence of M. 
paratuberculosis. However, the numbers of IBD tissues positive for these 
Mycobacteria in culturing experiments have been too small to be of statistical 
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significance. 
Culturing Mycobacteria from gut tissue requires several months and is prone to 
contamination from luminal bacteria not involved with disease pathogenesis. 
Moreover, the presence of Mycobacteria in ulcerated tissue may be due to an 
opportunistic secondary infection of diseased tissue, and therefore results from 
culturing experiments may be of little significance. 
Serology. A study by Walmsley et al. (1996) analysed the sera of 40 patients 
with Crohn's disease and 61 control patients for anti-M. paratuberculosis IgA 
and IgG titres. No significant difference in antibody titres between Crohn's and 
control sera was observed and no correlation between antibody titre and disease 
activity was observed within the Crohn's disease group; results supported by a 
previous study (Stainsby et al. 1993). A subsequent immunohistochemical study 
of tissue from two French families with a high prevalence of Crohn's disease 
similarly failed to detect any association with M. paratuberculosis (van 
Kruiningen et al. 1993). 
PCR In an experimental model of gastrointestinal ulceration, Anthony et al. 
(1995) identified Mycobacteria within granulomatous of inflamed tissue, 
implicating Mycobacteria in the formation of granulomas. 
The discovery and characterisation of the insertion sequence (IS) 900 by a group 
at St. George's Hospital (Green et al. 1989; Tizard et al. 1992) enabled PCR to 
be used for the detection of M paratuberculosis DNA in IBD tissue. IS900 is a 
1451 bp insertion element, highly specific to M. paratuberculosis and present at 
a copy number of 15-20 in the bacterial genome. Results from PCR experiments 
however, have been contradictory and inconclusive with numbers of M. 
paratuberculosis positive Crohn's disease samples ranging from 65% 
(Sanderson et al. 1992) to 0% (Rowbotham et al. 1995; Dumonceau et al. 1996). 
It remains possible that M. paratuberculosis is present in Crohn's disease tissue 
below the sensitivity limits of PCR and work is underway at St. George's 
Hospital to develop a PCR-based capture assay capable of detecting any M. 
paratuberculosis present in Crohn's disease tissue. 
Taken together, culturing, serology and PCR studies so far suggest that 
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secondary infection by Mycobacteria may play an opportunistic role in the 
pathogenesis of IBD, but is unlikely to be involved with disease aetiology. 
1.4.2. Listeria 
Listeria monocytogenes/ has also been implicated in the aetiology of Crohn's 
disease after its identification in resection tissue (Liu et al. 1995). Seventy five 
percent of Crohn's disease tissues were positive throughout the inflamed mucosa 
for the bacteria using immunohistochemistry compared to 13% of ulcerative 
colitis tissues and none of the control tissues. However, significant numbers of 
tissues also gave positive immunohistochemical staining for Escherichla coil 
(E. coli; 57%) and Streptococcus (44%), indicating that the presence /steria 
may represent an opportunistic secondary invasion of diseased tissue rather than 
involvement in disease aetiology. 
A recent immunohistochemical study has failed to find any association between 
Listeria infection and affected IBD tissue (Walmsley et al. 1997). Furthermore 
no molecular evidence of Listeria monocytogenes/ infection in Crohn's disease 
has been published, limiting the significance of the immunohistochemical 
results. 
1.4.3. Conclusions 
Several studies have provided evidence that an infectious agent(s) plays an 
important role in the aetiology of Crohn's disease. However, studies of 
Mycobacteria, Listeria and virulent E. coil strains in Crohn's disease tissue have 
given variable and contradictory results and it is likely that the presence of these 
-5 organisms represen opportunistic secondary infections. Furthermore, antibiotic 
treatment of patients with IBD does not lead to clear-cut remission, suggesting 
that bacteria are involved with disease pathogenesis rather than aetiology. 
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Chapter 2: CROHN'S DISEASE AND MEASLES VIRUS 
2.1. BACKGROUND 
2.1.1. Viruses and Crohn's disease 
The possibility that Crohn's disease may have a viral aetiology is attractive as 
this would provide a relatively simple explanation for such a complex disease. 
Several groups have investigated such a possibility with varying success. In 
1970, Mitchell and Rees injected homogenates of Crohn's disease tissue into 
footpads of immunode 
f 
cient mice, and reported the development of focal giant 
cell granulomas up to one year after inoculation. However, the formation of 
granulomas could have been due to the transfer into mice footpads of foreign 
material that was antigenically different to the host andýpro-inflammatory 
cytokines . 
This was followed in 1975 by an experiment by Aronson et al. who incubated 
homogenates of Crohn's disease tissue with cell cultures and observed a 
cytopathic effect characteristic of a viral infection. The next year, Gitnick et al. 
(1976) reported the isolation of viral agents from Crohn's disease tissue using a 
rabbit ileum tissue culture system and later putitively identified the virus as a 
picornovirus by electron microscopy (Gitnick and Rosen, 1976). 
Later work, however showed that homogenates of control as well as Crohn's 
disease tissue elicited a cytopathic effect in cell culture (Yoshimura et al. 1984). 
In addition, no virus particles could be identified by electron microscopy and no 
virus could be passaged in cell culture suggesting that non-infectious factors 
were responsible for the cytopathic effect. 
It is possible that in Crohn's disease tissue, very low numbers of viral particles 
are present which prevents their efficient isolation using cell and tissue culture 
methods. In addition, such a virus may be have a defective replication by virtue 
of its persistence in diseased tissue, further inhibiting its efficient isolation and 
detection in cell culture. Such factors may explain the inconsistent reports of 
virus isolation from Crohn's disease tissue. 
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2.1.2. Measles virus 
Epidemiological data supports an infectious aetiology for Crohn's disease 
(Ekbom et al. 1990; Ekbom et al. 1991; Gent et al. 1994). Measles, a 
paramyxovirus, has emerged as a candidate agent involved in the aetiology of 
Crohn's disease (Wakefield et al. 1993). 
During acute measles infection, a range)o'tissues are infected including 
lymphoid tissue of the gut. Infection of lymphoid follicles may play a role in the 
development of viral persistence (Fournier et al. 1986), or in long term 
sequestration of viral antigens that may be responsible for the longevity of 
immunity to measles virus (Griffin et al. 1994). Persistent measles virus has 
been detected in a range of tissues and cell types (Brown et al. 1989) (including 
endothelial cells (Esolen et al. 1995)) many years after acute infection or 
vaccination (Kawashima et al. 1996b), and has been associated with the 
aetiology and pathogenesis of a number of chronic inflammatory diseases (Salmi 
et al. 1972; Norrby et al. 1974; Niedermeyer and Arnold, 1995; Schulz et al. 
1992; Reddy et al. 1995; Reddy et al. 1996). / 
Occasionally, Kopl k spots (a characteristic of acute measles) are observed in 6 
the gut (Carter and ter Meulen, 1990) which resemble, histologically, the 
aphthoid ulcers seen in Crohn's disease, and giant cell formation (a characteristic 
of measles virus infection in vitro and in vivo) is observed in foci of 
granulomatous inflammation in Crohn's disease (Wakefield et al. 1993). 
The striking similarities between measles virus infection of the gut and the 
histopathological features of Crohn's disease were first reported in 1970 by 
Monif and Hood in a case of fatal measles with ileocolitis. The authors observed 
congested capillaries, extensive lymphocyte infiltration and lymphoid 
hyperplasia within infected intestinal tissue and argued that measles virus was 
responsible for the ileocolitis. 
Persistent infection of endothelial cells with cytomegalovirus in the absence of 
cytopathology has been demonstrated (Smiley et al. 1988) and varicella-zoster 
virus infection of endothelial cells leading to vasculitis has been observed 
(Erhard et al. 1995). Measles virus has been shown capable of inducing 
vasculitis through infection of endothelial cells during acute infection (Carter 
and ter Meulen, 1990; Csonka et al. 1990). Expression of measles 
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haemagglutinin protein on the surface of infected cells has been shown to induce 
monocyte adhesion (Soilu-Hanninen et al. 1996) and in vitro studies by Mazure 
et al. (1994) have shown that infected endothelial cells express tissue factor, an 
important pro-coagulant. Persistent measles virus infection of endothelial cells 
has been observed in subacute sclerosing panencephalitis (SSPE; Kirk et al. 
1991; Esolen et al. 1995; Isaacson et al. 1996), a disease caused by persistent 
measles infection. It has been postulated that infection of these cells may be 
responsible for the infiltration of inflammatory cells into infected tissue via 
monocyte adhesion (Cosby and Brankin, 1995). 
Given these findings concerning viruses and endothelial cells, it is not 
unreasonable to postulate that measles virus may persistently infect a small 
number of intestinal microvascular endothelial cells for many years, eventually 
inducing a vasculitis leading to chronic intestinal inflammation. Measles is 
capable of infecting and causing ulceration throughout the gut but more 
specifically has tropism for lymphoid-rich tissue such as the terminal ileum -a 
commonly affected site of Crohn's disease. 
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2.2. EVIDENCE FOR AN ASSOCIATION BETWEEN MEASLES VIRUS 
AND CROHN'S DISEASE 
Various epidemiological and immunological evidence has been accumulated by 
our group and others (some of which remains controversial), for and against an 
association between measles virus and Crohn's disease. 
2.2.1. Epidemiology 
A study of the Upsalla population in central Sweden found that more IBD births 
occurred during a three month period following measles epidemics compared 
with controls (Ekbom et al. 1994). This association was found to be statistically 
significant and suggests an association between early exposure to measles virus 
and the later development of IBD. 
In contrast, Thompson et al. (1995b) analysed questionnaires concerning 
perinatal risk factors from almost 5,000 patients with IBD and controls in the 
UK. No birth-cohort effect for the development of IBD was seen in this group 
and no association between perinatal exposure to measles virus and subsequent 
development of IBD was observed. However, the same study (which illicited a 
response rate of only 20%) failed to show an association between exposure to 
measles virus and subsequent development of SSPE, a degenerative neurological 
disorder caused by a persistent measles virus infection, in which early exposure 
to measles virus has been shown to be a major risk factor (Clements and Cutts, 
1995). Therefore, it could not be concluded from this study that early exposure 
to measles virus was not a risk factor for the later development of Crohn's 
disease. 
Subhani et al. (1997) recently published results from a study of twins discordant 
for Crohn's disease, showing evidence that childhood measles infection (but not 
other childhood viral infections) is a significant risk factor for the development 
of IBD (relative risk = 2.1). In addition, work at the Royal Free Hospital 
(Montgomery, S. M., personal communication) has shown concurrent measles 
and mumps infections, below the age of seven, to be a significant risk factor for 
the development of Crohn's disease (relative risk = 9.1). 
Ekbom et al. (1996) recently reported a study concerning Crohn's disease and in 
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utero measles virus exposure. Records of 25,000 pregnancies between 1940 and 
1949 in Upsalla, Sweden, were studied and four cases of overt measles during 
pregnancy were identified. Three of the four children from these pregnancies 
were found to have developed Crohn's disease. Furthermore, the onset of 
Crohn's disease in each case was reportedly preceded by antibiotic-resistant 
pneumonia, suggestive of a viral infection. The only child not to develop 
Crohn's disease had typical measles at six years of age, indicating that although 
the mother was diagnosed with measles at the time of delivery, the baby was not 
infected with the virus and no immunity to measles developed. 
It is important to note that the choice of time period for this study was based on 
two known cases of in utero measles virus infection followed by Crohn's 
disease during this time. Even allowing for this, the third case of in utero 
measles infection and Crohn's disease provides strong evidence for the 
involvement of perinatal measles virus exposure in the aetiology of Crohn's 
disease. Furthermore, immunogold electron microscopy has provided evidence 
of a persistent measles infection in tissue from these patients (Ekbom et al. 
1996). 
Contrary to these data, Jones et al. (1997) recently studied a cohort of over 3,000 
individuals exposed to viruses in utero, including 47 exposed to measles. None 
of these individuals (aged 16-53) had progressed to develop Crohn's disease at 
the time of study. 
In addition to this study, Nielsen et al. (1998) have also published negative 
findings concerning in utero exposure to measles virus and subsequent 
development of Crohn's disease. This study followed up 26 children of mothers 
admitted to hospital with measles during pregnancy. None of these children (36- 
79 years old at the time of study) subsequently developed IBD. 
The lack of Crohn's disease cases in these studies raises the question as to 
whether the phenomenon of in utero exposure to measles virus and subsequent 
development of Crohn's disease is dependent on other factors. It is possible that 
the different populations studied were exposed to different strains of measles 
virus, accounting for the discrepancies in results between these studies. 
Additionally, infant mortality rates may be a confounding factor: in areas of high 
infant mortality, individuals infected with measles virus at an early age may not 
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have survived, whereas in areas of low infant mortality, individuals may have 
survived measles infection and later developed Crohn's disease. A study from 
the Royal Free Hospital has shown infant mortality rates to be inversely 
proportional to IBD incidence rates, supporting this possibility (Montgomery et 
al. 1997). The rate of infant mortality is also higher in the UK than in Sweden 
and Denmark, and this may contribute to the differences between the studies of 
Ekbom et al. (1996), Jones et al. (1997) and Neilsen et al. (1998). 
Measles vaccination. As discussed earlier, the incidence of IBD in children has 
increased y4s dramatically since the 1970's (Barton et al. 1996; Cosgrove et al. 
1993). In view of this, Thompson et al. (1995a) decided t study the possibility 
114 
of live, attenuated measles vaccine as a risk factor for the later development of 
IBD. This study determined the prevalence of coeliac disease, peptic ulceration, 
Crohn's disease and ulcerative colitis in over 3,500 individuals who had taken 
part in the Medical Research Council's 1964 trial of the live, attenuated measles 
vaccine. The control group for this study consisted of over 11,000 individuals 
from the National Child Development Study (NCDS), a longitudinal study of 
over 16,000 people born in the UK during a week in 1958 (11 years before the 
start of the national measles vaccination program). No significant associations 
were observed between coeliac disease or peptic ulcers and measles vaccination. 
However, the relative risk of measles vaccination was found to be 2.95 and 2.05 
for the later development of Crohn's disease and ulcerative colitis respectively, 
indicating that measles vaccination may be a significant risk factor for the later 
development of IBD. 
The vaccine study group were born throughout the year while the NCDS group 
were born in one week of the year and therefore seasonal variations, in terms of 
birth dates of patients with IBD, may contribute to artifactual differences in the 
prevalence of IBD between these two groups. However, no studies have reporte 
seasonality for IBD births in UK populations. 
G"A/ 
Differences in the questionnaires sent to vaccine recipients and control groups 
may have led to an ascertainment bias, despite which, the rate of IBD prevalence 
in the control group was the highest reported rate in the world up to the time of 
the study (254 per 100,000). 
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The higher mean age of the NCDS group (33 years compared with 31 years) 
should have led to even more reported cases of IBD compared with the vaccine 
trial group. Therefore the increased risk of the development of IBD associated 
with measles vaccination is more likely to be a real phenomenon and not an 
artefact of the study method. 
Contrary to these data, Hermon-Taylor et al. (1995) analysed the incidence of 
Crohn's disease in the UK and demonstrated that the incidence of Crohn's 
disease was increasing before the introduction of the measles vaccine in 1968. 
This indicates that measles vaccination may not have played a significant role in 
the observed increase in Crohn's disease incidence since the 1940s. Moreover, a 
recent study of a UK population (Feeney et al. 1997) has shown no association 
between measles vaccination and the later development of IBD in a study of 140 
IBD patients and 280 controls. Although a different methodological approach 
was used, the population studied was similar to that of Thompson's study and 
would have received the same vaccine. 
2.2.2. Electron Microscopy 
In 1993, Wakefield et al., using transmission electron microscopy, reported the 
presence of inclusion bodies containing paramyxovirus (the family containing 
measles virus) nucleocapsid-like particles at the foci of granulomas and in the 
submucosal endothelium associated with vascular injury in all 9 patients with 
Crohn's disease studied. Inclusion bodies are a feature of persistent 
paramyxovirus infection, consisting of condensations of viral nucleocapsids. 
This work was supported by a subsequent independent electron microscopy 
study by Knibbs et al. (1993) who analysed diseased tissue from two French 
families with a high frequency of Crohn's disease for the presence of viral 
particles and described intranuclear inclusions, containing paramyxovirus-like 
particles, in submucosal vascular endothelial cells. 
2.2.3. In situ hybridisation 
In the same study, Wakefield et al. (1993) used in situ hybridisation, with an 
RNA probe complementary to measles nucleoprotein genomic RNA on Crohn's 
disease and control tissue. The probe hybridised to the cytoplasm of giant cells 
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within granulomas and to the nucleus of macrophage and lymphocytes within 
lymphoid follicles in all of 10 cases of Crohn's disease studied. Moreover, 
hybridisation signal also was observed within the submucosal microvasculature 
of 9 of 10 of these cases of Crohn's disease. Four out of 10 cases of ulcerative 
colitis and 3 out of 10 non-inflammatory control cases also gave hybridisation 
signal, suggesting that measles virus infection of intestinal tissue may not be a 
rare phenomenon. 
Negative control experiments using probes complementary to vector sequences, 
Epstein-Barr sequences and cytomegalovirus sequences all gave negative 
staining. Moreover, ribonuclease digestion of tissue sections, prior to in situ 
hybridisation, prevented hybridisation signal using the measles-specific probe. 
Therefore, the hybridisation signals generated within Crohn's disease 
granulomas are unlikely to be artefactual. 
2.2.4. Serology 
Blazon et al. (1997) have recently reported raised serum measles IgM levels in 
patients with IBD using an indirect fluorescent antibody measles test system. 
Thirty six patients with Crohn's disease, 22 patients with ulcerative colitis and 
89 control patients were tested for measles IgM. Seventy eight percent of 
Crohn's disease sera showed raised measles IgM levels, compared to 59% of 
ulcerative colitis sera and 3% of control sera and no correlation was found 
between total IgM levels and measles IgM levels. These results are suggestive of 
an ongoing immune response to measles in patients with IBD. 
Support for these results has come from a recent Argentinean study of measles 
IgM levels in IBD patients and controls (Boerr et al. 1997). Twenty nine percent 
of Crohn's disease patients were found to have raised measles IgM levels, 
compared to 10% of ulcerative colitis patients and 3.7% of controls. 
In contrast, Trouze et al. (1995) used an immunoflourescence assay to measure 
measles IgM levels in IBD and control patients. No significant difference was 
observed in between IBD and control samples with only one sample from each 
group giving a positive result. In addition, Fisher et al. (1997) found no 
significant difference between Crohn's disease sera and control sera in terms of 
anti measles IgG and measles IgM using a complement fixation test and ELISA 
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respectively. Lower levels of measles antibodies were observed in Crohn's 
disease sera which the authors argued may be indicative of a host immune 
defect. 
It is possible that the different populations studied may account for these 
contradictory results. 
2.2.5. Immunohistochemistry 
Immunohistochemical studies have been performed by Wakefield et al. (1993), 
using a monoclonal antibody directed against measles nucleoprotein. 
Experiments showed positive staining in the foci of granulomatous 
inflammation in 13 of 15 patients with Crohn's disease. The monoclonal 
antibody used was shown to give positive staining in measles-infected neuronal 
cells of SSPE and measles inclusion body encephalitis (MIBE) tissue. 
Subsequently, double staining experiments were performed at the Royal Free 
Hospital using an antibody against either a cytotoxic lymphocyte marker or a 
macrophage marker, together with a measles nucleoprotein polyclonal antibody, 
to determine the type of immune response directed against measles-infected 
cells in Crohn's disease granulomas (Wakefield et al. 1997). The measles 
polyclonal antibody sera used in this study was raised against an E. coli vector 
expressing recombinant measles nucleoprotein. As a negative control, 
polyclonal antibodies directed against E. coli did not give positive signal in the 
same tissue samples (unpublished data). Control tissue from patients with SSPE 
and measles appendicitis showed infected cells to be associated with cytotoxic 
lymphocytes while Crohn's disease granulomas showed infected cells to be 
associated with macrophages. These data are suggestive of an attenuated 
cytotoxic lymphocyte response in conjunction with an abnormal macrophage 
response to measles virus-infected cells in patients with Crohn's disease. 
Support for these results has come from an independent study by Miyamoto et 
al. (1995) who identified a monoclonal antibody directed against the measles 
matrix protein which produced a positive signal in a significant number of 
Crohn's disease tissue specimens studied compared to ulcerative colitis and 
controls, using immunoflourescence. In addition, positive fluorescence was 
more commonly associated with granulomatous areas. Antibodies specific to 
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other measles virus antigens were negative, as were antibodies against herpes 
simplex virus type 1. 
Contrary to these data, Liu et al. (1995) were unable to detect measles 
nucleoprotein in Crohn's disease tissue using a measles monoclonal antibody. 
Such a monoclonal antibody, recognising a single epitope on a measles antigen 
may lack the sensitivity of a polyclonal antibody and may not be able to detect 
low copy number measles antigens. Additionally, mutations involved with 
measles virus persistence may alter viral protein epitopes, allowing measles 
antigens to evade monoclonal antibody detection. 
Liu et al. also used a measles nucleoprotein polyclonal antibody employed by 
Lewin et al. (1995), Ekbom et al. (1996) Wakefield et al. (1997) and Daszak et 
al. (1997), and described non-specific staining in a variety of cell types in tissue 
from Crohn's and control patients. 
The discrepancy between the results of Liu et al. and Wakefield et al. in terms of 
polyclonal antibody staining may be explained by different methodologies, 
tissue samples, or interpretation of results. Work is underway at the Royal Free 
Hospital to reproduce positive immunohistochemistry results on Crohn's disease 
tissue using polyclonal antibody sera raised against measles nucleoprotein 
produced by an adenovirus vector. 
2.2.6. Immunogold electron microscopy 
The same polyclonal antibody sera used to generate staining in the granulomas 
of Crohn's disease tissues was labelled with gold particles for use in electron 
microscopy studies . This labelled antibody showed the predicted staining 
pattern in SSPE tissue at a resolution high enough to be able to show antibody 
binding in pairs along the length of viral nucleocapsids (Lewin et al. 1995). Six 
granulomatous Crohn's disease tissues and two ileocaecal tuberculosis tissues 
were examined for the presence of measles nucleoprotein using this technique. 
Five of the Crohn's disease samples and one of the ileocaecal tuberculosis 
samples showed positive staining in the foci of granulomatous inflammation. 
Moreover, as in SSPE tissue, pairs of antibodies binding to nucleocapsid-like 
particles were observed. The signal generated by this technique was very focal 
and indicated the presence of measles nucleocapsids at a much lower copy 
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number than that seen in SSPE tissue (Figure. 2.1). These results indicate the 
presence of a focal, low copy number persistent measles virus infection and may 
partly explain the reported inability to detect measles RNA in Crohn's disease 
tissue using reverse transcription-PCR as discussed below (Smith, 1994; Lewey 
et al. 1995; Iizuka et al. 1995; Fan et al. 1996; Haga et al. 1996). 
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Figure 2.1: Immunogold electron microscopy for measles nucleoprotein 
in Crohn's disease. 
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(a. ) Electron micrograph of immunogold staining for measles nucleocapsids in 
SSPE tissue. 
(b. ) Electron micrograph of SSPE tissue section with no primary antibody as a 
negative control. 
Low power (c. ) and high power (d. ) electron micrographs, receptively, of 
immunogold staining for measles nucleoprotein in a Crohn's disease granuloma. 
Data supplied by Dr A. Wakefield (personal communication). 
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2.2.7. Reverse transcription-PCR 
Confirmation of the presence of measles RNA in IBD tissue, but not in control 
tissue, would provide strong evidence for a causal association between measles 
virus and IBD. RT-PCR is an ideal method for the detection of measles RNA 
due to its specificity and sensitivity (Bruce, 1993). Moreover, measles PCR 
products can be sequenced to determine the strain and origin of the virus, for 
instance if the virus originated from measles vaccine or a circulating wild-type 
virus (Rima et al. 1995). 
In a study at the Royal Free Hospital, Smith (1994) reported negative measles 
N-gene RT-PCR results for measles virus RNA in IBD and control resection 
tissue. Positive PCR results were shown to have arisen as a result of PCR 
contamination in these experiments following sequence analysis. However, the 
sensitivity limit of the detection method used was not accurately determined and 
may not have been optimal. 
In a letter to Lancet in 1995, lizuka et al. reported negative RT-PCR results for 
measles matrix (M), haemagluttinin (H), and fusion (F) gene RNA from 
resection and biopsy specimens of 15 patients with Crohn's disease. RT-PCR for 
measles nucleoprotein RNA generated non-specific products, suggesting sub- 
optimal reaction conditions. Moreover, formalin-fixed, paraffin embedded 
resection tissue was used as a source of total RNA and efficient RNA isolation 
from this material is difficult. In addition, quantification of measles RNA 
detection sensitivity was not provided, allowing for the possibility that any 
measles RNA present was below the sensitivity limit of the detection assay. 
In the same year, Lewey et al. (1995) reported results of an RT-PCR study 
directed against measles M-gene RNA using ileocolonic biopsy material from 
IBD and control patients. None of the samples gave positive results after RT- 
PCR although supernatant from measles infected cell culture, spiked into control 
biopsy sample yielded a positive result using the method described. 
Quantification of detection sensitivity was not provided in this study, allowing 
for the possibility that any measles RNA present may have been below the 
detection limit of this particular method. 
In 1996, Haga et al. reported negative results from measles RT-PCR 
experiments using resection tissue from IBD and control patients. Measles N- 
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and F- gene RNA, in addition to mumps and rubella RNA, were used as targets 
for amplification. The authors claimed to be able to detect one measles genome 
in the samples tested, a claim which was based on the assumption that one 
measles viral genome is present per measles virion (one plaque forming unit of 
measles virus). However, Lund et al. (1984) have shown that approximately 
1000 copies of the measles virus genome may be present in each measles virion. 
Moreover, more than one virion may be responsible for the formation of a 
plaque on a cell monolayer, therefore the measles RNA detection limit may have 
been several orders of magnitude less sensitive than that described. The authors 
also reported a long delay (between 20 and 90 minutes) between resection and 
freezing of tissue samples. This delay could lead to significant RNA 
degradation, particularly in the case of low copy number RNA species. In order 
to assess RNA integrity and detect significant RNA degradation, a low copy 
number RNA species should have been used as an internal positive control. 
Instead, a high copy number RNA species (ß-actin mRNA) was used to detect 
RNA degradation. ß-actin mRNA may have been detectable after degradation of 
low copy number RNA species and is therefore a poor indicator of RNA 
integrity. Therefore the results of this study do not preclude the possibility that 
measles RNA is present in IBD tissue below the detection sensitivity limit of the 
assay used. 
Fan et al. (1996) have also used RT-PCR to search for measles RNA in IBD 
tissue. Biopsy and resection samples were obtained from IBD and control 
patients with 9 of the 10 Crohn's disease samples containing granulomas. The 
presence of Epstein-Barr virus DNA in approximately half of all samples and 
cytomegalovirus DNA in a minority of all samples did not represent a 
statistically significant difference. A combined RT-PCR reaction with rTth DNA 
polymerase, failed to detect measles N-gene RNA in any sample, although this 
method successfully amplified measles N-gene RNA in samples from measles 
vaccine recipients. As in previous studies to determine the presence of measles 
RNA in IBD tissue, the sensitivity of detection methods was not accurately 
quantified. 
It is possible that measles antigens are present in the absence' of detectable 
measles RNA. For instance, measles nucleoproteins may accumulate in the 
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nucleus of infected cells during persistent infection, and these may be present 
long after measles RNA has been degraded during chronic inflammation. 
2.2.8. Conclusions 
Epidemiological studies have provided strong circumstantial evidence for an 
association between early exposure to measles virus and the later development 
of IBD, in particular Crohn's disease. Some serological studies have shown 
raised measles IgM levels in IBD patients compared to controls. Electron 
microscopy studies have shown the presence of paramyxovirus nucleocapsid- 
like particles in Crohn's disease tissue. Studies to determine the presence of 
measles antigens in IBD tissue have yielded conflicting results although 
immunogold electron microscopy data suggest the presence of a persistent, low 
copy number measles virus infection restricted to the foci of granulomatous 
inflammation. In situ hybridisation experiments have supported these results, 
showing a very focal distribution of measles RNA. 
However, the epidemiological, serological, and immunohistochemical data in 
favour of an association between measles virus and IBD have all been 
contradicted by various studies. One possible explanation for this is that 
exposure to measles virus may be an aetiological factor in a certain subgroup of 
IBD patients. Therefore, studies on different populations of IBD patients are 
likely to yield different results. 
RT-PCR experiments from four different groups have not detected measles virus 
RNA in any IBD sample tested, however none of these studies have accurately 
quantified measles RNA detection sensitivity. In addition, some of these studies 
used an inappropriate target to assess RNA integrity (e. g. ß-actin mRNA) rather 
than a low copy number housekeeping RNA species. The possibility of low 
copy number measles RNA present in these tissues, as suggested by other data, 
cannot be excluded. Difficulties in detecting measles N-gene RNA by RT-PCR 
may be responsible for negative results in some cases (Griffin, D. E., Johns 
Hopkins University, Baltimore; personal communication). These difficulties 
may arise due to mutations in the N-gene during persistent infection, preventing 
efficient amplification of N-gene RNA. Alternatively, strong binding of measles 
nucleoprotein to measles N-gene RNA as described by Andzhaparidze et al. 
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(1987) may prevent its efficient extraction leading, to false negative results. 
Also, measles nucleoprotein bound to N-gene RNA may prevent its efficient 
reverse transcription and amplification. 
The evidence so far justifies further investigation to determine the presence of 
measles RNA in IBD tissue using molecular biology techniques. 
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2.3. MMR VACCINE-ASSOCIATED ILEO-COLONIC LYMPHOID 
HYPERPLASIA AND NON-SPECIFIC COLITIS IN CHILDREN 
WITH DEVELOPMENTAL DISORDER (AUTISTIC 
ENTEROPATHY) 
An ongoing study at the Royal Free hospital has identified a group of children 
with ileo-colonic lymphoid hyperplasia, non-specific colitis and developmental 
disorder (Wakefield et al. 1998b). This new syndrome has been termed "autistic 
enteropathy" bearing a temporal association with the combined measles, mumps 
and rubella (MMR) vaccine introduced in 1988. Developmental disorder is 
similar to autism but differs in that patients develop normally for the first few 
years of life before degenerating to an autistic condition. Of twelve children 
studied in depth, all but one were male, reflecting the sex ratio seen in autism. 
Onset of behavioural abnormalities varied between one day and 8 weeks from 
the time of vaccination. On endoscopic examination, lymph node hyperplasia 
was seen in the terminal ileum, in 10 of 12 patients. One further patient, in 
whom the terminal ileum was not intubated, was found to have had lymph node 
hyperplasia on barium follow through. Histological examination showed the 
presence of chronic, non-specific colitis in 11 of 12 patients, while nine age- 
matched control tissues were found to be histologically normal. It has been 
suggested that these patients may represent early cases of chronic IBD 
(Wakefield et al. 1998b). 
Gut abnormalities have previously been reported in autistic children and have 
been associated with disease aetiology (D'Eufemia et al. 1996), and exposure to 
measles and rubella virus have been associated with the development of autism 
(Wing, 1996). In addition, persistent measles vaccine strain RNA has recently 
been detected in peripheral blood cells of patients with autoimmune hepatitis 
(Kawashima et al. 1996b), indicating that attenuated measles vaccine strain 
virus may be able to persist in some individuals. 
2.3.1. Immunohistochemistry 
Immunohistochemical studies were performed to determine which cells were 
involv with the inflammatory process in these cases and if there was any 
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evidence of viral involvement. Antibodies against CD68, a macrophage marker, 
and CD3 a pan T cell marker, showed a significant increase in the number of 
these cells in the submucosa and lamina propria of affected cases compared to 
controls. Immunohistochemistry for MHC class II antigen showed a marked 
increase in the number of antigen presenting cells compared with controls, 
including staining on endothelial cells, monocytes and epithelial cells in the 
cases studied. These results are indicative of chronic intestinal inflammation. 
2.3.2. Evidence for the presence of measles virus 
Immunohistochemistry for measles nucleoprotein was performed using 
polyclonal antibody sera (RAd 68) from mice raised against recombinant 
measles nucleoprotein purified from an adenovirus expression system 
(Wakefield et al. 1998a). Staining was shown in 5 out of 10 cases studied in 
lymphoid follicles and double staining with an antibody against CD21 (a 
dendritic cell marker) showed co-localisation of measles nucleoprotein staining 
with discrete follicular dendritic cells. Only 1 of 10 control biopsies stained 
positively for measles nucleoprotein. 
RAd 68 showed positive staining in adenovirus-infected cells, indicating the 
presence of adenovirus-specific antibodies in the measles polyclonal sera. As a 
negative control, no staining was observed for adenovirus antigens in any 
intestinal tissue, indicating that adenovirus-specific antibodies present in RAd 
68 were not responsible for the reported positive measles nucleoprotein staining. 
Moreover, preimmune sera from the measles virus nucleoprotein-immunised 
mouse gave negative staining in all tissues. However, a measles nucleoprotein 
monoclonal antibody failed to show any staining on any of these tissues. This 
may be due to an absence of measles monoclonal antibody recognition of 
mutated measles antigens, or low measles monoclonal antibody sensitivity. 
Viral infection of dendritic cells. Follicular dendritic cells have been shown to 
be a reservoir for human immunodeficiency virus in AIDS patients leading to 
lymph node hyperplasia (Tacchetti et al. 1997). In these cells, HIV escapes 
recognition by cytotoxic T lymphocytes, enabling the virus to persist and infect 
CD4+ T helper cells. In addition, follicular dendritic cells may retain viral 
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antigen for long term memory, although evidence for this remains controversial 
(Doherty et al. 1996). 
It has been demonstrated that de ritic cells of the central nervous system 
become infected during persistent measles virus persistence in SSPE (Allen et 
al. 1996). Recently, it has been shown that infection of dendritic cells infected 
with wild-type or vaccine strain measles virus reduces IL-12 production 
(Grosjean et al. 1997). Reduced IL-12 production may be responsible for 
disrupting the homeostasis of the gut, giving rise to chronic intestinal 
inflammation. 
2.3.3. Conclusions 
This group of paediatric patients may represent individuals with early onset 
inflammatory bowel disease. The temporal association with MMR vaccination 
and the initial immunohistochemical results, indicating the presence of measles 
virus in follicular dendritic cells, justify a molecular biology study to determine 
the presence of measles, mumps or rubella in clinical samples from these 
patients. 
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Chapter 3 
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Chapter 3. MEASLES VIRUS 
3.1. ACUTE MEASLES INFECTION 
Measles is an RNA virus of the genus morbillivirus within the paramyxoviridae 
family, containing a 15,898 base single-stranded genome of negative polarity. 
Other morbilliviruses include canine distemper virus and rinderpest virus. First 
isolated in 1954 by Enders and Peebles, measles virus infection has since been 
shown to be restricted to higher primates and is responsible for over one million 
deaths per year world-wide. 
3.1.1. Sites of infection 
Measles is a highly infectious virus which enters the host via the upper 
respiratory tract, infecting local lymph nodes (Carter and ter Meulen, 1990). The 
primary viremia consists of virus spread and replication in the rest of the 
respiratory tract and the reticuloendothelial system via the blood. This is 
followed several days later by the secondary viremia, consisting of infection of 
endothelial and epithelial cells via infected circulating leukocytes. 
Multinucleated giant cells (also known as Warthin-Finkeldy cells) containing 
inclusion bodies, form in all infected tissues (including the gastrointestinal tract; 
Tokunaga et al. 1980; Monif and Hood, 1970) and lymphoid hyperplasia occurs 
in infected organs, associated with inflammatory cell infiltrates (Carter and ter 
Meulen, 1990). Infection of the gastrointestinal tract can lead to measles enteritis 
in some individuals (Tamboen et al. 1991). 
Following the secondary viremia, virus shedding occurs in sputum, 
nasopharyngeal secretions and urine. Koplik spots, small apoid ulcers 
characteristic of acute measles, develop in buccal mucosa and conjunctivae 
(Carter and ter Meulen, 1990). This is followed by the appearance of a 
maculopapular rash spreading over the entire body. Complications of acute 
measles include giant cell pneumonia and autoimmune encephalomyelitis, 
resulting from a host immune response to myelin basic protein in the CNS in the 
apparent absence of measles virus (Carter and ter Meulen, 1990). 
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3.1.2. Immunology 
During the rash (approximately 16 days after initial infection) measles IgM is 
produced followed by measles IgG (Schluederberg, 1965). The major antibody 
response is directed against measles nucleoprotein, while antibodies against 
measles haemagglutinin protein are the major neutralising antibodies, preventing 
further viral infection, clearing the virus from the blood and lysing infected cells 
(Norrby and Gollmar, 1972). There is some evidence to suggest that this 
response clears infectious virus particles, allowing defective virus particles to 
establish a persistent infection (Rammohan et al. 1981). 
The cell-mediated immune response plays a major role in clearance of measles 
virus from infected tissues. CD8+ cytotoxic T cells, recognising measles virus 
antigens associated with MHC class I molecules, are detectable in the blood 
during acute infection and are responsible for lysis of measles-infected cells 
(Griffin et al. 1989). CD4+ T cells, recognising measles antigens associated with 
MHC class II molecules are also responsible for lysis of infected cells in 
addition to secreting a range of cytokines involved with the recruitment of 
monocytes and the regulation of B and T cell differentiation (van Binnendijk et 
al. 1990). 
It has been shown that prior to the appearance of the rash, Thl cells are 
activated, while following the rash, Th2 cells (producing IL-4) are activated 
(Griffin and Ward, 1993). 
IL-4 is involved with B cell activation and levels of serum IL-4 remain elevated 
for several weeks following acute infection (Ward and Griffin, 1993). Reduced 
Thl cell activation results in poor cell-mediated immune response and is 
responsible for the observed immunosuppression following acute infection, 
leading to opportunistic secondary infections responsible for much of the 
morbidity and mortality associated with acute measles (Burstrom et al. 1995). 
Longevity of measles immunity.. The longevity of the antibody response to 
measles virus has led some researchers to suggest that persistence of some 
component of the virus may be essential in stimulating lymphocytes and 
maintaining measles adequate antibody titres (Griffin et al. 1994). Indeed, a sub- 
optimal cell-mediated immune response during the later stages of infection may 
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aid the establishment of persistent measles virus infection in lymphoid tissues 
which may be involved with this longevity of immunity to measles. Although 
there is little evidence of widespread persistence of infectious measles virus in 
an immune population, it is possible that a defective form of measles virus or 
measles antigen may persist in lymphoid tissue which is not readily detected 
using molecular or cell culture methods. However, the role of antigen retention 
in long-term immunity as proposed by Mandel et al. (1980) based on earlier 
work by Tew and Mandel (1979) remains controversial (Doherty et al. 1996). 
Such a mechanism would however, offer an explanation as to the discrepancy 
between negative RT-PCR results (Smith, 1994; Fan et al. 1996; Lewey et al. 
1995; Iizuka et al. 1995; Haga et al. 1996) and positive immunohistochemical 
results (Miyamoto et al. 1995; Wakefield et al. 1993; Lewin et al. 1995; Daszak 
et al. (1997); Wakefield et al. 1997) for the presence of measles virus in IBD 
tissue. 
3.1.3. Diseases associated with measles 
Measles inclusion body encephalitis (MIBE). First described in 1977, MIBE is a 
rare, fatal neurological disorder caused by a defective measles virus infection of 
the central nervous system (CNS) in some immunosuppressed individuals 
following acute measles (Alcardi et al. 1977). 
Subacute sclerosingpanencephalitis (SSPE). SSPE, another rare, fatal 
neurological disease, was proposed to be caused by a persistent measles virus 
infection after the detection of measles antigens in diseased tissue by 
immunofluorescence (Legg, 1967). Raised measles antibody levels in serum and 
cerebrospinal fluid of SSPE patients were observed (Connolly et al. 1971) and 
subsequently, electron microscopy (Tellez-Nagel et al. 1967), in situ 
hybridisation (McQuaid et al. 1993) and more recently, RT-PCR studies (Godec 
et al. 1990) confirmed the presence of a persistent measles virus infection of the 
CNS, responsible for chronic inflammation and demyelination in affected 
individuals. 
Autoimmune Hepatitis (AIH). AIH has also been associated with persistent 
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measles virus infection since Christie et al. reported elevated measles antibodies 
in the sera of patients with chronic hepatitis in 1983. Later Robertson et al. 
(1987) identified measles N-gene RNA in the peripheral blood mononuclear 
cells (PBMCs) of 12 of 18 AIH patients and these results have recently been 
supported by Kawashima et al. (1996b) who demonstrated the presence of 
measles H-gene RNA in the PBMCs of patients with AIH using RT-PCR. In the 
latter study, sequence analysis of PCR products identified vaccine strain measles 
virus in all four AIH paediatric patients studied, and wild-type measles RNA 
identified in the two adult AIH patients studied. Moreover, vaccine strain 
measles was detected in paediatric patients up to 11 years following vaccination, 
indicating that live attenuated measles vaccine may persist in peripheral blood 
for many years. 
Otosclerosis. Recently, measles RNA has been shown to be present in diseased 
tissue from patients with otosclerosis a chronic inflammation of the 
otospongiotic area. McKenna et al. (1986) demonstrated the presence of 
paramyxovirus nucleocapsid-like structures in otosclerotic lesions using electron 
microscopy and measles antigens were subsequently identified in the foci of 
active disease using immunohistochemistry (McKenna and Mills, 1989). This 
work has been supported by recent data from Niedermeyer and Arnold (1995) 
who have detected measles RNA using RT-PCR in diseased bone tissue of 13 
out of 14 cases of otosclerosis. 
Paget's Disease. Nucleocapsid-like structures have been identified using 
electron microscopy in bone tissue from patients with Paget's disease (Mills and 
Singer, 1976) a chronic proliferative disease of bone osteoclasts. Subsequently, 
in situ hybridisation was used to detect measles RNA in diseased tissue (Basle et 
al. 1986) and measles RNA has been detected in PBMCs (Reddy et al. 1996) 
and diseased tissue (Reddy et al. 1995) of patients using RT-PCR. However, 
other studies have reported the presence of canine distemper virus in tissue from 
these patients (Cartwright et al. 1993; Gordon et al. 1992) and it is possible that 
co-infection with both measles and canine distemper virus may lead to the 
development of Paget's disease. 
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Others. Measles virus has been proposed to be in olved with the aetiology of 
Kawasaki disease (Bansil et al. 1997; Dhib-Jalbut et al. 1990), a systemic 
vasculitis in young children, and multiple sclerosis (Schulz et al. 1992) although l4 
evidence for these associations remains controversial (Godec et al. 1992). 
3.1.4. Conclusions 
The detection of measles virus in conditions other than acute measles indicates 
that wild-type or vaccine strain measles virus can persist in some individuals for 
many years, causing chronic disease in a variety of tissue types. In most cases 
where an association has been shown between disease development and 
presence of measles virus, electron microscopy and immunology studies have 
been followed by RT-PCR studies to confirm the presence of measles virus in 
diseased tissue. 
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3.2. MEASLES VIRUS STRUCTURE AND REPLICATION 
3.2.1. Transcription 
It is thought that measles virus replicates in the same manner as other 
paramyxoviruses such as Newcastle disease virus (Hamaguchi et al. 1983), via 
an RNA-dependent RNA polymerase encoded by the measles phosphoprotein 
and large protein genes. This polymerase has no proof-reading activity, 
preventing the correction of errors in the nucleic acid sequence generated during 
virus replication, and accounting for the sequence variation between measles 
strains (Rima et al. 1995). It has been proposed that this lack of proof-reading 
ability is involved in the development of measles virus persistence in SSPE 
(Schneider-Schaulies et al. 1995). 
The viral polymerase binds to a leader sequence at the 3' end of the negative 
strand measles genome (containing the N-gene) and sequentially transcribes the 
individual measles virus genes towards the 5' end (containing the large protein 
gene). During transcription, the polymerase detatches from the gen/omic RNA 
at intergenic regions following polyadenylation of mRNA and then reattaches to 
transcribe the next gene (Horikami and Moyer, 1995). In this manner a gradient 
of viral mRNA is produced from N- to L-gene mRNA (Cattaneo et al. 1987, 
Sidhu et al. 1994). 
r As is the case for vesicular 
smatis 
virus (Blumberg et al. 1981), the synthesis 
of high levels of measles nucleoprotein is thought to trigger a switch from 
transcription of viral mRNA to transcription of full length antigenomic RNA, for 
transcription back to negative genomic RNA. In this manner, no measles DNA 
is produced at any stage of the replication cycle. A diagram of a measles virion 
is shown in Figure 3.1. and a schematic diagram of measles virus replicative 
cycle is given in Figure 3.2. 
3.2.2. Encapsidation 
Genomic and antigenomic RNA molecules are encapsulated by measles 
nucleoproteins (N), forming tubular nucleocapsid structures which can be 
identified using electron microscopy (Nakai et al. 1969) and condensation of 
nucleocapsids leads to the formation of characteristic inclusion bodies in the 
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nucleus and cytoplasm of infected cells. Measles RNA polymerases associate 
with nucleocapsids during virion assembly (Huber et al. 1991), enabling active 
transcription to occur immediately on virus entry into host cells. 
Measles matrix protein is thought to be involved with virion maturation, 
promoting the association between nucleocapsids (Hirano et al. 1992) and 
envelope proteins on the cell membrane and leading to virus budding (Peebles, 
1991). Host cell-derived actin molecules have been shown to be associated with 
functional virions and these may also be involved with virus maturation (Tyrrell 
and Norrby, 1978). Mature virions may contain up to 1000 nucleocapsids, each 
containing a full-length molecule of genomic or antigenomic RNA (Lund et al. 
1984). 
Figure 3.1: Measles virus structure. 
Nucleoprotein 0 Haemagglutinin protein m 
Phosphoprotein ' Matrix protein " 
Fusion protein Large protein " 
RNA Lipid bilayer 
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Figure 3.2: Measles virus replication. 
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measles RNA is transcribed into mRNA then translated to viral proteins. A 
critical level of measles nucleoprotein is thought to be neccessary to switch 
transcription to full-length antigenomic RNA which is subsequently transcribed 
back to full-length genomic measles RNA. 
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3.2.3. Virus entry 
Entry to the host cell requires binding of measles haemagglutinin protein to its 
receptor, CD46 (Naniche et al. 1993) -a glycoprotein involved with down- 
regulating the complement cascade (Hourcade et al. 1989). Internalisation of 
CD46, as a consequence of virus entry, results in its down-regulation leading to 
complement-mediated lysis of infected cells (Schnorr et al. 1995). Lysis of 
infected endothelial cells in this manner could potentially contribute to 
vasculitis. 
Measles fusion protein mediates coalescence between the virion lipid bilayer 
and host cell membrane (Alkhatib et al. 1990), leading to the release of measles 
nucleocapsids into the cell cytoplasm and expression of fusion protein on 
infected cells leads to syncl'tia formation, resulting in giant cell formation and 
cell death. 
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3.3. SUBACUTE SCLEROSING PANENCEPHALITIS 
Persistent measles virus infection of the CNS is known to be the cause of SSPE. 
The risk of developing SSPE after acute measles infection and following 
measles vaccination, has been reported to be 4 and 0.14 in 100,000, respectively 
(Miller et al. 1992). Early exposure to measles virus (acute or sub-clinical 
infection) has been identified as a risk factor for the development of SSPE 
(Miller et al. 1992) and the first symptoms of this disease can appear many years 
after virus infection. Measles antigens and RNA have been detected in SSPE 
tissue (Godec et al. 1990; Legg, 1967); however replicating virus particles have 
never been directly isolated from SSPE tissues, indicative of defective viral 
replication (Carter and ter Meulen, 1990). High measles antibodies titres have 
been detected in the sera and cerebrospinal fluid of affected individuals 
(Freeman et al. 1967; Connolly et al. 1967), suggesting an active host immune 
response to the persistent infection. Infection of a range of cell types, including 
endothelial cells (Isaacson et al. 1996; Esolen et al. 1995; Kirk et al. 1991), has 
been shown to occur in the CNS and disease pathogenesis is characterised a 
massive inflammatory cell infiltrate and demyelination of neuronal cells (Poser, 
1990). 
3.3.1. Mechanisms of measles virus persistence 
No single strain of measles virus has been associated with SSPE, suggesting that 
the establishment of viral persistence occurs as a consequence of mutations 
following virus replication within the host. There are several possible 
mechanisms for the development of measles virus persistence in SSPE, which 
have been the subject of intense study as persistent measles virus infections may 
be involved with the aetiologies of a range of chronic diseases (Katz, 1995). 
It is thought that virus enters the CNS during acute infection and the 
establishment of viral persistence follows in some individuals (Billeter and 
Cattaneo, 1991). Measles virus antigens and RNA have been detected in brain 
endothelial cells of children following acute measles (Esolen et al. 1995) 
indicating that infection of the CNS during acute measles may not be 
uncommon. Measles RNA sequences have also been detected in autopsied brain 
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tissue of patients without SSPE (Esolen et al. 1995), suggesting that measles 
persistence in the CNS may be more common than previously thought and this 
persistence may play a role in the longevity of immunity to further measles 
infection. 
Persistence may also occur in other parts of the body prior to the establishment 
of persistence in the CNS (Schneider-Schaulies et al. 1991; Brown et al. 1989). 
Interestingly, Fournier et al. (1986) have detected measles RNA in lymphoid 
tissue of the appendix prior to the development of SSPE, raising the possibility 
that gut lymphoid tissue may serve as a reservoir for persistent measles 
replication. 
In SSPE, a period of latent, subclinical infection of lymphoid tissue, blood 
leukocytes or neuronal cells, lasting several years is followed by a period of 
abnormal virus replication in neuronal cells which leads to the production of a 
range of cytokines, such as IL-2, IL-6 and IFN-ß (Nagano et al. 1994), eliciting 
a chronic inflammatory response. 
Mutations. A lack of virus polymerase proof-reading activity, together with a 
host cell double-stranded RNA unwinding/modifying enzyme activity, causes a 
high mutation rate during measles virus replication (Cattaneo et al. 1989). The 
host immune response recognises and lyses infected cells which express viral 
antigens on their surface, therefore mutations which prevent or decrease the 
expression of viral antigens on the host cell surface favour unchallenged viral 
replication. Such mutations can occur in the measles M-gene (Hirano et al. 
1992; Hirano et al. 1993), preventing efficient virus maturation, or in the 
cytoplasmic tail region of the measles F-gene (Schmid et al. 1992), preventing 
efficient virus budding. In addition, mutations in the regulatory sequences of 
these genes may lead to down-regulation of their expression (Schneider- 
Schaulies et al. 1989; Hummel et al. 1994), leading to reduced virus maturation 
and budding. 
In this manner, mutated measles virus can escape host immune detection for 
many years. During this period, mutations accumulate in genes not essential for 
viral persistence, such as the envelope genes (H and F) and the M-gene, causing 
their reduced expression, with no deleterious effect to viral RNA replication. 
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This accounts for the steep measles mRNA transcription gradient observed in 
SSPE tissue (Sidhu et al. 1994) since H, F and M genes are towards the distal 5' 
end of the viral genome (Figure. 3.3. ). Sequencing of SSPE-derived measles 
RNA reveals the high level of mutations which makes the determination of the 
original persistence-inducing mutation(s) difficult. 
Without efficient virus maturation or budding, measles nucleocapsids 
accumulate in the nucleus and cytoplasm of infected cells and spread throughout 
the CNS via cell-cell interactions (Cattaneo and Rose, 1993). 
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Defective interfering particles. Another proposed mechanism of, the 
development of measles virus persistence is the generation of defective 
interfering (DI) particles. Also known as 5' copy-back sequences, these particles 
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result from the aborted transcription of full-length measles antigenomic RNA to 
negative-strand genomic RNA (Sidhu et al. 1994; DePolo et al. 1987). Binding 
of the virus polymerase to a transcription promoter site at the 5' end of genome 
(containing the L-gene) promotes the transcription of genomic RNA during viral 
replication. However, transcription is occasionally aborted approximately 100 
nucleotides downstream, leading to the formation of a hairpin-loop structure 
within this short transcript. The viral polymerase then binds to an internal 
pseudo-transcription promoter site, synthesising a second RNA strand. In this 
manner a DI particle is generated, consisting of a double stranded RNA region 
and a hairpin loop representing the terminal 5' end of the measles virus genome 
(Sidhu et al. 1994). 
These DI particles contain transcription promoter sites and binding sites for 
measles nucleoproteins enabling their replication and encapsulation. Therefore 
DI particles compete with full-length measles genomic and antigenomic RNA 
for viral polymerase and nucleoproteins, leading to the restriction of functional 
virus replication and the possible establishment of persistence. DI particles have 
been detected in SSPE tissue (Sidhu et al. 1994) although it is unclear whether 
these particles are involved with the establishment of measles persistence or are 
generated as a consequence of persistent infection. 
The detection of DI particles in preparations of live measles vaccine (Calain and 
Roux, 1988) has led to the possibility that these particles may be involved with 
the attenuation of the measles vaccine. Generation of these particles may provide 
a mechanism whereby measles vaccination could lead to viral persistence and 
the generation of lifelong immunity associated with measles. 
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3.4. MEASLES VACCINATION 
Measles vaccination using a live, attenuated form of measles virus (introduced 
in the UK in 1968) has virtually eradicated the disease and its associated 
morbidity and mortality in developed countries (Clements and Cutts, 1995), 
although outbreaks of measles do occur in susceptible populations (Outlaw and 
Pringle, 1995). 
Although vaccination programs have been successful in developed countries, 
measles virus has not been eradicated due to incomplete vaccination of 
populations in developing countries (Norrby, 1995) and world-wide, over one 
million people die each year from measles-associated illness. 
In 1988 single measles vaccination was replaced by a combined preparation of 
live, attenuated measles, mumps and rubella (MMR) viruses and this has now 
been augmented by a two-dose vaccine schedule. However, adverse effects of 
MMR vaccination have been reported (Bennett et al. 1994; Miller et al. 1993), 
and persistent vaccine-strain measles virus has been detected in the liver 
(Kawashima et al. 1996b) and CNS (Matsuzono et al. 1995) associated with 
disease processes. In addition, cases of SSPE have been reported in individuals 
following measles vaccination (Miller et al. 1992). 
3.4.1. Lifelong immunity 
Circulating maternal measles antibodies confer protection to early acute measles 
infection (Norrby, 1995). However, prior to exposure to wild measles or measles 
vaccine, all individuals are susceptible to infection. Measles infection is known 
to confer lifelong immunity in all but immunosuppressed individuals without the 
need for re-exposure to the virus (Griffin et al. 1994). The mechanism for the 
longevity of immunity to measles is unknown although there is little evidence of 
widespread measles viral persistence in the general population. 
It has been postulated that follicular dendritic cells may trap immune complexes 
containing measles antigens for many years, stimulating memory B-cells 
(Griffin et al. 1994) and it is possible that these cells, expressing measles 
antigens, could stimulate a chronic inflammatory response in some individuals 
with an immune dysfunction. 
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3.4.2. Vaccine preparation 
Initial vaccine trials in the 1960s using inactivated measles virus gave rise to 
adverse side effects and incomplete immunisation leading to the development of 
a live attenuated measles vaccine (Enders et al. 1960). The Schwarz strain of 
measles vaccine is used in the UK, derived from the Edmonston B strain as are 
most measles vaccines used throughout the world. 
Adapted to replication in chick embryos by repeated passaging, measles virus 
vaccine strains replicate poorly in human tissue, theoretically, allowing 
clearance of the virus by the host immune system before the development of 
acute disease. Although the exact mechanism of measles virus attenuation is 
unknown, it is likely that several mutations are responsible for the adaptation of 
the virus to efficient replication in chick embryos. There is also evidence to 
suggest that defective interfering particles may also be involved with the 
attenuation of measles virus (Calain and Roux, 1988). 
As is the case with acute measles infection, although to a lesser extent, exposure 
to measles vaccine is followed by a transient period of immune suppression 
(Griffin et al. 1994), possibly enabling the establishment of a persistent 
lymphoid tissue infection which may be responsible for the longevity immunity 
to measles. 
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3.5. MOLECULAR METHODS FOR THE DETECTION OF MEASLES 
RNA 
In conditions associated with persistent measles virus infection (such as SSPE, 
otosclerosis and Paget's disease) electron microscopy has initially been used to 
identify paramyxovirus nucleocapsid-like particles in diseased tissue (Legg, 
1967). Subsequently, immunohistochemical techniques have been used to 
confirm the presence of measles antigens and to study the distribution of 
measles antigens in diseased tissue (McKenna and Mills, 1989; Legg, 1967). In 
situ hybridisation has been used to determine the presence of measles RNA, to 
ascertain the location and type of infected cells, and to study the expression of 
different measles RNA species (Basle et al. 1986; McQuaid et al. 1993). 
Due to the limitations of in situ hybridisation, in terms of specificity and 
A sensitivity, RT-PCR for measles RNA has been used to confirm 
ýmmunohistochemical findings and provide definitive evidence of measles 
infection in diseases where an association has been postulated (Kawashima et al. 
1996b; Reddy et al. 1995b; Niedermeyer and Arnold, 1995b). 
3.5.1. Target for measles RNA amplification 
Measles N-gene RNA is the choice amplification target in IBD tissue for several 
reasons: 
1. Measles virus nucleocapsids have been identified in IBD tissue using electron 
microscopy (Wakefield et al. 1993; Knibbs et al. 1993) and measles 
nucleoprotein has been identified in IBD tissue using immunohistochemistry 
and immunogold electron microscopy (Wakefield et al. 1993; Miyamoto et 
al. 1995; Lewin et al. 1995; Ekbom et al. 1996; Daszak et al. 1997; 
Wakefield et al. 1997). Furthermore, measles N-gene RNA sequences have 
been detected in a majority of IBD tissues analysed using in situ 
hybridisation (Wakefield et al. 1993). 
2. A gradient of transcription of measles mRNA occurs in measles-infected cells 
(Barrett et al. 1991) and this gradient has been shown to be exaggerated in 
persistently infected SSPE tissue (Sidhu et al. 1994). Therefore measles N- 
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gene RNA is the most abundant measles RNA species in infected tissue, and 
therefore the most likely measles RNA species to be detectable. 
3. Several studies have successfully used measles N-gene RNA as a target for 
measles RNA amplification (Reddy et al. 1995; Reddy et al. 1996). 
In cases of measles virus persistence, mutations may occur which interfere with 
the efficient amplification of certain viral RNA sequences. For this reason, it is 
useful to use a second measles RNA sequence, such as measles H-gene RNA, as 
another target for amplification to provide further evidence as to the presence or 
absence of measles RNA in IBD tissue. RT-PCR for measles H-gene RNA has 
been used to determine the presence of persistent measles infection in other 
conditions (Kawashima et al. 1996b). 
Choice of material. For RNA viruses such as measles where no viral DNA 
should be present, amplification methods must be RNA-based. Measles genomic 
and antigenomic RNA species do not contain the poly-A tails of mRNA (Barrett 
et al. 1991), therefore extraction of total RNA from clinical samples is necessary 
to aid the efficient detection of all measles RNA species. 
3.5.2. RNA-based amplification reactions 
RT-nested PCR. In recent years, techniques capable of amplifying nucleic acid 
sequences have been developed, enabling the sensitive, specific and rapid 
detection of specific DNA or RNA from clinical samples (Bruce, 1993). PCR 
using Taq DNA polymerase, has enabled the amplification of specific DNA 
sequences (Saiki et al. 1988). In the case of RNA templates, a reverse 
transcriptase enzyme derived from a retrovirus (such as MMLV or AMV), must 
first be used to transcribe the RNA target to a complementary DNA (cDNA) 
strand which can then be amplified using PCR. This reaction uses either specific 
primers to generate specific cDNA; random primers to generate a random pool 
of eDNA; or an oligo-dT primer to generate a pool of cDNA corresponding to 
expressed mRNA. However, the efficiency of RT reactions is low and only a 
minority of the population of RNA molecules is reverse transcribed to cDNA 
(Zhang et al. 1991). As a consequence, the sensitivity of RT-PCR as a method 
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can be limited. This therefore ideally requires the quantification of the methods' 
detection sensitivity prior to use, especially in cases where it is likely that 
particular RNA species are present at low copy number. 
PCR utilises two oligonucleotide primers which bind upstream and downstream 
to specific DNA target sequences. A thermostable DNA polymerase, such as 
Taq DNA polymerase (from Thermus aquaticus), extends these oligonucleotides 
using dNTPs also present within the reaction mixture until a copy of the original 
DNA sequence has been synthesised. Repeated thermal cycling (typically 30 
cycles) of the reaction mixture permits synthesis of more DNA copies in what is 
theoretically an exponential manner. When high annealing temperatures are used 
for thermal cycling, oligonucleotides may bind to DNA in a specific manner. 
The mechanism of RNA amplification by RT-PCR is shown in Figure 3.4. 
In addition, a second nested PCR (nPCR; using an internal primer pair) or semi- 
nested PCR (using one internal primer and one external primer) can be used to 
increase sensitivity and specificity of DNA amplification (Mullis and Faloona, 
1987). 
RT-PCR has been used extensively for the detection of measles RNA in clinical 
samples of patients with acute measles in order to confirm disease diagnosis and 
to determine the strain and origin of virus (Shimizu et al. 1993; Matsuzono et al. 
1994; Kawashima et al. 1996). 
rTth-mediated RT-PCR. Among alternative RT-PCR methodologies has been a 
combined RT and PCR reaction using rTth DNA polymerase -a recombinant 
enzyme from Thermus thermophilus - in a single buffer system (Myers and 
Sigua, 1997). Using this method, RNA is reverse transcribed by the enzyme in a 
bicine buffer at an elevated temperature and then thermally cycled to allow 
nucleic acid amplification. This combined reaction provides several advantages 
over a conventional two-step RT-PCR reaction: 
1. Firstly this method is convenient since only one reaction mixture needs to be 
prepared for each sample. 
2. Secondly, the RT reaction with rTth DNA polymerase and EZ buffer is faster 
than that carried out by either MMLV or AMV reverse transcriptase, enabling 
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samples to undergo RT-PCR in a relatively short time (under four hours). 
3. Thirdly, the elevated temperature used for RT by rTth DNA polymerase 
(60°C) compared with that of MMLV or AMV reverse transcriptase (37- 
42°C) reduces any transcription problems encountered with RNA secondary 
structure leading to more efficient RT. 
4. Fourthly, a coupled RT-PCR reaction may represent a more efficient method 
of RNA amplification than a two-step RT-PCR reaction since all the reagents 
are in the same reaction vessel throughout this method. 
5. Finally, the transfer of RT reaction products into PCR reaction mixtures 
during two-step RT-PCR reactions may lead to contamination with PCR 
products from previous reactions. Since these PCR products can act as 
templates for new amplification reactions, contamination leads to false- 
positive results (Persing, 1991). The probability of PCR contamination is 
therefore reduced using a combined RT-PCR method. 
NASBA. NASBA - an isothermal RNA-based amplification technique - has 
been applied successfully to the detection of a variety of RNA templates since 
its development by Guatelli et al. in 1990 (van der Vliet et al. 1993; van Gemen 
et al. 1993). It has been suggested that NASBA is a more efficient method of 
amplification than RT-PCR since it is a continuous, isothermal amplification 
reaction which is not limited by thermal cycling times (Compton, 1991). In 
addition, NASBA has been shown to be more sensitive than RT-PCR for the 
detection of HIV RNA in clinical samples (Vandamme et al. 1995; Coste et al. 
1996). 
A full description of the NASBA method is provided by Kievits et al. (1991); 
briefly, AMV reverse transcriptase, RNase H and T7 RNA polymerase are used 
in combination to achieve amplification; AMV reverse transcriptase reverse 
transcribes the target RNA using a downstream primer linked to a T7 RNA 
polymerase promoter; RNase H digests the template RNA from the newly 
formed RNA/DNA hybrid, and AMV reverse transcriptase then uses an 
upstream primer to synthesise the second DNA strand. The double-stranded 
DNA product thus formed contains a T7 RNA polymerase promoter site and can 
be used, therefore, as a template by T7 RNA polymerase to continually 
84 
synthesise large numbers of RNA transcripts. Each transcript acts as a new 
template during the NASBA reaction. Typically 1012 to 1013 RNA transcripts are 
synthesised during a NASBA reaction. The mechanism of RNA amplification 
by NASBA is shown in Figure 3.4. 
Due to the isothermal nature of this reaction, non-specific primer annealing and 
hence non-specific amplification frequently occurs. As a consequence, gel 
electrophoresis followed by northern blotting and hybridisation with an internal 
probe, is required to determine the specificity of reaction products. 
RNA reaction products may be further amplified using RT-PCR to generate 
DNA products which can be cloned into plasmid vectors for convenient 
sequencing and long-term storage. Alternatively, RNA products may be reverse 
transcribed to cDNA followed by the synthesis of a second DNA strand to 
enable cloning and sequencing. 
Quantification of reaction sensitivity. To assess the ability of a method for 
measles detection, quantification of measles virus is often performed using a 
plaque-forming assay, which determines the number of plaque-forming units 
(PFU) of measles virus in a given homogenate of measles-infected cells 
(Koschel et al. 1995). However, this method cannot accurately quantify the 
number of measles RNA templates in a sample i. e. it cannot quantify in a 
molecular genetic fashion the presence of measles virus RNA An option to 
address this is to synthesise a measles RNA transcript which can be quantified 
in terms of numbers of molecules per unit volume and used as a target for 
amplification. It is also necessary to used total RNA from measles-infected 
cells, and from measles vaccine samples as templates for amplification in order 
to confirm the ability of a method to detect a range of measles RNA types. 
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Figure 3.4: RT-PCR and NASBA 
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3.5.3 Detection of low copy number measles RNA 
Results generated from immunohistochemistry, immunogold, and in situ 
hybridisation experiments indicate the presence of a low copy number, persistent 
measles virus infection, restricted to the foci of granulomatous inflammation in 
Crohn's disease (Wakefield et al. 1993; Lewin et al. 1995; Daszak et al. 1997). 
The failure of several PCR studies to detect measles RNA in IBD tissues implies 
that if measles RNA is present, extremely sensitive detection methodologies 
must be employed to permit its detection. 
Hybrid capture. Amplification reactions are inhibited by large amounts of RNA 
or DNA (Pikaart and Villeponteau, 1993), therefore following the isolation of 
RNA from diseased tissues, sample RNA must be diluted to a working 
concentration, reducing the measles RNA detection sensitivity. This may 
explain several groups have failed to detect RNA in IBD tissue using RT-PCR 
(Smith, 1994; Lewey et al. 1995; Iizuka et al. 1995; Haga et al. 1996; Fan et al. 
1996). 
Hybrid capture, using oligonucleotides (capture sequences) bound to 
paramagnetic, solid-phase supports, has been used successfully for the detection 
of a range of nucleic acid species, including measles RNA (Albretsen et al. 
1990). The detection of low copy number enterovirus RNA from clinical 
samples of patients with cardiac disease has been aided by hybrid capture (Muir 
et al. 1993) and this method, coupled with RT-PCR has been used to quantify 
human immunodeficiency virus RNA expression in vitro (Volsky et al. 1990) 
Magnetic bead hybrid capture has been shown to improve the sensitivity of 
Hepatitis C virus RNA detection in blood samples (van Doom et al. 1994), has 
been used for the isolation of mRNA from clinical samples (Homes and 
Korsnes, 1990) and for the purification of phage DNA from bacterial cell lysates 
(Fry et al. 1992). 
As a consequence, in order to detect any such low copy-number measles RNA, it 
may be necessary to enrich total RNA from diseased tissue for measles RNA 
prior to amplification reactions. Such an enrichment may be performed by 
hybrid capture using measles-specific oligonucleotides linked to magnetic solid- 
phase supports. Elutants from these supports may contain purified measles RNA 
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and can be used for measles RNA amplification. 
Virus culture. Alternatively, isolation of the virus from clinical samples, and 
propagation in African green monkey kidney Vero cells may generate detectable 
amounts of measles RNA. Culturing of virus from clinical samples may provide 
a source of replicating virus which can then be used to study the functional 
characteristics of any virus recovered. However, as in the case of SSPE, a 
defective form of measles virus may be present which cannot be cultured. 
3.5.4. Mumps and rubella 
Mumps is an acute infection that occurs primarily in children, characterised by 
swelling of salivary glands. Meningitis is an important complication, occurring 
in up to 10% of acute cases (Baum and Litman, 1996). Vaccination, using live 
attenuated virus, was introduced in 1967 and is now incorporated into the MMR 
triple vaccine. Mumps virus belongs to the paramyxovirus genus anda similarg 
j-- t 
structure and replicative cycle to that of measles virus (Galinski and Wechler, 
1991). 
Rubella is an RNA virus belonging to the togaviridae family (Gershon, 1996). 
Rubella is an acute infection of children and adults, characterised by fever and 
rash. Congenital rubella can result in a range of transient, permanent and 
developmental manifestations including mental retardation. Vaccination, using a 
live, attenuated virus was introduced in 1969 and is now incorporated into the 
MMR triple vaccine. 
Both mumps and rubella viruses are non-retroviral RNA viruses, therefore, as is 
the case with measles virus, molecular detection methods are RNA-based. 
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3.6. HYPOTHESIS 
Observations of the behaviour of measles virus have led to the hypothesis that, 
as is the case with SSPE (Miller et al. 1992), early exposure to measles virus in 
some individuals (possibly with a host immune dysfunction) leads to viral 
persistence and susceptibility to IBD later in life (Pounder, 1994; Pounder, 
1995; Wakefield et al. 1995). This hypothesis proposes that early exposure to 
measles virus (wild-type or vaccine) leads to a persistent infection of intestinal 
follicular dendritic cells in some individuals. An environmental or genetic event 
later in life triggers virus replication and infection of lymphocytes which come 
into contact with infected dendritic calls. Infected circulating lymphocytes home 
to the intestine via the submucosal vasculature, infecting endothelial cells during 
infiltration. 
Infected submucosal endothelial cells express measles antigens triggering 
aggregation of circulating mononuclear cells, including monocytes, 
macrophages and lymphocytes, and leading to occlusion of submucosal 
microvasculature, ischaemia and infarction. Tissue damage is then followed by 
invasion of opportunistic luminal bacteria, leading to chronic inflammation. 
Ongoing vasculitis, ischaemia and secondary bacterial infection leads to the 
perpetuation of this chronic inflammation. 
Infection of follicular dendritic cells by measles virus or a secondary pathogen 
may also be involved with the perpetuation of chronic inflammation via 
inappropriate IL-12 production and a disruption of gut homeostasis. 
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3.7. AIMS OF PROJECT 
1. A comparison of the relative sensitivity and fidelity of molecular 
amplification techniques, and the development of new methodologies for 
measles RNA detection will be performed to determine the optimum method 
for the identification of any measles RNA in IBD clinical samples. 
2. This optimised method will be used to determine the presence of measles 
L,,,, RNALPBMCs and resection tissue from patients with IBD and controls. 
h-- Sequence analysis will be used to characterise any measles-specific 
amplification products from the samples analysed to determine the strain and 
origin of virus detected. 
3. Clinical samples will be analysed from patients with autistic enteropathy for 
the presence of measles, mumps and rubella RNA to investigate an 
association between MMR vaccination and the development of this 
syndrome. 
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Chapter 4 
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Chapter 4. MATERIALS AND METHODS 
4.1. MATERIALS 
4.1.1. Chemicals, biologicals and enzymes 
Unless otherwise stated, all chemicals, of both analytical and reagent grade, and 
biologicals were obtained from the Sigma Chemical Co. (Poole, UK) or BDH 
Ltd. (Dagenham, UK). Restriction enzymes were obtained from New England 
Biolabs. (Hitchin, UK) and radiolabelled nucleotides and "ThermoSequenase" 
cycle sequencing kits from Amersham International (Amersham, UK). dNTPs 
for PCR reactions and "Total RNA isolation reagent" were obtained from 
Advanced Biotechnologies (Leatherhead, UK). rTth DNA polymerase and "EZ 
buffer" were obtained from from Perkin Elmer (Warrington, UK). MMLV 
reverse transcriptase was obtained from Gibco BRL (Paisly, UK) as was T4 
DNA ligase, Taq DNA polymerase, random hexamers and acrylamide gel mix 
solution. Alkaline phosphatase and DNaseI were obtained from Boehringer 
Mannheim (Lewes, UK) and NASBA reagents from Organon Technika (Boxtel, 
The Netherlands). T4 DNA polymerase, ribonuclease inhibitor, T7 transcription 
kits and T4 polynucleotide kinase were obtained from Helena Biosystems 
(Sunderland, UK) and oligonucleotides for PCR, NASBA and hybrid capture 
were supplied either by Perkin Elmer, Organon Technika or the University of 
Greenwich (London, UK). "Lymphoprep" solution was obtained from Nycomed 
(Oslo, Norway). Finally, "Copy kit" cDNA synthesis kits were obtained from 
Invitrogen (Leek, The Netherlands) and "Wizard" PCR and plasmid purification 
kits were obtained from Promega (Southampton, UK). 
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Table 4.1: Bacteria, viruses and cells 
Bacteria/virus/ Strain/Genotype Source 
cell 
MAX efficiency F- ý80d/acZAM 15 A(/acZYA- C; ibco BRL. (Paisley, 
E. coli cells argF)U 169 dcoR recAl endAl UK) 
hsdR 17 (rK-, mK )phoA su pE44 ?J 
thi-1 gvrA96 re/A I 
African green Catalogue number 8411300 1; European Collection 
monkey kidney susceptible to a range of viruses, of Cell Cultures 
Vero cells including measles mumps, and (Porton Down, UK) 
rubella 
Measles virus Hut strain, from a clinical isolate Gift from B. K. Rima, 
Queen's University 
Belfast, Northern 
Ireland 
Measles vaccine Schwarz strain; > 1,000 plaque Evans Medical 
forming units ofvirus per dose, (Horsham, UK) 
supplied as a lyophilised solid 
derived from infected chick embryo 
fibroblasts 
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Table 4.2: RNA and DNA 
RNA/DNA Description Source 
Mumps RNA Total RNA isolated from the Gift from Professor 
supernatant of Vero cells infected with Enders (Stuttgart, 
the VR 106 strain of mumps virus Germany) 
Rubella RNA Total RNA isolated from Vero cells Gift from Professor 
infected with the M33 strain of rubella Enders (Stuttgart, 
virus Germany) 
pT7B1ueE T/A cloning vector AMS Biotechnology 
(Witney, UK) 
HIVI gagt 144 bp Pstl / Sphl restriction Gift from B. van 
DNA endonuclease fragment (Tennen (Organon 
Technika) 
Table 4.3: Sizes of RNA and DNA size markers in base pairs 
G3151 
RNA 
marker 
(Promega) 
0.24-9.5 kb 
RNA marker 
(Gibco BRI. ) 
X1741Haelll 
1)NA marker 
(Gibco 13121) 
I kb DNA 
marker 
(Cibco BRI. ) 
100 bp 
DNA marker 
(Ilclcna 
13iosy stems) 
9488 9490 1353 11216 1636 1000 
6225 7460 1078 11198 101$ 900 
3911 440 872 10180 517 800 
2800 2370 603 9162 516 700 
1898 1350 310 8144 396 600 
872 240 281 7126 344 500 
562 271 6108 298 400 
363 234 5090 220 300 
194 4072 201 200 
118 3054 154 SU 
72 2036 134 
75 
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4.1.2. Buffers and solutions 
All buffers and solutions were made up in I litre of double deionised water (dd 
H2O), unless otherwise indicated, and sterilised by autoclaving at I20'(' 161* 
30 minn. 
Table 4.4: Buffers and solutions 
Buffer/solution Description 
Bromophenol blue/ I ml of solution was mixed with 4 nil ul tiorinamide 
xylene cyanol before use as a 6x loading dye. 
solution 
Denaturing solution 0.5 M sodium hydroxide and 1.5 M sodium chloride 
Fetal Bovine Serum Heat inactivated; sterile 
(FBS) 
Fix solution 5% (v/v) acetic acid and 15% (v/v) methanol. Not 
autoclaved 
Hybridisation buffer 5x SSC (v/v), 0.2% polyvinylpyrolidonc (w/v), (). 21), o 
(w/v) BSA, 0.2% (w/v) licoll, 8 nmM Na, I1PO4,13 nmM 
NaH"P04 and 7`%o (w/v) SDS. Not autoclaved 
(MOPS)-EDTA- IOx stock contains 0.4 M MOPS pH, 7.0, O. 1 M sodium 
sodium acetate buffer acetate, 10 mM FD'FA 
Neutralisation IM tris and 1.5 M sodium chloride in ddl 1,0, adjust 
solution pH to 7.4 with concentrated I ICI 
Phosphate buffered 8g sodium chloride, 0.2 g potassium chloride, 1.44 g 
saline (PBS) Na, HPO4,0.24 KH2PO4, Adjust pl I to 7.4 with 
concentrated I1('I 
RNA loading buffer 1.5 ml of stock loading butler contains 750 lil dcionised 
tormamnide, 240 pl 37% (v/v) lormaldehydc, 150 pl I Ox 
MOPS-ED'i'A-sodium acetate bul fcr, 180 ltl DFP('- 
treated dd11,0,100 pI glycerin and 80 pII O"%io (w/v) 
bromophenol blue. Not autoclaved 
Saline sodium citrate 20x stock; 175.3 g sodium chloride, S8.2 g sodium 
(SSC) citrate per liter ofddl 1,0. Adjust the pl I to 7.2 with 
concentrated NaOI I 
Tris-acetate-EDTA 50x stock; 242 g tris, 57.1 nil glacial acetic acid, IOO ml 
(TAE) 0.5 M EDTA (pH 8.0) 
Tris-borate-EDTA 5x stock; 54 g tris, 27.5 g boric acid, 20 nil 0.5 M 
(TBE) EDTA, pH 8.0 
Trypan blue 0.4 (w/v) % sterile solution. 
Wash buffer 3x (v/v) SSC and 1% (w/v) SI)S. Not autoclaved 
Washing/binding 1M sodium chloride, 10 mM Iris and I mM [1)'I'A in 
(WB) buffer DEPC-treated ddl F. O. Adjust the hI I to 7.4 using 
concentrated I ICI 
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Table 4.5: Culture media 
Culture media Description 
RPM 1 1640 media Sterile, filtered, endotoxin tested, without glutaminc. 
5 ml 200 mM L-glutamine. 50,000 U penicillin and 50 
mg streptomycin were added per liter before use 
Dulbecco's modified Sterile, filtered, with 4.5 gl glucose, without sodium 
Eagles media (Gibco pyruvate. 50,000 U penicillin, SO mg streptomycin and 
BRL; Paisley, UK) 100 ml FBS were added per liter before Lise 
Lymphoprep solution Obtained sterile and stored in the dark 
Luria-Bertani (LB) 10 g bacto-tryptone, 10 g sodium chloride, 5g hacto- 
media yeast extract in 1 liter ddli, O. Sterilised by autoclaving 
Agar plates 15 g bacto-agar per liter of sterile LB media and 
autoclaved. The solution was cooled to 50"(' before the 
addition of ampicillin to a final concentration o1' 
50 [tgml 
I 
and then poured into sterile agar plates (30) 
ml per plate) and left to set. For blue/white colony 
screening, 35 pl of 50 mgml I `egal and 20 pl o1' 
100 mM I PTG were spend over the surläcc ot'plates 
and allow to dry before use 
SOC media 10 g hacto-tryptonc, 5g bacto-yeast extract, 0.5 g 
sodium chloride and 10 nil of 250 mM potassium 
chloride in I liter d11,0, adjusted pl 1 toi 7.0 with 
concentated NaOl I and sterilise by autoclaving. 20 nil 
of sterile IM glucose solution and 5 nil sterile 2M 
magnesium chloride were added before use. 
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Table 4.6: Equipment and consumables 
Equipment Supplier Address 
Cell cuture flasks Fisons Loughborough, UK 
Eppendorf tubes Fisons Loughborough, IK 
Filter tips Advanced Leathencead, UK 
Biotechnologies 
Haemacytometer Fisons Loughborough, UK 
Horizon electrophoresis Gibco Paisley, tIK 
tanks and accessories 
(models 1 1: 14 and 58) 
Magnetic stands Dynal Wirral, UK 
Micropestels (sterile, BDH Ltd. Dagenham, UJK 
disposable) 
Mini-vertical Biorad I leniel Ilempstcad, UK 
electrophoresis system 
Nylon membranes Amersham International Amcrsham, UK 
(Hybond-N) 
PCH-2 thermal cycler Techne Cambridge, 11K 
Polaroid film (black and GRI Dunmow, I JK 
white; type 667) 
Sequencing gel unit and Amersham International Amcrshani, I IK 
accessories 
Ultra Turax T25 rotor Marathon Laboratory London, I JK 
and 8 mm dispering shaft Supplies 
Ultraviolet (UV) UVP San Gabrielle, USA 
transilluminator 
Uvikon Kontron Instruments Watford, l1K 
spectrophotometer 
------------ -- - --- - X-ornat automated x-ray Kodak --- --- -- ----- San Fransisco, IJSA 
processor 
X ray film (Fuji RX; GRI I)unniow, UK 
20x30 cm and 30x45 
cm) 
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4.2. METHODS 
4.2.1. General considerations 
RNA is a highly labile molecule and susceptible to degradation by 
ribonucleases. Ribonucleases are ubiquitous in living cells and highly resistant 
to heat inactivation. For this reason, all equipment and most reagents used in 
experiments involving RNA were treated in such a way as to destroy any 
ribonucleases present. 
DEPC was used to deactivate ribonucleases which it does by virtue of its ability 
to modify histine and tyrosine residues in proteins. DEPC was added to double 
deionised water (ddH2O) to a concentration of 1% (v/v) and the solution left to 
mix with a magnetic bar for 16 hrs at 20°C. The mixture was then autoclaved to 
remove DEPC. All glassware was cleaned with detergent, washed with tap water 
followed by ddH2O, baked at 180°C overnight and wrapped in aluminium foil 
prior to use. Prior to use, lectrophoresis tanks were filled with 3% hydrogen 
peroxide for 2 hrs, then rinsed with DEPC-treated ddH2O. Plasticware was 
soaked overnight in water containing 1% (v/v) DEPC then autoclaved, wrapped 
in aluminium foil and dried and prior to use. Disposable nuclease-free pipette 
filter tips were used in all experiments involving RNA. 
All RNA isolation procedures were performed in a 4°C cold room in order to 
protect RNA from potentially damaging enzyme activity. 
All reagents and buffers for DNA work were made up in ddH2O and autoclaved 
whenever possible. Sterile Eppendorf tubes were used. 
4.2.2. Cell culture and virus propagation 
Cell culture and PBMC isolation experiments, and measles virus propagation 
experiments were performed in separate laboratories in order to minimise the 
possibility of contamination. All cell culture experiments were performed in 
sterile hoods and incubations performed in 5% CO2 at 37°C. 
In order to permit the identification of any measles, mumps or rubella in PBMC 
samples, PBMCs were cocultivated with donor PBMCs and/or African green 
monkey kidney Vero cells. Cocultivation aids the isolation of virus by 
increasing the amount of virus present. 
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Cultivation of PBMCs. PBMCs were isolated from blood samples as described 
in section 4.2.3. Pellets of PBMCs were resuspended in 5 ml of RPMI 1640 
medi% and 50 pl of this suspension mixed with 50 µl of tryptophan blue 
solution. 50 µl of this mixture was placed on a haemacytometer slide and live 
cells counted by phase contrast microscopy. 106 PBMCs were used for 
cultivation experiments. The remaining PBMC suspension was centrifuged at 
400 g for 10 mins and PBMCs resuspended in 1 ml of 10% DMSO in FBS and 
stored at -70°C until required. 
106 PBMCs were made up to a volume of 5 ml with RPMI 1640, transferred to a 
sterile plastic flat-bottomed 25 cm2 cell culture flask and phytohaema utjinin 
(PHA)-L was added to a final concentration of 5 pgml". After three days of 
hU 
incubation, cells were transferred to a sterile 20 ml universal tube and 
centrifuged at 400 g for 30 mins. The resulting pellet was resuspended in 4 ml of 
RPMI 1640 medand split into four equal aliquots: 
z 
1. One aliquot was resuspended in RPMI 1640 medjdcontaining 2 Uml" IL-2 
and cells passaged three times to stimulate viral replication. Medi was 
changed three times per week and after each passage cell stocks were stored 
at -70°C for total RNA preparation. 
2. One aliquot was stored in 10% FBS in DMSO at -70°C as described above. 
3. One aliquot was cocultivated with donor PBMCs to stimulate viral 
replication. Live cells were counted as described above and 105 PHA-L- 
stimulated PBMCs were seeded with 105 PBMCs from a healthy donor in one 
well of a sterile 24 well plate. Cells were incubated for three days in 2 ml of 
RPMI 1640 mediä containing 2 Uml" IL-2. Cells were then centrifuged and 
either used directly for total RNA preparation or cocultivated with Vero cells. 
4. One aliquot of PBMCs was cocultivated with Vero cells as described below. 
Cultivation of Vero cells. Vero cell stocks, containing 106 cells were thawed at 
37°C, added to 10 ml of Dulbecco's modified Eagle's media and centrifuged at 
400 g for 10 mins. Cell pellets were then resuspended in 20 ml Dulbecco's 
modified Eagle's med, seeded in sterile plastic flat-bottomed 75 cm2 cell 
culture flasks and medi changed every three days. At confluence cells were 
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detached from the flask by the addition of 5 ml of trypsin/EDTA solution and 
incubated for 10 mins at 37°C. 10 ml of Dulbecco's modified Eagle's mediVwas 
then added and the solution transferred to a sterile 50 ml Falcon tube. The 
suspension was centrifuged, cell pellets were resuspended in 10 ml of 
Dulbecco's modified Eagle's meth and live cells were counted as described 
above. 
Cocultivation of Vero cells and PBMCs. 105 Vero cells, in 5 ml of Dulbecco's 
modified Eagle's mediý, were added to one well of a sterile, plastic 24 well plate 
and incubated. At subconfluence, med was replaced by either PBMCs or 
PBMC cocultures/mixed 1: 1 with Dulbecco's modified Eagle's media. 
After a1 hr incubation at 37°C, Vero cell coculture supernatants were discarded, 
Vero cells washed with PBS, and 5 ml of fresh Dulbecco's modified Eagle's 
mediaadded. Med%was changed three times per week and cells passaged up to 
seven times by trypsinisation, centrifugation and resuspension of cells as 
described above. Cells were checked for cytopathic effects (characteristic of 
measles virus infection) at each passage and aliquots of cells were stored at - 
70°C after each passage. Cell derived from individual PBMC samples were 
pooled, centrifuged and pellets used directly for total RNA preparation as 
described in section 4.2.3. 
Propagation of measles virus. Measles-infected Vero cells were used as a source 
of measles RNA for use as a positive control in measles RNA amplification 
reactions. Sterile 75 cm2 flasks containing confluent monolayers of Vero cells 
were obtained as described above. Measles virus stocks (lysates of previously 
infected cell cultures) were diluted 1: 10. Dulbecco's modified Eagle's mediV 
/Jdfý( was replaced by 2 ml of diluted virus solution and Vero cells and virus 
left to incubate for 2 hrs at 37°C. 8 ml of Dulbecco's modified Eagle's medidwas 
then added and the infected cells incubated for between 1 and 3 days until a 
clear cytopathic effect was observed. Cells were then scraped into sterile 20 ml 
universal tubes, centrifuged at 400 g and the resulting pellets used directly for 
total RNA preparation as described in section 4.2.2. Aliquots of infected cell 
pellets were also resuspended in 1 ml Vero medi and stored at -70°C for future 
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measles virus infections. 
4.2.3. RNA purification 
Cells. Cultured Vero cell monolayers were scraped from flasks, transferred to a 
50 ml sterile Falcon tube and centrifuged at 600 g for 10 mins at 20°C. The 
supernatant was aspirated and cell pellet resuspended in 3 ml of "Total RNA 
isolation reagent" by gentle pipetting, and the equal volumes of the emulsion 
transferred to two 1.5 ml sterile Eppendorf tubes. Total RNA was isolated 
according to the manufacturer's instructions (based on a method developed by 
Chomczynski and Sacchi, 1987). Total RNA pellets were resuspended in 50 µl 
of DEPC-treated ddH2O and RNA concentration determined spectro- 
photometrically (section 4.2.8. ). 30 U of ribonuclease inhibitor was added and 
samples stored at -70°C until required. 
Measles Vaccine. Four doses of a lyophilised sample of measles vaccine were 
resuspended in 1 ml of "Total RNA isolation reagent" and RNA isolated 
according to the manufacturer's instructions. RNA concentration and purity was 
determined spectrophotometrically (section 4.2.8. ). 
Blood. 10 ml of blood was taken from IBD, autistic enteropathy and control 
patients in EDTA-coated tubes. Blood samples were transferred to sterile 20 ml 
universal tubes and mixed with equal volumes of sterile PBS. Blood/PBS 
mixtures were gently laid onto 0.5 volumes of sterile lymphoprep solution (in 
sterile 20 ml universal tubes) using a sterile Pasteur pipette and centrifuged at 
600 g for 30 mins at 20°C. Buffy coats containing PBMCs were aspirated using 
sterile Pasteur pipettes and transferred to fresh sterile 20 ml universal tubes 
which were filled with PBS. The suspensions were centrifuged at 600 g for 
30 mins at 20°C. Supernatants were discarded and the PBMC pellets gently 
resuspended in 1 ml of "Total RNA isolation reagent". Total RNA was isolated 
according to the manufacturer's instructions. Isolated RNA pellets were 
resuspended in 30 µl DEPC-treated ddH2O and RNA concentration and purity 
determined spectrophotometrically. 
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Resection tissue. Intestinal resection tissue samples were obtained from 1131) or 
control patients undergoing surgical removal of diseased sections of large or 
small bowel. Areas of intestinal resection tissue were charcterized as 
macroscopically inflamed or normal and full-thickness intestinal resection tissue 
was divided into approximately 500 mg segments. Tissue samples were placed 
in sterile 2 ml cryovials and snap-frozen on liquid nitrogen prior to storage at - 
70°C. In all cases, the post-resection time until snap freezing was less than 
5 mins. 
Frozen resection tissue samples were transferred to a sterile 50 ml Falcon tube 
containing 3 ml of "Total RNA isolation reagent" and homogenised using an 
Ultra Turrax rotor and 8 mm dispersing shaft at 15,000 rpm for 2 mins. The 
emulsion was transferred to two sterile 1.5 ml Eppendorf tubes, total RNA was 
isolated according to the manufacturer's instructions, and RNA concentration 
and purity determined spectrophotometrically (section 4.2.8. ). 
Biopsy samples. Intestinal pinch biopsy samples were obtained from autistic 
enteropathy patients undergoing colonoscopy. Biopsies were transferred to 
sterile 2 ml cryovials, placed in liquid nitrogen then stored at -70°C within 
5 mins of biopsy removal. 
Frozen biopsies were transferred to sterile 1.5 ml Eppendorf tubes containing 
1 ml of "Total RNA isolation reagent" and a micropestel used to manually grind 
the biopsy into an emulsion. Total RNA was isolated according to the 
manufacturer's instructions and RNA concentration and purity determined 
spectrophotometrically (section 4.2.8. ). 
In vitro RNA transcripts. In vitro transcription reactions were depro ised as 
follows: an equal volume of phenol/chloroform/isoamyl alcohol (25: 24: 1) was 
added to the RNA transcript-containing solution in a sterile 1.5 ml Eppendorf 
tube and the mixture vortexed and centrifuged at 12,000 g for 5 mins at 20°C. 
The upper aqueous phase (containing RNA transcripts) was transferred to a fresh 
sterile 1.5 ml Eppendorf tube and 1 volume of cold isopropanol added. RNA 
was left to precipitate at -70°C for 16 hrs then centrifuged at 12,000 g for 
15 mins at room temperature. The supernatant was discarded and the RNA pellet 
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washed twice with 70% (v/v) ethanol, air dried and resuspenn 50 µl of DEPC- 
treated ddH2O. Total RNA concentration and purity was determined spectro- 
photometrically (section 4.2.8. ). 
The molecular mass of RNA transcripts was determined from their length and 
from this, concentrations of RNA transcripts were calculated in terms of 
molecules µl-l. 30 U of ribonuclease inhibitor were added and transcript RNA 
serially diluted in DEPC-treated ddH2O and stored at -70°C until required. These 
dilution series were subsequently used in later experiments to quantify the 
sensitivities of measles RNA detection methods (Chapters 5 and 8). 
4.2.4. Hybrid capture for measles N-gene RNA 
Magnetic solid-phase supports (MSPSs) were prepared according to a 
previously described method (Davies et al. 1997). 5'-amino modified capture 
sequences (HC I and HC2; Table 4.8) were covalently attached to 
carboxymethyl (CM) -modified MSPS by a water soluble carbodiimide- 
mediated coupling reaction described below. 
CM-MSPS (100 µl settled volume) was washed with 0.2 M 
morpholineethanesulphuric acid (MES), pH 6 (3 x 200 µl), then resuspended in 
200 pl 0.2 M MES/0.1 M 1-(3-dimethylaminopropyl)-3-ethyl carbomide (EDC), 
pH 6.0.25 pmol each of the HC1 and HC2 capture sequences (2.5 µl of a 
100 mM stock) were added, and the mixture shaken gently at 20°C for 24 hrs. 
The supports were then washed three times with 0.1 M potassium phosphate 
buffer (PB; 1 ml each), pH 7, and stored in a further 500 pl PB, p11 7, at 4°C 
until needed. 
50 µl of MSPS-capture sequence suspensions were placed in a sterile 0.5 ml 
Eppendorf tube. The MSPS was then immobilised using a magnetic stand and 
the supernatants removed. 50 µl of sample (containing up to 40 pg of total 
RNA) was diluted with an equal volume of WB buffer (see Materials), heated at 
65°C for 2 mins, added to the MSPS and the mixture was shaken gently at 20°C 
for 5 mins. MSPS was magnetically immobilised, the supernatants removed and 
MSPS was washed twice with WB buffer (150 µl each). To elute captured 
RNA, 10 pl of 2 mM EDTA, pH 7.4 was added to the MSPS and the mixture 
heated at 65°C for 5 mins, the MSPS magnetically immobilised and the RNA- 
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containing supernatant removed to a fresh sterile 1.5 ml Eppendorf tube and 
stored at -70°C until required. 
4.2.5. RT-PCR 
Reverse transcription. Reverse transcription reactions were carried out in lx RT 
reaction buffer containing 10 mM DTT, 0.5 mM each dNTP, 2.5 µM random 
hexamers (or 0.75 µM specific primer - see Table 4.8. ), 2U ribonuclease 
inhibitor and 200 U MMLV Superscript II reverse transcriptase. The reaction 
mixture was made up as a "master mix" and dispensed into sterile 0.5 ml 
Eppendorf tubes in 10 µl aliquots as required. 
10 µl of sample RNA (containing up to 5 µg of RNA) was denatured by heating 
to 70°C for 10 mins, cooled on ice and added to the 10 µl of RT reaction 
mixture. The mixture was incubated at 37°C for 2.5 hrs followed by a5 minute 
incubation at 95°C, to inactivate the MMLV reverse transcriptase. Product 
cDNAs were stored at -20°C until required for PCR. 
PCR. PCR reactions were carried out in lx PCR reaction buffer containing 
1.5 mM MgC12,0.2 mM each dNTP, 250 nM each primer and 1.25 U Taq DNA 
polymerase. Primer details are given in Table 4.8. The reaction mixture was 
made up as a "master mix" and dispensed into sterile 0.5 ml Eppendorf tubes in 
48 µl aliquots as required. Reaction mixtures were overlayed with 50 µl of 
mineral oil and 2 µl of reverse transcription mixture (see above) was added to 
each reaction mix. Reactions were cycled on a PCH-2 thermal cycler using the 
parameters given in Table 4.7. 
For nested or semi-nested PCR reactions, second round PCR reaction mixes 
were made up containing a pair of primers which annealed internally to those 
used in the first round reactions, and the same reagent final concentrations with 
1 µl of first round product in a total volume of 25 µl. The mixtures were 
overlayed with 40 µl of mineral oil and thermally cycled using the parameters 
given in Table 4.7. 
4.2.6. rh-mediated RT-PCR 
rTth RT-PCR reactions were carried out in lx EZ buffer containing 2.5 mM 
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Mn(OAc)2,300 µM each dN'1'P, 450 nM each primer and 5U rhh DNA 
polymerase. Primer details are given in Table 4.8. The reaction mixture was 
made up as a "master mix" and dispensed into sterile 0.5 nil I: ppendoýrl'tubes in 
40 µl aliquots as required. Reaction mixtures were overlaid with 50 fºI uI 
mineral oil before the addition of 10 µI of sample RNA thermal cycling using 
the parameters given in "fable 4.7. 
Table 4.7: 1 (R cycling parameters. 
Reaction 
P('R RT-P('R 
Template Measles N- 
and 11-genes 
11lA and 
mumps P-gene 
Rubella El 
gene 
Li l A, measles N- 
and II-genes 
Step I 95`'C, 5 rains 95"C, 5 rains 95"C, 3 minn 60"(', 30 rains 
Step 2 56"C, 30 secs 56°C, 30 secs 60"C, 1 min 95"C, I thin 
Step 3 72°C 30 secs 72°C, 30 secs 72"C, I min 56"C, I min 
Step 4 95°C, 30 secs 95°C, 30 secs 95"C, 30 secs 60"C, 7 minn 
Step 5 72°C, 5 mins 72°C, 5 rains 72"C, 5 minn 
Comments Steps 2,3 and 4 
repeated 35 
times lot owed 
by 25 times for 
nested P('R 
Steps 2,3 and 4 
repeated 40 times 
Steps 2,3 and 4 
repeated 40 
limes li0Itowed 
by 25 times Iclr 
nested P('R 
Steps 2 and 3 
repeated 40 tillies 
4.2.7. NASBA 
NASBA reaction mixtures were carried out in Ix NASBA hunter containing 
250 µM each dNTP, 500 µM each of ATP, I FIT and ("IT, 375 µM (u IT, 
125 µM FIT, and 250 µM each primer in DIT('-treated (ICII . ). Primer details 
are given in Table 4.8. The reaction mixture was made up as a "iiiastLr mix" and 
dispensed into sterile 1.5 nil Fppendort'tubes in 10 µI aliquots as required. 5 µI 
of sample RNA (containing 100 ng total RNA) was added and ddrººýºturecl by 
heating to 65"C 1iOr 5 rains. Reaction mixtures W ere suhSCyucntly transferred toi a 
41"C' water bath for 5 minn and 5 µl of'NASRA enzyme mix (which had been 
previously warmed to 20"(') was added to give final concentrations of 
0.1 U RNase H, 32 U T7 polynicrasc and 6.5 U AMV reverse transcriptase. 
rains. Reactions were mixed by gentle pipelting and incLºhated at 4I"(' for 90 
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Fahle 4.8: Oligonucleotide primer and probe sequences with 
target/annealing positions. 
Oligo Target Sequence 
Measles N-gene hybrid capture 
11(1 1329-1368 A(iA AA 1(AAI'A(']l(i(i(i('II(il('Ui(iliI('('AA('l'(i(Iß ; A1 ( 
II('2 128S- 122 GI I ICA (iA(iAll (('A: %I(i('Anl' IV I(IA(i(iA( ý. ýli: ýl l Ali 
Measles N-gene amplification 
Mvl 1192(-I2It) II i\ ((i(i (A\ (\U A (i U '\A66 
MV2 161 0- 1631 (111(11 CY'(i A(iA IY' ('l(i ('('A 
MV3 I249-12Mt A(i(' A'll' I (i A AC I ('(i(i 1AI CAC 
MV4 1480-1501 A(GC"IV I ('G(' Al(' A('l I(i(' '(`I' 
M V5 1348-1368 ACTA AA I GAI AC I G(i G(' II GI' 
A1320N(NASBA) 121)0-1219 A(i(i(iC'AA(iA(iAI GGI AA(i(AA 
A1122N(NASI3A) 1351)-1379 'Ill 'I I'. I. 'I77'. I%'. IU(1 (; (iA I('A ('('(i IGl A(iA 
AAI 
OA(' A 
All 10(IIRI') 1289-1309 (ill WA(iA(iAI'! (i('AAI(i('A 
Measles Il-gene RNA amplification 
mil 7_209-7_'; ; (i('II('('('I('I(i(i('('(i AA(' AA IA f(' (i 
113 ))l06-8125 ('. AU I('A(i1AAI(iAIC I('AG(' 
116 9677-8701 (11 I (iAA I(I ((iC IAI ('('A (' f(' ('AA I 
117 8 147-8 17 1 (iA(i('ICAAACI( (i('A1161 C 
114 8158-8482 AI('(I I ('AA I(i(i I(i('('('A('I('(iC(iA 
115 8370-81,921 1('l' ('l iA ('AA ('A(' 6A A ('AG A 10 Al' 
UIA RNA amplification 
tIAI 583-603 (i(i( cc(; (ICA ICI G(iI (i('A IAA 
UTA2 378-400 ('AO IAI (iCC'AA(iA('( (iAC ICA OA 
IIIAIN(NASIA) 593-61)3 IIl 1('1'. L17'. 1('(1.1('T('. I('717'. IC(I(i. 1G. l(i(i('l'l'(i(i('AICI (i(il 
(i('A IAA 
(IIA3 (1UlP) 451-472 A(iA A(iA (i(iA A(i(' ('('A AGA (i('C A 
Mumps P-gene RNA amplitication 
MUI') 2121)-21 ') (I( AI I ((i' AAI ('('A OAG CA 
MUI'2 2324-2343 AI(iAA('('1(i IU (ill (i(iA IA 
MUP3 ? 181-220)) AA(i I('A AA(i GG(' A(i'1 ((il' Il' 
Rubella El-gene RNA amplification 
R1 9807-9826 ('AA ( nl' lil'l' (('A '(i(i A( 'A A( 
R7 x )72-R9')I ('('A ('AA (i('l (i('li Ali(' Ali I ('A 
RII 882h-11)45 ('IC'(jA(i(ill'('A(i(iIC(I(i('C 
RR(' K94')-1)961) (iAA I OG ('C II ((i ('AA A((' CC 
Sequencing primers (for sequencing of DNA in vector pT7I3Iuc) 
I: I' 23-43 ('IAAIAC'(inl'ICA('IAIAC(i(i 
RI' 144-162 (i1. ll rc('('Al iI ('A('(in('C I 
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4.2.8. RNA and DNA analysis 
Agarose gel electrophoresis of RNA. 1.3 g of agarose was added to 100 ml 
MOPS-EDTA sodium acetate buffer made up in DEPC-treated ddH2O. This 
mixture was microwaved until the agarose melted then cooled to approximately 
50°C before the addition, in a fume hood, of 5.1 ml 37% (v/v) aqueous 
formaldehyde. The solution was mixed and poured into either a Horizon 11: 14 
or a Horizon 58 electrophoresis tank. After setting (approximately 30 mins), the 
gel was soaked in MOPS-EDTA-sodium acetate buffer for a further 30 mins 
prior to electrophoresis. 
RNA (up to 2 µg in a total volume of 5 µl), 5 µl of NASBA reaction products or 
1 µg of an RNA size marker, was added to 10 µl of RNA loading buffer and 1 pl 
of 1 mgml'1 ethidium bromide and the mixture heated to 70°C for 10 mins to 
denature the RNA. Samples were immediately loaded into gel wells and 
electrophoresed at 100 volts for 1 hr. The gel was placed on a ultraviolet (UV) 
transilluminator and photographed using a Polaroid camera fitted with black and 
white type 677 film. 
Agarose gel electro horesisniof DNA. 1.3 g agarose was added to 100 ml TAE 
buffer, made up in ddH2O, and microwaved until the agarose melted. The 
solution was cooled to approximately 50°C before the addition of 10 µl of 
10 mgml" ethidium bromide. The solution was mixed and poured into either a 
Horizon 11: 14 or a Horizon 58 electrophoresis tank and left to set for 
approximately 30 mins. 
10 µl of PCR reaction products, or 1 µg plasmid DNA, were mixed with 2 µl 
bromophenol blue-cyanol solution and loaded into gel wells, and DNA 
. 
electrophoresisLat 100 volts for 1 hr. The gel was placed on a UV 
transilluminator and photographed as above. 
Spectrophotometry. 2 µl of purified DNA or RNA was made up to 300 µl with 
dd H2O. Ths solution was added to a clean 300 µl spectrophotometry cell and 
the optical density (OD) of the solution was measured at 260 and 280 nm 
wavelengths using a Uvkon spectrophotometer. Nucleic acid concentration was 
determined by the OD260 value and nucleic acid purity determined by the OD260: 
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OD280 ratio. 
4.2.9. Nucleic acid hybridisation 
Blotting. Following electrophoresis, NASBA reaction products were transferred 
directly to a "Hybond-N" nylon membrane as described by Sambrook et al. 
(1989a) and RNA was subsequently cross-linked to membranes by 5 mins 
irradiation on a UV transilluminator. Membranes were stored at 4°C until 
required. 
PCR products were denatured by soaking in 200 ml of denaturing solution for 
40 mins at 20°C. The gel was then rinsed with ddH2O and soaked twice in 
200 ml of neutralising solution. DNA was then transferred to a "Hybond-N" 
nylon membrane as described by Sambrook et al. (1989b) and subsequently 
cross-linked to membranes by UV irradiation for 5 minn. Membranes stored at 
4°C until required. 
Probe production. All experiments involving radiolabelled probes were 
performed in a designated radioisotope laboratory under conditions in 
accordance with University of London radioisotope handling guidelines. 
Oligonucleotides were 5'-labelled to generate probes for hybridisation 
experiments by incubation of 5 pm oligonucleotide in 50 µl of T4 
polynucleotide kinase reaction buffer containing 15 µl of 3,000 Ci/mmol [y32P]- 
ATP and 15 U of T4 polynucleotide kinase for 5 mins at 37°C. Reactions were 
subsequently terminated by the addition of 2 µl 0.5 M EDTA and stored at - 
20°C until required. 
The percentage incorporation and specific activity of probes was determined by 
a filter-binding assay: 1 µl of reaction product was mixed with 100 µl 0.2 M 
EDTA and 3 µl of this solution spotted onto each of two pieces of Whatman 
3MM filter paper. One piece was washed twice with 0.5 M NaPO4, pH 7.4 for 
5 mins to remove unincorporated [y32P]-ATP. Both filters were then air dried, 
added to separate scintillation vials containing scintillation fluid, and counts per 
minute (cpm) measured for each sample in a scintillation counter. The 
percentage incorporation was calculated as the incorporated cpm, divided by the 
total cpm multiplied by 100. Results indicated that the reactions had consistently 
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generated [y32P]-ATP incorporation efficiencies of over 80%. 
The specific activity of the probe was calculated as the total cpm incorporated 
divided by the amount of labelled oligonucleotide expressed, as cpmµg'1. 
Hybridisation. All hybridisations were performed at 50°C. Nylon membranes 
were placed in a plastic container with a secure lid containing between 50 and 
200 ml (depending on the size of the membrane) of prewarmed hybridisation 
buffer. This container was placed in an outer plastic box containing prewarmed 
water and the boxes placed in a water bath gentle shaking for 2 hrs. Following 
prehybridisation, the inner container was removed and 2 µl of oligonucleotide 
labelling reaction was added per 100 ml of hybridisation buffer. The container 
was replaced in the outer box and gently shaken at 50°C for 16 hrs. 
Membranes were subsequently removed and washed twice in 100 ml of 
prewarmed wash buffer at 50°C for 10 mins each. Membranes were air dried, 
wrapped in cling film, placed in an autoradiography cassette, covered with Fuji 
RX X ray film (20x 30 cm) and placed at -70°C for 2 hrs. Film was processed 
automatically using a Kodak X-omat processor according to the manufacturer's 
instructions. If necessary, membranes were stored with X ray film for longer 
periods of time (up to several weeks) to allow for weak hybridisation signals to 
develop. 
Membrane reprobing. To permit reprobing of membranes, hybridised 
membranes were stripped of probe by placing in a glass beaker containing a 
solution of 0.1% SDS and 0. lx SSC and boiling for 10 mins. Membranes were 
subsequently removed, air dried, wrapped in cling film, and autoradiographed. 
The absence of any image on the film was taken as an indication that all, or at 
least a significant proportion of the hybridised probe had been removed and that 
the membranes were suitable for reprobing 
ELGA. For some studies, NASBA reaction products were analysed by an 
enzyme-linked gel assay method (van der Vliet et al. 1993) consisting of a liquid 
hybridisation with a HRP-labelled DNA probe (AB 10 or U1 A3) followed by 
polyacrylamide gel analysis in a mini-vertical electrophoresis system. 
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4.2.10. Cloning 
All cloning procedures described in this project were performed in accordance 
with University of London genetic manipulation guidelines. 
Three types of recombinant plasmid were produced in this study: 
1. pT7BIue plasmids containing PCR products, or cDNA derived from NASBA 
products which were used in sequencing experiments. 
2. pT7Blue plasmids containing MV1/MV2 PCR products - termed pT7BlueE - 
for the in vitro production of a measles RNA transcript which was used in 
experiments to quantify the sensitivities of measles RNA detection methods. 
3. pT7BlueE plasmids containing a HIV I gag I DNA insert - termed 
pT7B1ueE144 - used for the in vitro production of a modified measles RNA 
transcript which was used for competitive RT-PCR experiments. 
Figure 4.1: pT7Blue; a T/A cloning vector 
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Kpn 1(112) 
Sac I(118) 
EcoR 1(120) 
Bsb 1(415) 
moo, 
, 
Dra 111(508) 
BsaA 1(508) 
Drd 11(513) 
ýýgoA IV(609) 
, ý, Lg\ 
ýXmn 1(1058) 
Ap (81ý. 
1 BsaH 1(1119) 
Sca l(1 177) 
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4.2.11. Insert preparation 
NASBA products. NASBA reactions were deproj, ý/ised by phenol/ (v 
chloroform/isoamyl alcohol separation and precipitated in isopropanol. Blunt- 
ended cDNA was prepared from 5 pg of product using a "Copy kit" according to 
the manufacturer's instructions (Gubler and Hoffman, 1983) and purified again 
by phenol/chloroform/isoamyl alcohol treatment and precipitation in 0.1 volume 
of 3M sodium acetate, pH 5.0, and 2.5 volumes of cold ethanol. cDNA was 
precipitated by incubation for 16 hrs at -20°C and recovered by centrifugation at 
12,000 g for 15 mins at 4°C. The supernatant was discarded, cDNA pellets 
washed twice in 70% (v/v) ethanol and resuspended in 20 µl sterile ddH2O. To 
check efficient isolation, cDNA was analysed by agarose gel electrophoresis and 
cDNA concentration was determined spectrophotometrically. 
5' termini of the blunt-ended cDNA7hosphorylated by incubation of 10 pm 
of purified cDNA in a 50 µl reaction containing lx T4 polynucleotide kinase 
reaction buffer, 4 mM ATP and 15 U T4 polynucleotide kinase for 5 mins at 
37°C. Reactions were terminated by the addition of 2 pl 0.5 M EDTA, reaction 
mixtures deproiised, and phosphorylated products precipitated as described 
previously. 
PCR products. 20 µl of PCR product were electrophoresed at 100 volts in a 2% 
low melting point agarose gel containing 10 pgml'1 ethidium bromide until the 
DNA fragment of interest was resolved. The gel was transferred to a UV 
transilluminator and a slice of gel containing the DNA fragment was removed 
with a sterile scalpel. The gel slice was transferred to a sterile 1.5 ml Eppendorf 
tube and melted by incubation at 70°C for 5 mins. DNA was separated from the 
melted gel using a "Wizard PCR preps DNA purification system" according to 
the manufacturer's instructions. DNA was eluted in 20 µl of sterile ddH2O and 
analysed by agarose gel electrophoresis and its concentration determined 
spectrophotometrically. 
HIVI gagl restriction fragment. 10 ng of a 144 bp PstI / SphI restriction 
endonuclease fragment from HIVI gagl DNA was made blunt-ended by its 
incubation with 5U T4 DNA polymerase in a 20 µl reaction containing lx T4 
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DNA polymerase reaction buffer, 100 µM each dNTP and 0.1 mgml"1 BSA for 
5 mins at 37°C. Reactions were subsequently terminated by heating to 75°C for 
10 mins. DNA was deproteinated, precipitated and recovered DNA resuspended 
in 20 µl sterile ddH2O. 
4.2.12. Vector preparation 
pT7BlueE. 1 µg of pT7BlueE was linearised by incubation 10 U NsiI in a 50 µl 
reaction containing lx reaction buffer for 2 hrs at 37°C. Reaction mixtures were 
depro iised, DNA precipitated, and recovered DNA resuspended in 20 µl of 
sterile ddH2O. To ensure complete plasmid linearisation, plasmid was analysed 
by agarose gel electrophoresis, and DNA concentration was determined 
spectrophotometrically. 
Linearised plasmid was blunt-ended using T4 DNA polymerase, reactions 
KV deproý e iised and DNA recovered as described previously. 
5' plasmid DNA termini were dephosphorylated by incubation with 1U alkaline 
phosphatase per pmol 5' DNA ends in a 50 µl reaction containing lx alkaline 
phosphatase reaction buffer for 15 mins at 37°C, then 15 mins at 56°C. A 
further 1U of alkaline phosphatase was added to the reaction and the 
incubations repeated. 
pT7Blue. For the ligation of blunt-ended insert DNA, 500 ng pT7Blue was 
blunt-ended using T4 DNA polymerase as described above. DNA was purified, 
analysed and DNA concentration determined as described above. 
4.2.13. Ligations 
PCR products and pT7Blue. PCR products can be ligated directly with a T/A 
cloning vector (Marchuk et al. 1991). 100 ng of plasmid pT7Blue and an equal 
molar ratio of purified PCR product were ligated in a 10 µl reaction composed 
of lx T4 DNA ligase buffer and 1 Wiess unit of T4 DNA ligase. Reactions were 
incubated at 16°C for 16 hrs and stored at -20°C. 
Blunt-ended cDNA and pT7Blue. 100 ng of phosphorylated, blunt-ended cDNA 
derived from NASBA reaction products were ligated with blunt-ended 
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pT7B1ueE at an insert: vector molar ration of 3: 1 as described previously. 
HIV1 gagl restriction fragment and pT7B1ueE. 10 ng of purified, blunt-ended, 
dephosphorylated plasmid pT7BlueE and all of the recovered blunt-ended, 
phosphorylated HIVI gag! DNA fragment were ligated as described previously. 
4.2.14. Transformation of competent E. coli 
All transformations were performed in triplicate. 1010 "MAX efficiency" 
competent DH5a E. coli cells were dispensed into 20 µl aliquots in sterile 1.5 ml 
Eppendorf tubes. 1 µl of ligation reaction mixture was added and the suspension 
mixed by gentle pipetting and left on ice for 30 mins. The suspension was 
shocked by placing at 42°C for exactly 40 sees then placed on ice for 2 mins. 
80 µl of sterile SOC media was added to the suspension and the mixture 
incubated with gentle shaking for 1 hr at 37°C. 
50 µl of the suspension was subsequently spread onto LB agar plates containing 
50 µgml-' ampicillin using a sterile glass rod and left to dry. Agar plates were 
incubated inverted at 37°C until the colonies developed. 
Controls were included to determine the rate of spontaneous mutation to 
ampicillin-resistance, and for transformation efficiency. 
4.2.15. Screening of transformants 
pT7Blue possesses a functional LacZ operon (coding for (3-galactosidase) for 
blue/white screening of recombinant plasmids. IPTG is an inducer of the LacZ 
operon while Xgal is a substrate for ß-galactosidase which when cleaved, 
releasing a blue indolyl derivative. Bacterial colonies containing recombinant 
plasmids retain a white colouration while those containing no insert DNA appear 
blue. 
Transformants containing pT7Blue vectors were screened by growth on LB agar 
plates containing Xgal and IPTG. Single white bacterial colonies were 
transferred to sterile 20 ml universal tubes containing 3 ml LB media and 
50 µgml"1 ampicillin using sterile pipette tips. The suspensions were incubated 
for 16 hrs with shaking at 37°C to culture transformed E. coli. 
To determine the efficiency of the ligation reactions, the blue bacterial colonies 
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(containing self-ligated plasmids) and the number of white bacterial colonies 
(containing recombinant plasmids) were counted following incubation of 
transformation reactions on agar plates containing Xgal and IPTG. The ligation 
efficiency was thus the number of white bacterial colonies divided by the total 
number of bacterial colonies. 
As pT7BlueE did not possess a functional LacZ operon, transformed bacterial 
colonies were cultured, plasmid DNA isolated and screened for insert DNA by 
restriction digestion reactions described below. 
4.2.16. Recombinant plasmid isolation and analysis 
Plasmid isolation. Recombinant plasmids were isolated from bacterial culture 
using a "Wizard plus minipreps DNA purification system". Recovered plasmid 
DNA was precipitated in ethanol and the recovered DNA resuspended in 30 µl 
sterile ddH2O. 
Plasmid analysis. 1 gg of plasmid DNA was analysed for the presence of 
measles-specific insert DNA by the following restriction endonuclease 
digestions: 
1. pT7B1ueE vectors (pT7Blue vectors containing MV1/MV2 PCR product 
insert) by digestion with 10 U Sac1 and 10 U NsiI in a 20 µl reaction 
containing 1x reaction buffer at 37°C for 2 hrs. 
2. pT7Blue vectors containing PCR products, or cDNA generated from NASBA 
products by restriction endonuclease digestion with 10 U NsiI in a 20 µ1 
reaction containing lx reaction buffer at 37°C for 2 hrs. 
3. pT7B1ueE vectors containing HIV-1 gagl insert DNA by restriction digestion 
with 10 U Hindlll in a 20 µ1 reaction containing Ix reaction buffer at 37°C 
for 2 hrs. 
Products from restriction digestion reactions were analysed by agarose gel 
electrophoresis. 
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4.2.17. In vitro transcription 
Template preparation. 10 µg of purified pT7B1ueE or pT7B1ueE144 were 
linearised downstream from the insert DNA sequence using 50 U EcoRI in a 
50 µl reaction at 37°C for 2 hrs. 1 µl of digested plasmid was analysed by 
agarose gel electrophoresis to ensure efficient plasmid linearisation. Reaction 
mixtures were depro 
e ised, linearised plasmids precipitated in ethanol and 
recovered DNA resuspended in 20 µ1 of DEPC-treated ddH2O. The 
concentration of recovered DNA was determined spectrophotometrically. 
In vitro transcription. 2 pg of purified, linearised plasmid DNA were used as 
templates for in vitro transcription using a "T7 Transcription kit" according to 
the manufacturer's instructions. Post reaction, template DNA was removed by 
the addition of 10 U RNase-free DNaseI and the mixture incubated at 37°C for 
15 mins. The reaction was stopped by the addition of 2 p1 0.5 M EDTA, 
A% depro4ised and transcript RNA recovered and stored as described in section 
4.2.3. 
Plasmid DNA contamination of transcripts. The presence of any contaminating 
plasmid DNA in the measles transcript RNA (e. g. from incomplete DNaseI 
digestion) was determined by performing PCR (using Taq DNA polymerase) 
without prior RT on a serial dilution of wild-type transcript. Primers MV3 and 
MV4 were used to amplify contaminating plasmid DNA in transcript RNA as 
described in section 4.2.5. 
Additionally, RNA transcripts were pretreated with 0.05 pgml'1 RNase A for 
30 mins at 37°C. Products were amplified by PCR as above to further 
demonstrate the presence of contaminating plasmid DNA in transcript RNA 
samples. 
4.2.18. DNA sequencing 
DNA sequencing in this project was carried out by the method developed by 
Sanger (1977). All sequencing reactions were performed in duplicate and in both 
directions to ensure that accurate sequence data was obtained. 
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Gels. Two large sequencing glass plates were cleaned thoroughly with 70% 
(v/v) ethanol in ddH2O. To prevent the gel sticking to the glass plates, 1 ml of 
dimethyldichlorosilane was spread over the surface of each plate using tissue 
paper. After 5 mins, tissues soaked in 70% ethanol were used to gently wipe 
away the dimethyldichlorosilane. Glass plates were assembled with spacers and 
sealed with tape to prevent leaking of the gel. 
100 ml of "gel mix" containing 3 mM TEMED and 0.6% ammonium 
persulphate was made up according to the manufacturer's instructions, mixed 
thoroughly and poured between the two glass plates. After 30 mins, the glass 
plates and gel were placed in the sequencing apparatus, covered with lx TBE 
and a shark-tooth comb positioned at the top of the gel. 
Sequencing reactions. All experiments using [a35S]-dATP were performed in 
accordance with the University of London radioisotope handling guidelines. 
1 µg of purified plasmid DNA obtained as described in section 4.2.13. was used 
as template for sequencing reactions using a "ThermoSequenase cycle 
sequencing kit" according to the manufacturer's instructions. Reactions 
contained [a35S]-dATP, one dideoxy NTP and either a forward (FP) or reverse 
(RP) sequencing primer (described in Table 4.8). Following cycle sequencing, 
2 µl of stop dye was added to terminate the reactions which were stored at -20°C 
until required. 
Gel analysis. Reactions products were denatured at 95°C for 5 mins and 3 µl 
loaded into the sequencing gel and electrophoresed at 1,600 volts for 3 hrs. 
Subsequently, the glass plates were separated and the gel still attached to one 
plate was carefully transferred to 21 of fix solution (Table 4.4. ). After gentle 
agitation for 30 mins at 20°C the gel and glass plate was removed from fix 
solution and a sheet of Whatman 3MM filter paper placed over the gel. residual 
fix solution was removed from the filter paper and the gel and filter paper was 
separated from the glass plate and covered in cling film. The gel was 
subsequently dried at 80°C under vacuum for lhr then cooled to 20°C and 
placed in an autoradiography cassette with Fuji RX X ray film (30x 40 cm). The 
cassette was left for 24 hrs at 20°C and the film developed automatically as 
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described previously. 
Automated DNA sequencing. As an alternative to manual DNA sequencing, 
500 ng of purified plasmid DNA and gel-purified PCR products were sequenced 
using an ABI Prism (version 2.1.1. ) automated DNA sequencer. This was 
carried out at the Microchemical Facility, Babraham Institute. 
117 
Chapter 5 
118 
Chapter 5: DEVELOPMENT OF AN ASSAY SYSTEM FOR USE IN 
EXPERIMENTS TO COMPARE THE SENSITIVITIES OF 
THREE NUCLEIC ACID AMPLIFICATION METHODS 
FOR MEASLES RNA DETECTION 
5.1. INTRODUCTION 
A region of the measles virus genome was cloned and used as a template for in 
vitro transcription. Measles RNA transcripts thus generated used as wý "we 
templates for measles RNA amplification to aid in detection sensitivity 
experiments. In addition, these transcripts could be used to "spike" samples 
during future methods development experiments described in Chapter 8. 
Three methods were used in this project for measles RNA detection: RT 
followed by nested PCR, using MMLV reverse transcriptase and Taq DNA 
polymerase; combined RT-PCR using rTth DNA polymerase; and NASBA. 
Experiments were conducted using the transcript generated above to assess their 
relative efficiencies of measles RNA detection in water. In addition, total RNA 
from a measles virus-infected cell line, and total RNA from a measles vaccine 
sample were also used to confirm the relative sensitivities of the three detection 
methods. 
Aim. The aims of this part of the project were to: 
1. Clone a region of the measles genome to permit the synthesis of measles 
RNA transcripts. 
2. Determine the relative sensitivities of three nucleic acid amplification 
methods using a range of measles RNA templates derived from different 
sources. 
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5.2. RESULTS 
5.2.1. In vitro measles N-gene transcript generation 
Cloning (Fi rgu e 5.1. ). Total RNA was isolated from measles-infected Vero cells 
as described in section 4.2.3.100 ng of isolated total RNA was used in an RT 
reaction with random hexamers and 1 µl of the product from RT used for PCR, 
with primers MV I and MV2 and Taq DNA polymerase (section 4.2.5). The 
resulting 433 bp PCR product contained both measles PCR and NASBA primer 
binding sites and 50 ng of this PCR product was gel-purified and ligated with 
pT7Blue (section 4.2.10. ). 
Plasmids were transformed into competent E. co1i (section 4.2.11. ), and blue and 
white screening was used to select four transformed bacterial colonies 
containing recombinant plasmids (section 4.2.12. ). Transformed bacterial 
colonies containing recombinant plasmids were cultured and recombinant 
plasmid DNA isolated (section 4.2.13. ). 
The presence of MV1/MV2 insert DNA, and its orientation within pT7Blue, was 
determined by double restriction endonuclease digestion of recombinant plasmid 
DNA with Sacl and NsiI as described in section 4.2.13. The NsiI restriction site 
is unique to the MV1/MV2 insert DNA sequence, while the Sacl restriction site 
flanks the insertion site on pT7Blue (Figure 4.1. ). Therefore recombinant 
plasmids containing measles insert DNA in the MV1/MV2 orientation gave rise 
to a 323 bp restriction fragment, while recombinant plasmids containing measles 
insert DNA in the opposite (MV2/MV1) orientation gave rise to a 133 bp 
restriction fragment (Figure 5.1. ). 
Recombinant pT7Blue vector from the transformed bacterial clone "E", 
containing measles DNA in the MV2/MV 1 orientation was selected for in vitro 
transcription. A diagrammatic representation of pT7BlueE and measles 
amplification primer binding sites is given in Figure 5.2. 
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Figure 5.1: Restriction digests of recombinant pT7BIueE. 
inant plasmids E to H digested with Nsil and Sac/ to determine the 
specificity and orientation of insert DNA as described in section 4.2.13. The 
points to a 133 bp DNA fragment indicating the presence of measles DNA 
in the MV2/MV 1 orientation (plasmids E, F and G). Plasmid li contains insert 
DNA in the MV I /M V2 orientation giving rise to a 323 hp restriction fragment. 
Lane M contain aI kb DNA size marker described in Table 4.3. 
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Figure 5.2: Measles amplification primer positions and relevant 
restriction sites on recombinant pT7BIueE. 
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In vitro transcription (Figure 5.3. ). 10 µg of pT7BlueE was linearised 
downstream from the insertion site by restriction digestion with 50 U EcoRI 
(section 4.2.14. ). 2 µg of linearised plasmid was recovered from this reaction 
and used as a template for in vitro transcription (section 4.2.14. ). 
Following in vitro transcription, plasmid DNA was removed by digestion with 
DNasel and measles wild type RNA transcripts (506 nt in length) of negative 
sense were recovered from the mixture (section 4.2.14. ). Transcript RNA was 
analysed by agarose gel electrophoresis (section 4.2.8. ), its concentration 
determined spectrophotometrically (section 4.2.8. ), and this concentration 
converted from ngµl-I to numbers of molecules µl-' as the length of the RNA 
transcript was known. A stock serial dilution of transcript RNA was made up in 
water, dispensed into aliquots containing between 109 molecules and 
1 molecule, and stored at -70°C until required. 
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Figure 5.3: Gel analysis of wild type measles RNA transcript. 
500 ng of measles wild-type 
- 
transcript (lanes E) analysed by 
agarose gel electrophoresis (section 
4.2.8. ). Lane M contains an RNA size 
marker (G315A; described in Table 
4.3. ). The arrow points to a predicted 
506 nt RNA transcript. 
Detection of plasmid DNA contamination ftigure 5.4. ). "I he presence of 
contaminating plasmid DNA in the recovered RNA transcripts may lead to an 
overestimation of the RNA transcript concentration. For this reason, it was 
important to check the measles RNA transcripts for contaminating plasmid DNA 
(section 4.2.14. ). 
PCR alone, using primers MV3 and MV5, was performed on the stock measles 
RNA transcript series. Reaction products were analysed by agarose gel 
electrophoresis (section 4.2.8. ) and hybridisation with a radiolabelled probe 
(AB 10; section 4.2.9. ). 
PCR products were detected only when at least 10q transcript molecules were 
used as a template for amplification. 
Next, PCR alone was performed on a serial dilution of RNA transcripts which 
had been pre-treated with RNase A to digest transcript RNA (section 4.2.14. ). 
No PCR products were generated. 
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Figure 5.4: PCR analysis of transcripts for contaminating plasmid DNA. 
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(a. ) Gel and (b. ) Southern blot analysis of amplification products from "a nested 
PCR reaction using Taq DNA polymerase with primers MV3 and MV5 (section 
4.2.5. ). Lanes l 
,, 
to 4 contain products from reactions with 109 to 106 measles 
transcripts pretreated with RNase and lanes 6 to 9 contain products from 
reactions with 109 to 106 measles transcripts without RNase pretreatment. Lanes 
4,10,11 and 12 contain products from negative control reactions with water. 
Lane13 contain products from a positive control reaction with cDNA from 1 ng 
measles-infected Vero cells. Southern blots were probed with radiolabelled 
AB 10 (section 4.2.9. ). 
The arrow points to a 120 bp MV3/MV5 PCR, product. Lane M contains a 
100 bpýDNA size marker. 
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5.2.2. Experiments to determine the relative sensitivities of RT-nPCR, 
rTth-mediated RT-PCR and NASBA. 
RNA templates for measles amplification reactions. Three different measles 
RNA samples were used as templates. Firstly, measles wild type RNA 
transcripts synthesised from pT7B1ueE. Secondly, total RNA isolated from Vero 
cells which had been infected with the Hu2 strain of measles virus (from a 
clinical isolate; Table 4.1. ) as described in sections 4.2.2. and 4.2.3. Thirdly, 
total RNA isolated from four doses of a Schwarz strain measles vaccine sample 
(Table 4.1. ) as described in section 4.2.3. In this latter case, the yield of total 
RNA was so low as to be unmeasureable spectrophotometrically and dilutions 
of vaccine RNA were quantified in terms of the dilution factor of the stock 
solution. 
Amplification reactions. 
1. RT-nPCR: RT, using random hexamers and MMLV reverse transcriptase, 
followed by nested PCR (primer pairs MV I and MV2, then MV3 and MV4) 
with Taq DNA polymerase (section 4.2.5. ). 
2. rTth-mediated RT-PCR: using rTth DNA polymerase, primers MV3 and 
MV4 and EZ buffer (section 4.2.6. ). 
3. NASBA: using primers AB20 and AB22 (section 4.2.7. ). 
Reaction products were analysed by agarose gel electrophoresis (section 4.2.8. ) 
and hybridisation with a 32P-radiolabelled probe (AB 10; section 4.2.9. ). 
All experiments were performed at least three times to confirm data. 
Measles wild type RNA transcript (Figure 5.5. ). 
1. RT-nPCR was observed to be able to detect as few as 108 copies of measles 
wild-type transcript RNA (Figure 5.5. a. and b. ). 
2. rTth-mediated RT-PCR was observed to be able to detect as few as 
100 copies of the same transcript RNA (Figure 5.5. c. and d. ). 
3. NASBA was observed to be able to detect as 
W 
as 1 copy of this transcript 
RNA (Figure 5.5. e. and f. ). 
These sensitivities are represented in Table 5.1. 
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Figure 5.5: RT-nPCR, rTdr-mediated RT-PCR and NASBA 
amplification of measles wild type transcript RNA. 
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(a. ) Gel and (b. ) Southern blot analysis (section 4.2.8. ) of RT-nPCR products 
copies (lanes I to 9) of (section 4.2.5. ). from a serial dilution from 1010 to 10' 
measles transcripts in water. Lane 10 contains products from a negative control 
reaction with water. The arrow points to the 253 bp MV3/MV4 PC R product. 
(c. ) Gel and (d. ) Southern blot analysis of r'1'th-mediated RT-PCR products 
(section 4.3.6. ) from a serial dilution from 10' to I copies (lanes I to II) of 
measles transcripts in water. Lane 12 contains products from a negative control 
reaction with water 
(e. ) Gel and (f. ) Northern blot analysis of NASBA products (section 4.2.7. ) from 
a serial dilution from 1O7 to 0 copies (lanes I to 9) of measles transcripts in 
water. Lane 10 contains products from a negative control reaction with water. 
The arrow points to a 179 nt AB2O/AB22 NASBA product. 
All reaction products were probed with radiolabelled AB 10. Lanes labelled M 
contain a ýX 174/Hae Ill DNA size marker, described in Table 4.3. 
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Total RNA from measles virus-infected Vero cells (Figure 5.6. ). 
1. RT-nPCR was observed to be able to detect measles RNA in as little as 10 pg 
total RNA from measles-infected Vero cells (Figure 5.6. a. and b. ). 
2. rTth-mediated RT-PCR was observed to be able to detect measles RNA in as 
little as I pg total RNA from measles-infected Vero cells (Figure 5.6. c. and 
a. ). 
3. NASBA was observed to be able to detect measles RNA in as little as 100 tg 
total RNA from measles-infected Vero cells (Figure 5.6. c. and f. ). 
These sensitivities are represented in Table 5.1. 
Total RNA from a measles vaccine sample (data not shown). 
1. RT-nPCR was observed to he able to detect measles RNA in a1 ft-4 dilution 
of measles vaccine RNA. 
2. rTth-mediated RT-PCR was observed to he able to detect measles RNA in a 
10-5 dilution of measles vaccine RNA. 
3. NASBA was observed to he able to detect measles RNA in a 1O" dilution of 
measles vaccine RNA. 
These sensitivities are represented in Table 5.1. 
Table 5.1: The relative sensitivities of R'T-nPCR, rTth-mediated RT- 
PCR and NASBA for measles virus RNA in water. 
Measles RNA template RT-nPCR r7Nr-mediated NASBA 
RT-PC R 
Total RNA from 10 pg 1 pg wo ig 
measles- infected Vero 
cells 
Measles wild type RNA 108 molecules 10 molecules I molecule 
transcript 
Total RNA isolated from 0-4 dilution 10-5 dilution 10-" dilution 
a measles vaccine sample 
127 
Figure 5.6: Amplification of total RNA from measles-infected Vero cells 
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(a. ) Gel and (b. ) Southern blot analysis (section 4.2.8. ) of RT-nPCR products 
(section 4.2.5. ) from a serial dilution from 10 ng to I pg (lanes I to 5) of tota! 
RNA from measles-infected Vero cells in water. Lane 6 contains products from 
a negative control reaction with water. The arrow points to a 253 hp MV3/MV4 
PCR product. Lane M contains a ýX 174/1/ae III DNA size marker. 
(c. ) Gel and (d. ) Southern blot analysis of rTth-mediated RT-PCR (section 
4.2.6. ) products from a serial dilution from I ng to 100 fg (lanes I to 5) of total 
RNA from measles-infected Vero cells in water. Lane 6 contains products 11-onm 
a negative control reaction with water. 
(e. ) Gel and (f. ) Northern blot analysis of NASBA products (section 4.2.7. ) from 
a serial dilution from I ng to I fg (lanes I to 7) of total RNA from nmeasles- 
infected Vero cells. Lane 8 contains products from a negative control reaction 
with water. The arrow points to a 179 nt AB20/AB22 NASBA product. Lane Ni 
contains a 100 bp DNA size marker (Table 4.3. ). 
All reaction products were probed with radiolabelled AB 10 (section 4.2.8. ). 
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5.3. DISCUSSION 
Cloning experiments successfully generated recombinant plasmids containing a 
region of the measles virus genome. One plasmid (pT7B1ueE) was selected for 
in vitro transcription which contained insert DNA in the MV2/MV 1 orientation. 
pT7BlueE yielded measles RNA transcripts representing the genomic, negative 
sense. Such negative sense measles RNA was an appropriate template with 
which to assess the efficiencies of nucleic acid amplification methods as 
negative strand genomic measles RNA is most likely to be detected in clinical 
samples persistently infected with measles virus, rather than positive strand, 
messenger RNA which is indicative of a replicating virus infection. 
pT7BlueE was used to generate a measles wild type RNA transcript which was 
subsequently used to accurately quantify the sensitivity of various measles RNA 
detection methods. In addition, this transcript was used in later studies (Chapter 
8) to spike samples in order to measure the efficiency of measles RNA isolation 
and amplification from clinical samples. 
PCR alone on the transcript stock dilution series yielded specific products when 
109 transcripts were used for amplification. However, these products may have 
arisen as a result of the reverse transcriptase activity of Taq DNA polymerase 
(Grabko et al. 1996), rather than from contaminating plasmid DNA. A 
subsequent experiment yielded no PCR products when transcript RNA was first 
digested with RNase A, indicating that the PCR products generated using at least 
109 transcripts had probably been due to the reverse transcriptase activity of Taq 
DNA polymerase rather than the presence of contaminating plasmid DNA. 
Total RNA was successfully isolated from measles-infected Vero cells and from 
a measles vaccine sample. This meant that three measles RNA templates were 
available test the relative sensitivities of each measles RNA amplification 
method. 
From experiments conducted to assess the relative efficiencies of the three 
methods to detect measles RNA in water, the results indicated that NASBA was 
the most sensitive method. NASBA showed at least a ten-fold increase in 
sensitivity over RT-nPCR and rTth-mediated RT-PCR (Table 5.1. ). 
The increased sensitivity of NASBA over RT-PCR may have been due to the 
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fact that NASBA is a continuous amplification process and therefore represents 
a more efficient method of RNA amplification compared to a two-step RT-PCR 
process. 
These experiments represent the first time that NASBA has been used for the 
amplification of measles RNA. 
The results of the detection sensitivity experiments showed at least a ten-fold 
increase in the sensitivity of measles RNA detection using rTth-mediated RT- 
PCR, compared to RT-nPCR for all the measles RNA templates analysed. This 
increase in sensitivity was particularly evident when the measles wild type 
transcript was used as a template for amplification. Such an increase could be 
due to the fact that elevated temperature (60°C) is used for reverse transcription 
when employing rTth DNA polymerase and EZ buffer, compared to MMLV 
reverse transcriptase (37°C). At this increased temperature RNA secondary 
structures could be reduced allowing more efficient reverse transcription. 
However, no increase in the detection sensitivity of RT-PCR using MMLV and 
Taq DNA polymerase was observed when RNA samples were denatured by 
heating prior to reverse transcription (data not shown). 
The results generated in this part of the study indicate that the methods are a 
sensitive and potentially useful way of detecting measles virus RNA. 
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Chapter 6: EXPERIMENTS TO DETECT MEASLES VIRUS RNA IN 
IBD TISSUE USING NASBA 
6.1. INTRODUCTION 
As a consequence of the results obtained from the previous study, NASBA was 
used in a preliminary study to analyse intestinal resection tissue from IBD 
patients for the presence of measles RNA. Full-thickness resection specimens 
were used for this study as they represented the most likely source of Crohn's 
disease granulomas - the location of measles antigen reported in previous studies 
(Wakefield et al. 1993 and 1997; Miyamoto et al. 1995; Lewin et al. 1995; 
Ekbom et al. 1996 and Daszak et al. 1997). 
In addition to IBD tissue, NASBA was used to analyse intestinal resection tissue 
from non-IBD control patients in order that the statistical significance of any 
measles RNA detected in IBD tissue could be determined. 
To assess isolated total RNA integrity, NASBA for a housekeeping RNA 
species, UTA RNA - forming part of the U1A spliceosome subunit (Sillekens et 
al. 1987) - was performed. In addition, total RNA isolated from tissue samples 
n was a/alysed 
by agarose gel electrophoresis. RNA samples which tested positive 
by U1A NASBA were used for measles NASBA reactions. 
As a positive control for the ability of NASBA to detect measles RNA in 
persistently infected tissue, NASBA was performed on total RNA isolated from 
autopsy material of patients with SSPE. 
To reduce the possibility of the generation of false positive results through 
laboratory contamination, the Norwood lab (University of Greenwich, London) 
was used for total RNA extraction and NASBA reactions, while laboratory 
10.324 (Royal Free Hospital, London) was used for NASBA product analysis. 
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Aims. The aims of this part of the study w 'to. 
1. Isolate total RNA from intestinal resection tissue and assess its integrity. 
2. Confirm the ability of NASBA to detect measles RNA in persistently 
infected, SSPE tissue. 
3. Use NASBA in a preliminary study to determine the presence of measles 
RNA in total RNA isolated from either IBD or control intestinal tissue. 
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6.2. RESULTS 
6.1.1. Isolation of total RNA and assessment of RNA integrity. 
Tissue samples and RNA isolation. Fresh-frozen intestinal resection tissue was 
obtained from 33 adult patients with Crohn's disease, 8 patients with ulcerative 
colitis and 20 non-IBD control patients. Post-resection time was below live 
minutes in all cases and samples had been stored at -70T for no longer than five 
years. Tissue samples were coded prior to analysis. 
SSPE autopsy brain material was supplied by the National Neurological 
Research Specimen Bank (Los Angeles, USA). 'l he Linie between death and 
freezing of brain tissue (autolysis time) was upp to 24 hrs. Three ul'the tour SSPE 
samples were measles antigen positive as determined by imnmunohistochenmistry 
(described elsewhere; Wakefield ei al. 1997; data not shown). Details of' SSPF 
tissue are given below. 
Total RNA was isolated from approximately 500 nng of coded tissue (4.2.3. ), 
and its concentration determined spcctrophotometrically (section 4.2.8. ). 
Table 6.1: Details of SSPF, tissue (N/A not available). 
SSPE sample Age of patient (yrs) "Tissue autolysis time (hrs) 
1 21 N/A 
2 11 5 
3 14 8 
4 6 24 
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Integrity of total RNA isolated from tissue samples (Figures 6.1. and 6.2. ). The 
integrity of total RNA isolated from tissue samples was assessed by agarose gel 
electrophoresis (section 4.2.8. ) and NASBA for UIA RNA (section 4.2.7. ). 
Following electrophoresis of 2 µg of total RNA isolated from intestinal tissue, 
28S and 18S ribosomal bands were clearly visible. 
100 ng of total sample RNA was used for NASBA amplification of UIA RNA 
and reaction products analysed by ELGA using a FIRP-labelled probe 0JI A3, 
section 4.2.9). 59 of the 61 intestinal RNA samples tested positive 16r UIA 
RNA. All four SSPE samples were UIA NASBA positive (data not shown). 
Figure 6.1: Gel analysis of total RNA isolated from intestinal tissue. 
4- DNA 
28S rRNA 
4 18S rRNA 
f tRNA and 
degraded RNA 
Representative agarose gel analysis (section 4.2.8. ) of 2 ýtg of total RNA 
prepared from intestinal resection tissue (lanes I to R). Lanes 9 and 10 contain 
500 ng total RNA from Vero cells as RNA standards. lane M contains an RN. A 
size marker (0.24 to 9.5 nt; Table 4.3. ). 
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Figure 6.2: ELGA analysis of NASBA products. 
123456789 10 
4 
Representative ELGA analysis of CJ IA NASBA products (section 4.2.8. ). Lanes 
I to 8 contained 100 ng total sample RNA in NAS13A reactions and lanes 9 and 
10 contain products from it negative control reaction with water. Reaction 
products were probed with ZIRP- lahelled UI A3 (section 4 2.9). 
The upper arrow points to probe hybridised with llIA NASBA products while 
the lower arrow points to unhybridised probe. 
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6.2.2. Detection of measles RNA in SSPE RNA using NASBA. 
Measles NASBA was performed using 100 ng oftotal RNA isolated from SSPF. 
tissue specimens with primers AB20 and AB22 (section 4.2.7. ). Reaction 
products were analysed by agarose gel electrophoresis (section 4.2.8. ) and 
hybridisation with a radiolabelled probe (AB 10; section 4.2.9. ). 
All four SSPE samples yielded positive results tbllowing measles NASBA. 
Figure 6.3: Analysis of total RNA from SSPE tissue for measles RNA 
using NASBA. 
MI234567 
FFy 
wi' 
a. I). 
(a. ) Gel and (b. ) Northern blot analysis of NASBA products (section 4.2.7. ) from 
total RNA isolated from SSPE autopsy material (lanes I to 4). Negative control 
reactions 5 and 6 contain water. Lane 7 contains products of a positive control 
reaction with l ng total RNA from measles virus-int-ccted Vero cells. 
Northern blots were probed with radiolabelled AB IO (section 4.2.9. ). Lane M 
contains an RNA size marker (0.24 to 9.5 nt; described in Table 4.3. ). 
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6.2.3. Detection of measles RNA in intestinal RNA using NASBA. 
Measles NASBA was performed using 100 ng of total RNA isolated from the 
59 intestinal tissue specimens which had tested positive tör UIA RNA, with 
primers AB20 and AB22 (section 4.2.7. ). Reaction products were analysed 
either by ELGA, using an HRP-labelled probe (AB 10; section 4.2.9. ), or by gel 
electrophoresis (section 4.2.8. ) and hybridisation with a radiolabclled probe 
(AB 10; section 4.2.9. ). 
Two of the 59 RNA samples (samples 9 and 44) yielded positive results 
following measles NASBA. The measles NASBA result for sample 44 is shown 
in Figure 6.4. After decoding, these samples were tinund to have originated from 
non-IBD control patients. 
Figure 6.4: Analysis of total RNA from intestinal tissue for measles RNA 
using NASBA. 
M43 44 45 46 47 48 ABCD 
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(a. ) Gel and (h. ) Northern blot analysis of NASBA reaction products (section 
4.2.7. ) from intestinal RNA samples 43 to 48. Lanes A and 13 contain products 
from negative control reactions with water. Lanes C and D contain products 
from positive control reactions with 10 pg and 1 pg, respectively, ol'total RNA 
from measles virus-infected Vero cells. 
Reaction products were probed with radiolahelled ABI O (section 4.2.9. ). Lane 
M contains an RNA size marker (0.24-9.5 nt; 'Fable 4.3. ). 
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6.3. DISCUSSION 
In experiments to determine the integrity of isolated total RNA, 28S and 18S 
ribosomal RNA bands were clearly visible following agarose gel analysis, 
indicating the isolation of good quality, undegraded RNA. Moreover, NASBA 
for low copy number U1A RNA confirmed this for all but two of the 
61 intestinal resection tissues, and all four SSPE tissue samples. 
Measles NASBA experiments using SSPE RNA yielded measles-specific 
amplification products, confirming the ability of NASBA to detect measles 
virus RNA in persistently infected tissue. Indeed, measles RNA was detected in 
one tissue where measles antigen had not been detected, emphasising the 
efficiency of the NASBA method. 
In experiments to determine the presence of measles RNA in intestinal tissue 
using NASBA, measles RNA was detected in two non-11313 control tissues 
(samples 9 and 44) but not in any of the IBD tissue samples analysed. 
It is possible that the positive results generated from intestinal samples 9 and 44 
were the result of contamination of measles NASBA reactions with the 
laboratory Hu2 strain of measles virus. To exclude this possibility, it is 
necessary to sequence the measles NASBA products from these samples and 
compare the sequences with the sequence of the Hu2 measles virus strain. Such 
sequencing studies also provide information concerning the strain of measles 
virus present in these tissue samples. 
The lack of detectable measles virus RNA in IBD tissue in this study may have 
been due to the sensitivity of the detection method employed. Although NASBA 
was found to be highly sensitive at detecting measles virus RNA diluted in 
water, the efficiency of measles RNA isolation and amplification from intestinal 
tissue homogenates was not determined and further studies are necessary to 
optimise the detection of low copy-number measles RNA in intestinal tissue. 
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Chapter 7. A COMPARISON OF THE RELATIVE FIDELITIES OF 
RT-nPCR, rTt/: -MEDIATED RT-PCR AND NASBA AS 
SOURCES OF DNA FOR SEQUENCING 
7.1. INTRODUCTION 
In order to confirm the specificity of a diagnostic amplification method, and to 
ü- char terize its products, cloning and sequencing of such products is often 
employed. In addition, cloned DNA products from amplification reactions may 
be required for in vitro transcription and translation studies and for long-term 
storage. 
Also, sequencing cloned amplification products of viral RNA or DNA templates 
enables the sequence variation within a viral RNA or DNA sample to be 
determined. This can provide valuable information concerning the quasispecies 
distribution within a given infected clinical sample (Ni et al. 1997). 
However, enzymes involved with nucleic acid amplification can generate errors 
through misincorporation of incorrect bases into products (Roberts et al. 1989; 
Ling et al. 1991; Yu et al. 1992). Therefore multiple clones are required to be 
sequenced in order to obtain an accurate consensus sequence of a particular 
DNA or RNA product. 
NASBA generates a majority of single-stranded RNA products which must first 
be converted to double stranded DNA to permit cloning. This can be achieved 
either by reverse transcription followed by synthesis of a second DNA strand, or 
by RT-PCR. 
Aims. The aims of this study were to: 
1. Generate plasmid clones of RT-nPCR, rTth-mediated RT-PCR and NASBA 
reaction products 
2. Compare the fidelities of the three methods by sequencing cloned reaction 
products. 
3. To sequence the measles NASBA products generated in the study described 
in the previous chapter. 
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7.2. RESULTS 
7.2.2. Generating plasmid clones of RT-nPCR, r7Nr-mediated R"I'-PCR 
and NASBA reaction products 
Amplification reactions. Total RNA was isolated from measles virus-inticted 
Vero cells (4.2.3. ) and 100 ng of this isolated RNA was used as a template for 
the following measles RNA amplification reactions: 
1. RT-nPCR: RT, using random hexamers and MM LV reverse transcriptasc, 
followed by nested PCR (primer pairs MVI and MV2, then MV3 and MV5) 
with Taq DNA polymerase (section 4.2.5. ). 
2. rTth-mediated RT-PCR: using primers MV3 and MV5 rTih DNA polymcrase 
and EZ buffer (section 4.2.6. ). 
3. NASBA: using primers AB20 and AB22 (section 4.2.7. ). 
Reaction products were analysed by agarose gel electrophoresis (section 4.2.8. ) 
and hybridisation with a radiolabelled probe (AB 10; section 4.2.9. ). 
Figure 7.1: Gel-purification of RT-PCR products 
MI2; MI?; 
4-- 
a. I} 
4-- 
(a. ) Gel analysis of rTih-mediated RT-PCR products (lanes 1,2 and 3; section 
4.2.6. ) from reactions containing total RNA from measles-infected Vero cells. 
(b. ) Gel analysis DNA gel purified from the above reaction (section 4.2.11. ). 
The arrow points to the 120 bp MV3/MV5 DNA fragment. 
Lane M contains a1 kb DNA size marker (Table 4.3. ). 
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Generating double-stranded DNA from NASBA reaction products (Fig ire 7. _2. 
j. 
NASBA reactions were deproteinised and recovered by isopropanol 
precipitation (section 4.2.11. ) prior to the generation of double-stranded 1)NA. 
Two strategies were employed to convert single-stranded RNA NASI3A 
products to double-stranded DNA for cloning and sequencing. Firstly, 5 pg of' 
purified NASBA product was used to generate blunt-ended, double stranded 
cDNA using a "Copy kit" (section 4.2.8. ). cDNA products were analysed by 
agarose gel electrophoresis (section 4.2.8. ). 
Secondly, 1 ng of purified NASBA products were used in an r"/'lh-nmcdiated R I'- 
PCR reaction containing primers MV3 and MV5 (section 4.2.6. ). and products 
identities confirmed by agarosc gel electrophoresis (section 4.2.8. ) and 
hybridisation with a radiolahelled probe (AB 10; section 4.2.9. ). 
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Figure 7.2: Generation of blunt-ended cDNA frone NASBA products 
%1 IMI2; 1; r. 
d 
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C. 
4- f 
h. 
(a. ) Gel and (b. ) Northern blot analysis of 5 pl NASBA products (section 4.2.7. ) 
generated from total RNA from mcaslcs-infected Vero cells (lanes I to 5). 
Negative control reaction 6 contained water. Reaction products were probed 
with radiolabelled AB 10 (section 4.2.9. ). 
The arrow points to a 120 nt AB20/AB22 NASE3A product. Lane M contains an 
RNA size marker (0.24-9.5 nt; Table 4.3. ). 
(c. ) Gel analysis of cDNA generated from the above NAS13A products (Lane I 
using a "Copy kit" (section 4.2.11. ). Lane 2 contains cI)NA generated li'onn 
HeLa mRNA which is supplied as a positive control supplied with the kit. I anc 
M contains a 100 bp DNA size marker (Table 4.3. ). 
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Cloning RT-PCR products. RT-nPCR and rTth-mediated RT-PCR reaction 
products were gel purified (section 4.2.8; Figure 7.1. ) before cloning and 10 ng 
of purified product from both reactions directly ligated with pT7BlueE using T4 
DNA ligase (section 4.2.10). Ligation products were transformed into competent 
Eco1i (section 4.2.11. ) and recombinant plasmids identified using blue and white 
screening (section 4.2.12. ). Ten transformed bacterial colonies containing 
recombinant plasmids were selected for culture and plasmid DNA was isolated 
from these cultures (section 4.2.13. ). 
Cloning cDNA generated from NASBA products. cDNA generated from 
NASBA products was blunt-end cloned into pT7BlueE. 10 pmol of blunt-ended 
cDNA generated from NASBA products was phosphorylated using T4 
polynucleotide kinase (section 4.2.8. ). 100 ng of pT7Blue plasmid DNA was 
blunt ended with T4 DNA polymerase and dephosphorylated with alkaline 
phosphatase (section 4.2.9. ). 
DNAs recovered from these reactions were ligated using T4 DNA ligase (section 
4.2.10. ). and ligation mixtures used to transformed competent E. coli (section 
4.2.11. ). 24 transformed bacterial colonies were selected for culture and plasmid 
DNA isolated from these cultures (section 4.2.13. ). Plasmids were screened for 
the presence of measles insert DNA by digestion with Nsil (section 4.2.13. ). Ten 
plasmid clones containing measles insert DNA were selected for sequencing 
experiments. 
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7.2.2. Fidelities of RT-nPCR, rTNi-mediated RT-PCR and NASRA 
reactions. 
Sequencing. Recombinant plasmids containing cloned measles insert DNA ýv ere 
sequenced manually in forward and reverse directions using a "Thermo- 
Sequenase" cycle sequencing kit (section 4.2.15. ). For each sct of' recombinant 
plasmid clones, a stretch of 79 base pairs between primers MV3 and MVS were 
analysed for changes from the consensus sequence (Figure 7.3. ). The error rate 
of each amplification method was defined as the percentage ()I' hau changes 
from the consensus sequence for the total 790 bases analysed. 
In a total of 790 bp sequenced, RT-nPCR generated no base changes and r7'i/, - 
mediated RT-PCR generated 3 base changes (error rate 0.811%o). 
For NASBA reaction products, cloned DNA which had been pencratcd using a 
"Copy kit" possessed 3 hast changes whilst that which had been generated by 
rTth-mediated RT-PCR contained 15 hast changes (error rate I. 9"o). "I'Ihe 
difference in error rate between these two NASBA product Cloning strýºte icti 
was found to be statistically significant (h (1. (1(19) using a Chi squared test. 
Table 7.1. summarises these results. 
Table 7.1: Error rates for measles RNA amplification reactions 
Reaction R'T-nPC'R rTth- 
mediated RT- 
PCR 
NASBA 
followed by 
cIN/ synthesis 
KASBA follmtied by 
rich- mediated R'I - 
11CR 
Error rate 0(VO 0.38% 0.38% 1.9111) 
Base A->'1 A- >'I A >(i (3) 
changes ('---T (i >(' A> 
(i -4A ( >I (' >(i 
(' >1 
(i >(' 
I >A (2) 
>(' (4) 
I >(i (? ) 
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Figure 7.3: Sequences of cloned measles RNA amplification products 
which contained base changes from the consensus sequence 
(Con) 
DNA from rTth-mediated RT-PCR 
Con MV3- TGC CGA GGA TGC AAG GC'F T(i 'i'FY' AGA GAT IU ' AA_I' G('_1 
1. MV3- ................................................................................................ 
I 
.............. 
Con TAC TAC TGA GGA CAA GAT CAG "FAG AG(' i1(, I'; I 66 ACC CAG A -MV 5 
1. I 
cDNA from NASBA reactions 
Con MV3- TGC CGA GGA TGC AAG GC'1' TG'I' 'I_I (' AGn (GA 1I 6C AA I G('A 
4. MV3- ................................................................................................................. 
10. MV3- ................................................................................................................. 
Con TAC TAC TGA GGA CAA GA'C (AG "I'AG AG(' A(G"I I GG AC(' CAG A -M V5 -------------- 4. ............................................ 
1...................... C................................................ -MV5 
10. ................................................................................ I .................................... -M Vi 
DNA from NASBA followed by r7Ni-mediated R'1'-11('R 
Con MV3- TGC CGA GGA TGC AAG GCT rG'i' t rc AGA GAT IG(' AA'r G('A 
1. MV3. .............................................................. C.................................................. 
2. MV3. ...................................................... ( ........................... (............................. 
3. MV3- ...................................................................... (.......................................... 
5. MV3- ......................................................................................... (....................... 
6. MV3- .......................... 
A......................... (....................................... I 
................. 
7. MV3- ...... 
G 
......................................................................................................... 
8. MV3- ................................................................................................................. 
9. MV3- ..................... 
C.......................................................................................... 
10. MV3- ................................................................................................................. 
S Con TAC TAC TGA GGA CAA GAT CAG 'I AG nG(' AGT FGG n('(' Cn(i A : MV 
1. ...................................................................................................................... -M 
VS 
2. (i..... NI V5 
3. 
...................................................................................................................... -MV; 
5. 
......................................................................................... 
n.......................... Mv s 
6. 
...................................................................................................................... 
Mb's 
7. 
...................................................................................................................... -MS'S 
8. G 
................................................................................................................... -MVO 
9. 
...................................................................................................................... -M 
Vs 
10. G ................................................... 
I...... -MV5 
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7.2.3. Cloning and sequencing measles NASBA products generated from 
total intestinal RNA (Chapter 6). 
For convenience, and the sake of cost, the second NASBA product cloning 
strategy was used for the analysis of NASBA products from samples 9 and 44 as 
described in the previous chapter. 10 µl of measles NASBA reactions were 
deprol ised and RNA recovered (section 4.2.8. ). In addition, measles NASBA 
products from a positive control reaction (described in the previous chapter) 
containing Hu2 strain measles virus was processed in parallel in order to 
compare the measles sequences from samples 9 and 44 with the laboratory Hu2- 
strain virus. 
1 ng of purified NASBA products was used as a template in an rTth-mediated 
RT-PCR reaction containing primers MV3 and MV5 (section 4.2.6. ). Reaction 
products gel-purified and cloned into pT7Blue as described above. Ten 
recombinant plasmid clones from each sample were used for DNA sequencing as 
described above. 
Following sequence analysis, the consensus sequences generated from samples 
9,44 and the Hut strain laboratory virus were all found to possess identical 
sequence homology. 
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7.3. DISCUSSION 
Reaction products generated by RT-nPCR and rTth-mediated RT-PCR were 
successfully cloned into pT7Btue. Two strategies were employed to generate 
double stranded DNA from NASBA reaction products. The first strategy used a 
"Copy kit" to generate blunt-ended cDNA for cloning, while the second strategy 
used rTth-mediated RT-PCR to generate DNA for cloning. 
In experiments to determine the relative fidelities of RT-nPCR and rTth- 
mediated RT-PCR, the results demonstrated that the former method had a higher 
fidelity than the latter method. 
Experiments conducted to determine the relative fidelities of two strategies used 
to generate cloned NASBA reaction products showed that the first (generation of 
cDNA) was found to have a significantly higher fidelity than the second (rTth- 
mediated RT-PCR). 
The fidelity of the first strategy was significantly lower than that reported by 
Sooknanan et al. (1994; error rates = 0.38% versus 0.03%) even though similar 
methods were used to amplify an RNA template generate double-stranded cDNA 
from NASBA products. Moreover, contrary to the results of Sooknanan et al. 
(1994), no deletions or insertions were observed in the sequences generated 
using this procedure. These differences may be explained by the use of different 
templates for amplification. 
The low fidelity of the second strategy (error rate = 1.9%) is difficult to explain, 
especially since the individual fidelities of these reactions are relatively high 
(Table 7.1. ). One explanation could be due to the fact that inosine triphosphate 
(ITP) is included in the NASBA reaction mix to improve the efficiency of the 
reaction. NASBA reaction products can threfore possess ITP. Inosine can base 
pair with all four bases (Martin et al. 1985) and it is possible that when NASBA 
products ar, e used as templates for rTth-mediated RT-PCR, the enzyme may 
incorporate any base when it reaches a position at which inosine is present in the 
template sequence. These "base changes" are detected following cloning and 
sequencing. 
The large numbers of errors arising during NASBA followed by rTth-mediated 
RT-PCR shows that this approach to sequencing NASBA products can only be 
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employed when large numbers of cloned reaction products are available to 
generate an accurate consensus sequence. Conversely, double-stranded cDNA 
synthesis from NASBA RNA products generated fewer errors and therefore 
fewer plasmid clones are required to generate an accurate consensus sequence. 
In experiments to determine the sequence of measles NASBA products derived 
from intestinal RNA samples 9 and 44 (described in the previous chapter). The 
results of the experiments involving samples 8 and 44 indicated that measles 
laboratory-strain positive control virus (Hu2; Taylor et al. 1991) was present. 
The measles Hu2-strain virus possesses ai iiidine to adenine substitution at ti 
1336 of the viral genome. 
Eppendorf tubes in which NASBA reactions were carried out were not opened 
in the laboratory where reactions performed (University of Greenwich) and it 
therefore seems likely that contamination arose from positive control RNA from 
measles-infected Vero cells at the Royal Free Hospital. % 
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Chapter 8: EXPERIMENTS TO TEST HYBRID CAPTURE AND 
MULTIPLEX RT-PCR AS METHODS FOR MEASLES 
RNA DETECTION AND TO GENERATE A 
COMPET/TIVE INTERNAL CONTROL 
8.1. INTRODUCTION 
Hybrid capture can increase the sensitivity of nucleic acid detection methods. In 
this project, two oligonucleotides (specific for measles genomic and messenger 
N-gene RNA) were attached to paramagnetic solid-phase supports and used to 
enrich total RNA samples for measles RNA prior to amplification reactions. 
oligonucleotide capture sequences were used in order to maximise the amount 
111-1 of measles RNA which could be enriched using this method. 
To measure the efficiency of measles RNA isolation and amplification, measles 
wild type RNA transcripts (generated from plasmid pT7BlueE as described in 
Chapter 5) were "spiked" into tissue and PBMC homogenates used in these 
experiments prior to RNA isolation, hybrid capture and measles RNA 
amplification. 
In this study, modified RNA transcripts were used as internal positive controls 
to measure the efficiency of RNA isolation and amplification, and as internal 
standards for quantitative, competitive RT-PCR in a manner analogous to that of 
Gilliland, et al. (1990). Such modified RNA transcripts give rise to RT-PCR 
products which can be differentiated from wild type RT-PCR products on the 
basis of size following agarose gel electrophoresis. In this study, a "spacer" 
DNA fragment was cloned into the MV1/MV2 measles insert possessed by the 
recombinant plasmid vector pT7BlueE (described in Chapter 5). Modified 
measles RNA transcripts were used as internal standards in later experiments for 
the detection of measles RNA (Chapter 9). 
Multiplex PCR was also used in this study in order to develop a method capable 
of simultaneously assessing total RNA integrity and determining the presence of 
measles RNA. Multiplex RT-PCR involves the coamplification of two or more 
targets using two or more primer pairs (Edwards and Gibbs, 1994). In this study, 
a multiplex RT-PCR reaction was optimised which contained measles and U1A 
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primer pairs. 
Aims. The aims of this part of the study were to: 
1. Test whether hybrid capture could improve the sensitivity of measles RNA 
detection in intestinal tissue and PBMC samples. 
2. Generate a modified measles RNA transcript for use as an internal positive 
control in measles RNA detection experiments. 
3. Develop a measles RNA assay system using hybrid capture and internal 
positive control transcript RNA. 
4. Develop a single multiplex RT-PCR method for the simultaneous 
determination of total RNA integrity using U1A and the presence of measles 
RNA. 
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8.2. RESULTS 
8.2.1. Experiments to investigate the application of hybrid capture for 
measles RNA detection. 
Efficiency of hybrid capture for measles RNA. Hybrid capture supports, 
derivatised with oligonucleotides HC1 and HC2 were synthesised as described 
in section 4.2.4. The ability of these supports to capture measles RNA was 
tested using measles wild type transcript RNA diluted in water (data not 
shown). Serial dilutions of such transcripts, from 106 to 1 molecules, were used 
for measles RNA hybrid capture (section 4.2.4. ) together with rTth-mediated 
RT-PCR using primers MV3 and MV4 (section 4.2.6). Reaction products were 
analysed by gel electrophoresis (section 4.2.8. ) and hybridisation with a 
radiolabelled probe (AB 10; described in section 4.2.9. ). 
The detection sensitivity of measles RNA transcripts following the hybrid 
capture procedure was found to be equal to that without hybrid capture - i. e. 
10 molecules. Therefore, this method of hybrid capture was capable of 
efficiently capturing measles RNA for use as a template in rTth-mediated RT- 
PCR reactions. 
Hybrid capture enrichment of measles RNA (Figure 8.1. ). A serial dilution of 
measles wild type RNA transcripts, from 107 to 103 molecules, was spiked into 
control intestinal resection tissue homogenates. Total RNA was isolated from 
these homogenates (section 4.2.3. ), and all of the isolated RNA (up to 40 µg) 
used for measles N-gene hybrid capture as described in section 4.2.4. 
To compare the relative efficiencies of rTth-mediated RT-PCR and NASBA for 
the detection of measles RNA eluted from hybrid capture supports, eluted RNA 
was used for rTth-mediated RT-PCR with primers MV3 and MV4 (section 
4.2.6; Figure 8.1. a. and b. ), or NASBA using primers AB20 and AB22 (section 
4.2.7; Figure 8.1. c. and d. ). Reaction products were analysed by gel 
electrophoresis (section 4.2.8. ) and hybridisation with radiolabelled probes 
(AB 10 or UTA3; described in section 4.2.9. ). 
To measure any improvement in measles RNA detection sensitivity that measles 
hybrid capture conferred, an experiment was performed in which 106 to 102 
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measles wild type RNA transcripts were "spiked" into control intestinal tissue 
homogenates. Total RNA was isolated from these homogenates (section 4.2.3. ) 
and 100 ng of total RNA was subsequently used for rTth-mediated RT-PCR 
using primers MV3 and MV4 (Section 4.2.6; Figure 8.2. e. and f. ). Reaction 
products were analysed by gel electrophoresis (section 4.2.8. ) and hybridisation 
with a radiolabelled probe (AB 10; section 4.2.9. ). 
It was observed that hybrid capture followed by rTth-mediated RT-PCR 
increased the ability to detect measles RNA 100-fold compared to rTth- 
mediated RT-PCR alone. This appeared as an improvement in the detection 
sensitivity limit from 106 to 104 measles transcript RNA molecules. This finding 
was also confirmed from results of experiments using total RNA from measles- 
infected Vero cells as a template for hybrid capture and rTth-mediated RT-PCR 
(data not shown). 
Hybrid capture followed by NASBA was significantly less sensitive than hybrid 
capture followed by rTth-mediated RT-PCR for the detection of measles RNA; 
a detection sensitivity limit of 107 compared to 104 measles transcript RNA 
molecules "spiked" into control tissue homogenates. 
All experiments were performed at least three times. 
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Figure 8.1: Detection of measles RNA with and without hybrid capture. 
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(a. ) Gel and (b. ) Southern blot analysis of measles rTth-mediated RT-PC R 
products. A serial dilution of wild type measles RNA transcripts (from 107 to 
103 molecules; lanes I to 4) was spiked into intestinal tissue homogenates and 
hybrid capture performed on total isolated RNA (section 4.2.4. ). Hybrid capture 
elutants were used for rTth-mediated RT-PCR of measles RNA (section 4.2.6. ). 
Lanes 6 to 8 contain products from negative control reactions with water. 
(c. ) Gel and (d. ) Northern blot analysis of measles NASBA reaction products 
(section 4.2.7. ) using hybrid capture eluants from the above experiment. Lanes 6 
to 8 contain products from negative control reactions with water. 
(e. ) Gel and (f. ) Southern blot analysis of measles rTth-mediated RT-PCR 
products. Total isolated RNA was isolated from intestinal tissue homogenates 
spiked with 106 to 102 measles wild type RNA transcripts (lanes I to 5). Lane 6 
contains products from a negative control reaction with water. 
All RT-PCR and NASBA products were probed with radiolabelled ABI O 
(section 4.2.9. ). Lane M contains a 100 hp DNA marker. 
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Detection of measles RNA within total PBMC RNA (Figure 8.2. . The 
sensitivity of measles RNA detection by rTth-mediated RT-PCR was determined 
by spiking a serial dilution from 10' to 102 wild type measles transcripts was 
spiked into control PBMC homogenates. Total RNA was isolated (section 
4.2.3. ) and 100 ng of total RNA used for r77h-mediated RT-PCR with primers 
MV3 and MV4 as described in section 4.2.6. Reaction products were analysed 
by gel electrophoresis (section 4.2.8. ) and hybridisation with a radiolahclled 
probe (AB 10; described in section 4.2.9. ). 
It was observed that as few as 104 wild type measles RNA transcripts could he 
detected in PBMC homogenates. This limit was not improved by applying 
hybrid capture (data not shown). 
Figure 8.2: Sensitivity of measles N-gene RNA detection in PBM('s. 
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(a. ) Gel and (b. ) Southern blot analysis of rJ h-mediated RT-PC R products 
(section 4.2.6. ), using total RNA from PBMC homogenates spiked 10 to 10 
measles wild type transcripts (lanes I to 6). Lane 7 contains products from a 
negative control reaction with water. 
RT-PCR products were probed with radiolabelled ABIO (section 4.2.9. ). Lane 
M contains a 100 hp DNA size marker. 
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8.2.2. Generation of an internal positive control RNA transcript. 
Modification of pT7BIueE (Figure 8.3. ). A "spacer" DNA fragment was cloned 
into pT7BlueE at the Nsi1 restriction site possessed by the MV1/MV2 DNA 
insert. Briefly, 10 ng of a 144 bp PstI / SphI restriction fragment (Table 4.2. ) 
was blunt ended using T4 DNA polymerase (section 4.2.11. ). 5' DNA termini of 
the DNA recovered from this reaction were phosphorylated using T4 
polynucleotide kinase (section 4.2.11. ). 
1 pg of pT7B1ueE was digested with Nsil (section 4.2.12. ) the ends of the 
linearised plasmid blunt ended with T4 DNA polymerase (section 4.2.12. ) and 
5' termini dephosphorylated using alkaline phosphatase (section 4.2.9. ). 
Insert and plasmid DNA were ligated using T4 DNA ligase (section 4.2.10) and 
lµl of ligation products transformed into competent E. coli (section 4.2.11. ). 
12 transformed bacterial colonies were cultured and plasmid DNA isolated 
(section 4.2.13. ). Purified plasmids were screened for the presence of HIV I 
gag! insert DNA by digestion with Hindill (section 4.2.13. ) since a Hindill 
restriction site is unique to the HIV1 gagl insert DNA sequence (Figure 8.3. ). 
The modified plasmid generated from this experiment - termed "pT7BlueE144" 
- was observed to contain an insert DNA sequence which was 130 bp, rather 
than 144 bp, larger than the original MV1/MV2 insert DNA sequence. This 
result is due to the fact that a total of 14 bp of DNA were removed from insert 
and vector sequences by T4 DNA polymerase during the blunt-ending 
procedures. 
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Figure 8.3: Diagram of pT7BIueEI44 containing the HIV1 gagl DNA 
insert. 
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In vitro transcription (Figure 8.4. ). pT7BlueEl44 was linearised downstream 
from the insert DNA sequence by digestion with EcoRI (section 4.2.17. ) and 
2 µg of linearised plasmid recovered from this reaction was used as a template 
for in vitro transcription (4.2.17. ). 
Following in vitro transcription, plasmid DNA was removed by digestion with 
DNasel and modified measles RNA transcripts (636 nt in length) of negative 
sense were recovered from the mixture (section 4.2.14. ). 1 µg of transcript RNA 
was analysed by agarose gel electrophoresis (section 4.2.8. ), its concentration 
determined spectrophotometrically (section 4.2.8. ), and this concentration 
converted from ng µl-I to numbers of molecules µl-I as the length of the RNA 
transcript was known. A stock serial dilution of transcript RNA was made up in 
water, dispensed into aliquots containing a total of 1010 molecules to 1 molecule, 
and stored at -70°C until required. 
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Figure 8.4: Gel analysis of modified measles transcript RNA. 
RNA gel analysis of modified measles RNA transcript generated by in rinro 
transcription of pT7BIueE 144. Lane E contains transcripts from pT7BlueE with 
a predicted size of 506 nt, and lane 2 contains transcripts from pT7Bluel' 144 
with a predicted size of 636 nt. Lane M contains an RNA size marker- (0.24 to 
9.5 nt; Table 4.3. ). 
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8.2.3. Development of a measles RNA assay system. 
Hybrid capture of modified measles RNA transcripts (data not shown). A serial 
dilution of modified measles RNA transcripts, from 108 to 10 molecules, was 
spiked into control intestinal resection tissue homogenates. Total RNA isolation 
(4.2.3. ), hybrid capture (section 4.2.4. ) and rfth-mediated RT-PCR (section 
4.2.6. ) was performed and reaction products analysed by gel electrophoresis 
(section 4.2.8. ) and hybridisation with a radiolabelled probe (AB 10; described in 
section 4.2.9. ). 
It was observed that 106 modified measles RNA transcripts could be detected. 
Coamplification of wild type and modified measles transcript RNAs (Figure 
85. ). A serial dilution of wild type measles RNA transcripts, from 10' to I 
transcript molecules, was amplified by r7'th-mediated RT-PCR using primers 
MV3 and MV4 (section 4.2.6. ). In a second set of reactions, 10-' modified 
measles RNA transcripts were added to a similar dilution series of wild-type 
measles RNA transcripts (from 10 3 to I transcript molecules) and amplification 
carried out in the same manner. Reaction products were analysed by gel 
electrophoresis (section 4.2.8. ) and hybridisation with a radiolabelled probe 
(AB 10; described in section 4.2.9. ). 
The ability to detect measles RNA was observed to be unimpaired when the 
modified measles RNA transcripts were present together with the wild type 
measles RNA transcripts. 
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Figure 8.5: Competitive RT-PCR using wild type and modified measles 
RNA transcripts. 
Gel analysis of rTth-mediated RT-PCR products using a serial dilution of 
measles wild-type transcript without (lanes I to 5) or with (lanes 6 to 10) 
103 molecules of modified measles transcript. Lanes I to 5 and 6 to 10 
contained products of reactions with 10-, l0-, 10,1 and 0 wild-type transcript 
molecules. 
The upper arrow points to 383 bp modified transcript RT-PCR products and the 
lower arrow points to 253 wild type transcript RT-PCR products. Lane M 
contains a 100 hp DNA marker (Table 4.3. ). 
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Detection of spiked wild type and modified measles transcript RNAs using 
hybrid capture followed by RT-PCR (Figure 8.6. ). 101,104, and 10' wild type 
measles RNA transcripts were spiked into one set of tissue homogenates. 
Another set of tissue homogenates was spiked with 105,10-4, and 103 wild type 
measles RNA transcripts together with 107 modified measles transcripts. 
107 modified measles RNA transcripts were used as this number represented the 
range of the limit of detection sensitivity as described previously. 
Total RNA was isolated (section 4.2.3. ), hybrid capture performed (section 
4.2.4. ) and measles transcript RNAs detected by rflhi-mediated RT-PCR using 
primers MV3 and MV4 (section 4.2.6. ). Reaction products were analysed by 
agarose gel electrophoresis (section 4.2.8. ) and hybridisation with a 
radiolabelled probe (AB 10; section 4.2.9. ). 
It was observed that the presence of modified measles transcript RNA did not 
diminish the efficiency of wild type measles transcript isolation. Hybrid capture 
and amplification permitted the detection of as few as 104 wild type measles 
RNA transcripts as well as 107 modified measles RNA transcripts. 
This experiment was repeated at least three times to ensure reproducibility of 
results. 
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Figure 8.6: Detection sensitivity of hybrid capture and competitive RT- 
PCR for measles RNA. 
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(a. ) Gel and (b. ) Southern blot analysis of measles rTlh-mediated RT-PCR 
products. Intestinal tissue homogenates I to 3 (lanes 1 to 3) were spiked with 
543 10,10, and 10 measles wild type RNA transcripts. Intestinal tissue 
homogenates 4 to 7 (lanes 4 to 7) were spiked with 101,104, and l0.1 measles 
wild type RNA transcripts together with 107 modified measles RNA transcripts. 
Lanes 8 and 9 contain products from negative control reactions with water. 
RT-PCR products were probed with radiolabelled AB 10 (section 4.2.9. ). Lane 
M contains a 100 bp DNA size marker (Table 4.3. ). 
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8.2.4. Development of a multiplex rTth-mediated RT-PCR assay. 
Optimisation of U1A and measles N gene coamplification. 10 ng of total RNA 
isolated from intestinal resection tissue (section 4.2.3. ) was spiked with 104 wild 
type measles RNA transcripts and the effect of different concentrations of UIA 
and measles primers on the efficiency of rTth-mediated RT-PCR was 
determined. Reaction products were analysed by agarose gel electrophoresis 
(section 4.2.8. ) and hybridisation with radiolabelled probes (AB IO and U1 A3; 
described in section 4.2.9. ) to differentiate between UIA and measles-specific 
PCR products. The different concentrations of UIA and measles primer pairs 
used in these experiments are shown in Table 8.1. 
From these experiments, it was observed that 750 nM primers MV3 and MV4, 
and 150 nM primers U1 Al and UI A2 was the optimal primer combination tor 
multiplex RT-PCR of both U1A and measles RNA (Figure 8.6. ). 
Table 8.1: Measles and U1A primer concentrations for multiplex RT- 
PCR 
Reactions Total MV3/MV4 conc. (nM) Total UTAI/UlA2 cone. (nM) 
1,2 450 450 
3,4 550 350 
5,6 650 250 
7,8 750 150 
9,10 900 0 
11,12 0 900 
13 450 450 
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Figure 8.7: Multiplex rTth-mediated RT-PCR for measles and U1A 
RNA. 
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(a. ) Gel analysis of rlth-mediated multiplex RT-PCR products (section 4.2.6. ). 
1 
U1A and measles primer concentrations are given in Table 8.1. Lanes I to 12 1 
contain products from reactions with 10 ng total RNA from human intestinal 
tissue and 104 wild type measles RNA transcripts. Lane 13 contains products 
from a negative control reaction with water. Lane 14 contains an MV3/MV5 
PCR product as a positive control for probe hybridisation. 
(b. ) Southern blot analysis of the gel from (a) probed with radiolahelled AB 10 
(section 4.2.9. ). 
(c. ) Southern blot analysis of the gel from (a) probed with radiolabellcd 111.1\3 
(section 4.2.9. ). 
Lanes M contain a 100 bp DNA marker (Table 4.3. ). 
Multiplex rTth-mediated RT-PCR for UIA RNA. measles wild type RNA 
transcripts and modified measles RNA transcripts. The optimised multiplex 
rTth-mediated RT-PCR assay described above was further developed to address 
the amplification of three RNA templates using 10 ng total intestinal RNA, 10 
modified measles RNA transcripts, and a serial dilution of measles wild type 
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transcripts, from 10' to 10 wild type measles RNA transcripts. Reaction 
products were analysed by gel electrophoresis (section 4.2.8. ) and hybridisation 
with a radiolabelled probe (AB 10; described in section 4.2.9. ). 
It was observed that the addition of modified measles RNA transcripts to the 
previous reaction diminished the apparent sensitivity of measles wild type 
transcript detection by a factor of ten (Figure 8.7. ). 
Figure 8.8: Multiplex RT-PCR for UIA RNA, wild type and modified 
measles transcript RNAs. 
a. 
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(a. ) Gel and (b. ) Southern blot analysis of rTth-mediated multiplex RT-PCR 
products (section 4.2.6. ). Lanes I to 5 contain products from reactions with 
primers MV3 and MV4 with 105 to 10 measles wild-type transcripts. Lanes 7 to 
I1 contain products of reactions with primers M V3, M V4, U1A1 and U1 A2 
with 105 to 10 measles wild-type transcripts, 10 ng of total intestinal RNA and 
103 modified measles transcripts. Lanes 6 to 12 contain products from negative 
control reactions with water. 
RT-PCR products were probed with radiolabelled AB 10 (section 4.2.9. ). 
Lane M contains a 100 bp DNA size marker. 
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8.4. DISCUSSION 
The results presented here indicate that hybrid capture increases the detection 
sensitivity of measles RNA within total RNA from tissue homogenates by a 
factor of 100 permitting the detection of as few as 104 measles RNA transcripts 
and represents the first time that magarose solid phase supports have been 
applied to the enrichment of RNA species. 
However, hybrid capture did not improve the detection sensitivity of measles 
RNA in PBMC homogenates. 
Hybrid capture and rTth-mediated RT-PCR was observed to be more sensitive 
than hybrid capture and NASBA (Figure 8.1. ). This was unexpected as 
previously NASBA was found to be more sensitive than rTth-mediated RT-PCR 
for the detection of measles RNA in water (Chapter 5). This observation could 
have been due to a susceptibility of NASBA to substances carried over from the 
hybrid capture procedure. Such poor robustness and versatility limit the use of 
NASBA to the detection of measles in RNA samples diluted in water. 
A modified measles RNA transcript was successfully produced by cloning a 
"spacer" DNA fragment into the MVI/MV2 sequence of pT7BlueE. These 
transcripts were used as an internal positive control in later experiments 
(Chapter 9). This transcript did not interfere with the detection of wild type 
measles RNA. 
It was observed that hybrid capture followed by RT-PCR could detect fewer 
wild type transcripts (104) than modified transcripts (106). This can be explained 
by the inefficient binding of modified transcripts to the hybrid capture 
sequences as a result of insertion of HIVI gagl DNA at the NsiI site 
interrupting the capture sequence target site. 
Previously, Albretsen et al. (1990) have used a hybrid capture method for the 
detection of measles RNA. Their method was not used in this study as it was 
thought more appropriate to use measles N- rather than measles H-gene RNA as 
a target for detection. The characteristic 5' to 3' measles RNA transcription 
gradient leads to a greater abundance of measles N-gene RNA transcripts 
compared to other measles RNA transcripts in infected cells. 
Also, the method developed by Albretsen et al. only captured mess ger and 7/ 
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antigenomic measles (sense) RNA, but in infected cells, measles genomic 
(antisense) RNA is also present. A strategy which only permitted the capture and 
detection of measles sense RNA is likely to be less sensitive that one which 
detected both senses together. 
Finally, this method developed could in theory form the basis of a general way 
by which other viral RNA species, such as mumps or rubella. 
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Chapter 9: EXPERIMENTS TO DETECT MEASLES RNA IN IBD 
INTESTINAL AND PBMC CLINICAL SAMPLES USING 
HYBRID CAPTURE FOLLOWED BY RT-PCR. 
9.1. INTRODUCTION 
The combined measles N-gene-specific hybrid capture and rTth-mediated RT- 
PCR method was used to enrich and amplify measles RNA present in total 
cellular RNA isolated from IBD and control intestinal tissue samples. Samples 
were: Crohn's disease tissue (n=10), ulcerative colitis tissue (n=4) and tissue 
from control patients undergoing resection for intestinal carcinoma (n=6) (Table 
9.1. ). All IBD tissues showed evidence of inflammation on histological 
examination (data not shown). All Crohn's disease tissues were selected on the 
basis that they contained granulomas. 
In addition to intestinal resection tissue, PBMC samples from IBD and control 
patients were also analysed for the presence of measles RNA. Blood samples for 
PBMC isolation were taken from patients with Crohn's disease (n=6), 
indeterminate colitis (n=3) ulcerative colitis (n=2) and control patients (n=2). 
Blood samples were also obtained from two patients with SSPE. Verbal consent 
was obtained from all IBD and control patients providing blood samples for this 
study. Ethics approval was obtained from the Royal Free Hospital Ethics 
Committee. Patient details are given in Table 9.1. 
RT-nPCR for measles H-gene RNA, using a previously published method 
(Kawashima et al. 1996b), was performed in order to confirm measles N-gene 
RT-PCR. 
RNA isolation, preparation of RT-PCR reaction mixtures and analysis of RT- 
PCR products were performed in separate laboratories, this time at the Royal 
Free Hospital, in order to minimise the possibility of PCR contamination. 
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Table 9.1: Details of patients used for measles RNA analysis. 
Patient Disease Age (yrs) Sex (M/F) 
Intestinal tissue 
I Crohn's 25 Ni 
2 UC 51 M 
3 Sigmoid vululus 60 M 
4 Crohn's 22 
5 Crohn's 36 
6 Crohn's 17 
7 U(' 55 M 
8 Crohn's 41 M 
9 UC 52 
10 UC 55 Ni 
II Ischaemia 49 
12 Crohn's 36 
13 Carcinoma 78 I 
14 Carcinoma 68 f' 
15 Crohn's 40 M 
16 Crohn's 27 M 
17 Carcinoma 52 M 
18 Carcinoma 45 I: 
19 Crohn's 21 F 
20 Crohn's 37 F 
SSPH: tissue 
SSI'lil SSPI:: 21 M 
SSPI: 2 SSPI II M 
SSPI3 SSPI' 14 M 
SSPI: 4 SSPIi 6 M 
Peripheral blood cells 
A Indeterminate colitis 45 I 
B UC 74 F 
C Crohn's 50 NI 
1) Crohn's 25 1 
E Crohn's 55 
C rohn's 34 M 
(1 Indeterminate colitis 41 F 
II Crohn's 49 M 
I Indeterminate colitis 13 F 
Rectal bleed H \1 
K UC 14 NI 
I. Crohn's 16 M 
M Autoimmune hepatitis 32 I 
Positive control PBM1('x 
X Vaccine recipient NA NA 
Y SSPI[ NA M 
Z SSI'I NA M 
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Aims. The aims of this study were to: 
1. Isolate total RNA from a coded series of resection tissue specimens and blood 
samples from IBD and control patients, and assess its integrity. 
2. To analyse IBD and control RNA samples for the presence of measles N- 
gene RNA using hybrid capture followed by rTth-mediated RT-PCR and to 
analyse the same samples for the presence of measles H-gene RNA using RT- 
nPCR. 
d' 3. To char4erize the strain of measles virus present by sequence analysis of 
measles RT-PCR products. 
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9.2. RESULTS 
9.2.1. Total RNA isolation and integrity. 
Tissue samples (Figure 9.1. ). Coded fresh-frozen intestinal resection tissue 
samples were obtained as described in section 4.2.3. Intestinal tissue 
homogenates were divided into two equal portions and 107 modified measles 
RNA transcripts added as an internal positive control to assess any negative 
effect on measles RNA detection that the isolation procedure may have had. 
Total RNA isolations were performed in duplicate (section 4.3.2. ). 
As a positive control to assess the methodgeneral ability to detect measles 
RNA within persistently infected tissue, RNA was isolated from four SSPE 
autopsy brain samples as described in section 4.2.3. Patient details are given in 
Table 9.1. 
To assess the integrity of total RNA isolated from intestinal ýf SSPE tissue c-r 
samples, 100 ng of RNA was used for rTth-mediated RT-PCR for U1A RNA 
(section 4.2.6. ) using primers U1A1 and U1A2. Reaction products were 
analysed by agarose gel electrophoresis (section 4.2.8. ) and hybridisation with a 
radiolabelled probe (U1A3; section 4.2.9. ). In addition, total RNA was analysed 
by agarose gel electrophoresis (section 4.2.8. ). 
All four SSPE RNA samples, and all but two intestinal RNA samples yielded 
the expected amplification products following rTth-mediated RT-PCR for U1A 
RNA. 28S and 18S ribosomal RNA bands were clearly visible in all RNA 
samples following agarose gel electrophoresis. 
PBMC samples igure 9.1. ). PBMCs were prepared from whole blood, and 
total RNA isolated (4.2.3. ). 5 µl of PBMC RNA samples were used for agarose 
gel analysis (section 4.2.8. ) and rTth-mediated RT-PCR for U1A RNA (section 
4.2.6. ) using primers UTA1 and UTA2. Reaction products were analysed by gel 
electrophoresis (section 4.2.8. ) and hybridisation with a radiolabelled probe 
(UTA3; section 4.2.9. ). 
As a positive control, PBMC RNA from a measles vaccine (strain AIK-C) 
recipient was supplied by H. Kawashima (Tokyo Medical School, Japan). 
All but one PBMC sample yielded the expected amplification products 
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following rTth-mediated RT-PCR for VIA RNA and 28S and 18S ribosomal 
RNA bands were clearly visible in all RNA samples following agarose gel 
electrophoresis. 
Figure 9.1: Analysis of isolated total intestinal RNA integrity. 
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(a. ) Representative gel analysis (section 4.2.8. ) of 5 pl of total RNA from PBMC 
samples A to H (lanes I to 8), and I pg total RNA From SSPE autopsy material 
(lanes 9 to 12). The upper and lower arrows point to 28S and 18S ribosomal 
RNA band, respectively. Lane M contains an RNA size marker (0.24-9.5 nt; 
described in Table 4.3. ) 
(b. ) Representative Southern blot analysis rTth-mediated RT-PC'R products from 
reactions containing intestinal RNA (lanes la to 5b). Lane II contains products 
from a negative control reaction with water. PCR products were probed using 
radiolabelled U1 A3 (section 4.2.9. ). The arrow points to a 225 hp PCR product. 
Lane M contains a 100 hp DNA size marker (Table 4.3. ). 
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9.2.2. Detection of measles RNA. 
Detection of measles N-gene RNA in tissue samples (Figure 9.2. ). Hybrid 
capture and rTth-mediated RT-PCR for measles N-gene RNA was performed on 
duplicate intestinal RNA samples as previously described. As a positive control, 
rTth-mediated RT-PCR for measles N-gene RNA was performed on 100 ng of 
SSPE RNA (section 4.2.6. ). Reaction products were analysed by agarose gel 
electrophoresis (section 4.2.8. ) and hybridisation with a radiolabelled probe 
(AB 10; described in section 4.2.9. ) 
Internal modified measles RNA transcripts were successfully amplified from all 
isolated intestinal RNA samples. Two samples (3a and 11b) yielded wild type 
RT-PCR products and these. samples were derived from one patient with Crohn's 
disease (patient 3) and one non-1131) control patent (patient 11). 
All four SSPE samples yielded positive results by rTth-mediated RT-PCR for 
measles N-gene RNA. 
176 
Figure 9.2: Analysis of intestinal and SSPE tissue for measles N-gene 
RNA. 
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Southern blot analysis of rTt{i-mediated RT-PCR products (section 4.2.6. ) from 
measles N-gene hybrid capture experiments using intestinal RNA samples la-5a 
(a. ) and I Oa- I 5a (b. ). Lane II conains products from a negative control reactions 
with water. The upper arrows point to a 383 bp RT-PC R product resulting from 
the amplification of the modified measles RNA transcript, and the lower arrows 
point to a 253 bp RT-PCR product resulting from the amplification of wild type 
measles RNA. 
(c. ) Gel and (d. ) Southern blot analysis of measles N-gene r7'th-mediated R'T- 
PCR products using total RNA from SSPE autopsy samples 1 to 4 (lanes I to 4). 
All RT-PCR products were probed with radiolabelled ABIO (section 4.2.9. ). 
Lane M contains a 100 bp DNA size marker. 
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Detection of measles H-gene RNA in tissue samples (data not shown). Measles 
H-gene RT-nPCR (section 4.2.5. ) was performed using 1µg of intestinal or 
SSPE RNA for RT with primer MF1, followed by nested PCR reaction with 
primer pairs H3 and H6 (first round), then H4 and H7 (second round). Reaction 
products were analysed by gel electrophoresis (section 4.2.8. ) and hybridisation 
with a radiolabelled probe (H5; described in section 4.2.9. ). 
No intestinal RNA samples were observed to be positive for measles H-gene 
RNA although all four SSPE samples yielded positive results. 
Detection of measles RNA in PBMC samples (Figure 9.3. ). 5 µl of RNA from 
PBMC samples were used for rTth-mediated RT-PCR for measles N-gene RNA 
(section 4.2.6. ). Additionally, 5 µl of RNA from PBMC samples were used for 
RT-nPCR for measles H-gene RNA (section 4.2.5. ). Reaction products were 
analysed by gel electrophoresis (section 4.2.8. ) and hybridisation with a 
radiolabelled probe (AB 10 or H5; described in section 4.2.9. ) to achiev, .L 
maximum sensitivity. 
One PBMC sample, derived from a patient with indeterminate colitis (patient 
A), was found to be positive for measles N-gene RNA. All other PBMC RNA 
samples were found to be negative for measles N-gene RNA, including PBMC 
RNA from two patients with SSPE (data not shown). 
The measles vaccine recipient PBMC RNA sample was found to be positive for 
measles H-gene RNA. All other PBMC RNA samples were observed to be 
negative for measles H-gene RNA. 
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Figure 9.3: Analysis of PBMC samples for measles RNA. 
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Legend for Figure 9.3. 
(a) gel and (b) Southern blot analysis of measles N-gene rT1h-mediated RT- 
PCR products (section 4.2.8. ) using PBMC RNA samples A to H (lanes A to H). 
Lane 9 contains products from a positive control reaction with I ng total RNA 
from measles-infected Vero cells and negative control reaction 10 contained 
water. 
(c. ) Gel and (d. ) Southern blot analysis of measles N-gene rTih-mediated R'I'- 
PCR products. Lanes 1 and 5 contain products from positive control reactions 
with 10 and I ng, receptively, of total RNA from measles virus-intected Vero 
cells. Lane 3 contains products from a reaction with 100 ng of total PBMC RNA 
from a measles vaccine recipient. 
All RT-PCR products were probed with radiolahelled AB 10 (section 4.2.9. ). 
(e. ) Gel and (t: ) Southern blot analysis of measles H-gene RT-nPCR products. 
RNA samples were the same as those described above (c. and d. ). RT-PCR 
products were probed with radiolabelled H5 (section 4.2.9. ). 
Lanes M contain a 100 bp DNA size marker (Table 4.3. ). 
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9.2.3. Sequence analysis of PCR products. 
Wild type measles N-gene RT-PCR products derived from intestinal samples 3a 
and l lb, and PBMC sample A, were gel-purified (section 4.2.8. ) and in order to 
generate appropriate amounts of PCR products for direct, automated sequencing, 
were subsequently reamplified using a semi-nested PCR with Taq DNA 
polymerase and primers MV3 and MV5 (section 4.2.5. ). These re-amplified 
PCR products were gel-purified (section 4.2.11. ) and sequenced directly using 
an automated DNA sequencer (4.2.15. ). An example of an automated 
sequencing result is shown in Figure 9.4. 
Measles H- and N-gene RT-PCR products from SSPE RNA, and measles H- 
gene RT-PCR products from the vaccine recipient PBMC RNA sample, were 
gel purified (section 4.2.11. ) and used tier direct, automated sequencing as 
described in section 4.2.15. 
Sequencing of RT-PCR products from samples 3a, l1b, and A showed that they 
all possessed identical sequences to that of the laboratory Hut-strain virus. Full 
sequences for measles H- and N-gene PC R products from SSPE RNA samples 
are given in Figures 9.5. and 9.6., respectively. 
Figure 9.4: Sequence analysis of measles PCR products. 
N 
i '. Iý i? ý 
a. b. 
Sequence data generated from PCR products (section 4.2.15. ) from reactions 
containing SSPE RNA sample I (a. ) and a laboratory Hu2 strain contaminant in 
sample 3a (b. ). Measles virus Hu2-strain can be identified by the substitution of 
A for G at position 1336 of the measles virus go-nome. 
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Figure 9.5: Measles N-gene sequences from SSPE RNA samples. Letters 
in superscript represent amino acid changes. 
1=DReading Frame 
Con TGCCGAGGATGCAAGGCTTGTTTCAGAGATTGCAATGCATACT 
SSPE1 ................................................................................................................ 
SSPE2 ................................................................................................................ 
SSPE3 ........................ C°-'D................................................................................ 
SSPE4 ........................................... ALS 
+l 
Con ACTGAGGACAGGATCAGTAGAGCGGTTGGACCCAGACAAGCC 
S SPE 1 ............................................................. 
AA--ºA........................................... 
SSPE2 ........................... 
AR-aK............................................................................. 
SSPE3 ................................................................................................................ 
SSPE4 ................................................................................................................ 
Con 
C 
CAAGTGTCATTTCTACACGGTGATCAAAGTGAGAATGAGCTA 
SSPE 1 ................................................................................... AE- 
ºE..................... 
SSPE2 ................................................................................................................ 
SSPE3 ................................................................................................................ 
SSPE4 ................................................................................... A-ºE..................... 
E 
Con 
C 
CGAGATTGGGGGGCAAGGAAGATAGGAGGGTCAAACAGAGT 
SSPE1 ................ GL- 
ºw........................................ TR-ºM....................................... 
SSPE2 ................................................................................................................ 
S SPE3 ... A-ýP ................... 
P 
.................................................................................. SSPE4 ................ GL' 
'w........................................ TR-ºM....................................... 
Con GAGGAGAAGCCAGGGAGAGCTACAGAGAAACCGGGCCCAGC 
S SPE 1 ......................................................................................................... 
Ts-->s 
SSPE2 ......................... 
AA-+D............................................................................... 
r 
........... SSPE3 .............................................................................................. T-, 
s 
s SSPE4 ......................................................................................................... 
T-ýs 
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Figure 9.6: Measles H-gene sequences from SSPE RNA samples. Letters 
in superscript represent amino acid changes. 
I=Reading Frame 
Con 
ACGGGGAAGATTCTATCACAATTCCCTATCAGGGATCAGGGA 
A 
SSPE1 
SSPE2 ... Tx 
>fi 
..................................................................................................... s S SPE3 ................................................................................................ T-ýs......... 
SSPE4 ................................................................................................................ 
Con AGGTGTCAGCTTCCAGCTCGTCAAGCTAGGTGTCTGGAAATCC 
SSPE1 ................................................................................................................ 
SSPE2 ................................................................................................................ 
SSPE3 ................................................................................................................ 
SSPE4 ................................................................................................................ 
Con CCAACCGACATGCAATCCTGGGTCCCCTTATCAACGGATGATC 
SSPE1 ................................................................................................................ 
SSPE2 ................................................................................................................ 
SSPE3 ................................................................................................................ 
SSPE4 ................................................................................................................ 
Con CAGTGATAGACAGGCTITACCTCTCATCTCACAGAGGTGTTAT 
SSPE 1 .......... Avýv .............................................................................................. 
SSPE2 ................................................................................................................ 
SSPE3 ................................................................................................................ 
SSPE4 ......................................................................................... 
Con CGCTGATAATCAAGCAAAATGGGCTGTCCCGACAACACGAAC 
R SSPE1 ................................................................................................. A-ºR....... SSPE2 ................................................................................................................ 
SSPE3 ................................................................................................................ 
Ti-+i......... Cn-'D .......................................................................... AR-ýR SSPE4 ...... 
Con AGATGACAAGTTGCGAATGGAGACATGCTTCCAACAGGCGTG 
SSPE1 
....................................................................................... GQ--*Q................. 
SSPE2 
....................................................................................... GQ-''Q................. 
SS PE3 ....................................................................................... GQ-'Q................. 
SSPE4 
....................................................................................... GQ-*Q................. 
Con TAAGGGTAAAATCCAAGCACTCTGCGAGAA 
SSPE1 ............................................................................... 
SSPE2 ............................................................................... 
SSPE3 ............................................................................... 
SSPE4 ............................................................................... 
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9.4. DISCUSSION 
Good quality total RNA was successfully isolated from PBMCs, SSPE material 
and intestinal resection tissue, as assessed by rTth-mediated RT-PCR for UTA 
RNA and agarose gel electrophoresis. Internal modified control transcripts were 
successfully amplified from intestinal RNA samples, implying that the measles 
RNA isolation procedure had not been destructive to measles RNA. 
Due to low yields of PBMC RNA, the concentration of PBMC RNA could not 
be accurately determined by spectrophotometry and 5 µl of PBMC RNA was 
used for gel analysis and RT-PCR experiments. 
In experiments with SSPE clinical samples, measles RNA was detected in all 
brain tissues tested confirming the ability of the methods described to detect 
measles RNA in persistently infected tissue. Indeed, as for NASBA (Chapter 6) 
measles RNA was detected in one tissue sample in the apparent absence of 
measles nucleoprotein (determined by immunohistochemistry), emphasising the 
increased sensitivity of RT-PCR over immunohistochemistry. 
Measles virus RNA was not detected in PBMCs of patients with SSPE. This 
concords with the findings of Schneider-Schaulies et al. (1991). This result 
could have occur/because of either a). measles virus RNA being present below 
the sensitivity limits described, or b). persistent measles virus was not present in 
the peripheral blood of the SSPE patients. 
In experiments to determine the presence of measles RNA in PBMCs of a 
vaccine recipient, measles H-gene was detected and sequence analysis 
confirmed the vaccine recipient PBMC RNA RT-PCR product to be from the 
AIK-C strain of measles virus (data not shown). The inability to detect measles 
virus N-gene RNA from a clinical positive control sample may, however, reflect 
specific problems associated with the extraction of measles virus N-gene RNA 
observed by others (D. Griffin, Johns Hopkins University, Baltimore, USA; 
personal communication). 
Due to the small amount of RNA from the vaccine recipient PBMC, the results 
of these experiments could not be repeated. It remains possible that the vaccine 
recipient PBMC RNA sample was contaminated with measles H-gene PCR 
products, especially as contamination problems have been reported in the 
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laboratory in which this PBMC RNA was generated (H. Kawashima, Tokyo 
Medical School, Japan; personal communication). 
In experiments to determine the presence of measles RNA in intestinal and 
PBMC samples from IBD and control patients, measles N-gene was detected in 
intestinal tissue samples 3a and l lb, and PBMC sample A. 
Sequence analysis experiments showed that RT-PCR products arising from 
SSPE RNA had not arisen as a result of PCR contamination with the laboratory 
Hu2-strain of measles virus. Sequence analysis of the rTh-mediated RT-PCR 
products from samples 3a, llb and A showed that they possessed identical 
sequences to laboratory strain (Hu2) virus, suggesting that they had arisen as a 
result of contamination of tTth-mediated RT-PCR reactions with laboratory 
Hu2-strain measles RNA. This was supported by the fact that duplicate reactions 
tested negative for measles N-gene RNA. Also, none of the IBD and control 
samples tested were positive for measles H-gene RNA. The presence of PCR 
contamination could be unequivocally demonstrated by the sequencing of 
measles N-gene PCR products and analysis for a guanidine substitution of 
adenine at position 1336 - characteristic of the measles laboratory Hu2 strain 
sequence. Therefore, artifactual results arising from PCR contamination were 
not misinterpreted as resulting from measles virus-infected clinical samples. 
In summary, other than as a contaminant, measles virus RNA was not detected 
in any sample from IBD or control patients in the experiments reported in this 
investigation. These results are discussed in detail in Chapter 11. 
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Chapter 10: ANALYSIS OF CLINICAL SAMPLES FROM PATIENTS 
WITH AUTISTIC ENTEROPATHY FOR THE PRESENCE 
OF MEASLES, MUMPS AND RUBELLA RNA USING RT- 
PCR 
10.1. INTRODUCTION 
Immunohistochemistry experiments have suggested the presence of measles 
nucleoprotein in biopsy samples from patients with autistic enteropathy 
(Wakefield et al. 1998a). Twenty two affected children were used for this study. 
The mean age was 5 years 6 months and the mean time between MMR 
vaccination and onset of symptoms (behavioural or physical) was 3 weeks for 14 
of the children. Symptoms of two children predated their MMR vaccination and 
information was not available for the remaining six children. PBMCs from 6 
age-matched controls were also used in this study. 
It was decided to test blood and biopsy samples (section 4.2.3. ) from these 
patients for the presence of both measles N- and H-gene by RT-PCR. In 
addition, since MMR vaccination may have been a factor leading to the 
development of autistic enteropathy (Wakefield et al. 1998b), it was also 
decided to test biopsy and blood samples from these patients for the presence of 
mumps and rubella RNA. Verbal consent was obtained from all affected and 
control patients (and their parents) providing blood samples for this study. 
Ethics approval was obtained from the Royal Free Hospital Ethics Committee. 
Because of the low amounts of total RNA which could be isolated from biopsy 
and PBMC samples, it was decided to generate a random pool of cDNAs from 
each RNA sample for subsequent PCR analysis of a number of templates. 
Cocultivation experiments were performed in this study for the isolation and 
propagation of measles, mumps and rubella viruses. Cocultivation of PBMCs 
with Vero cells may permit viral replication and hence enhance the chance of 
detecting measles, mumps and rubella viruses (Forthal et al. 1992 and 1993). It 
was therefore decided to cocultivate PBMC samples with Vero cells and use 
total RNA isolated from cocultures for RT-PCR for measles, mumps and rubella 
RNA. 
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The full strategy of viral RNA detection is represented in Figure 10.1. 
Figure 10.1: Strategy of measles, mumps and rubella RNA detection in 
clinical samples of patients with autistic enteropathy. 
Blood Sam le 
1 PBMC Pellet º Total RNA Isolation 
11 Culture with Coculture with 
"PHA-L/IL-2 Donor PBMCs 
Coculture with 
Vero Cells 
Store Pellets from Store Pellets from 
each Passage each Passage 
Pool Pellets Bio s 
Total RNA Isolation 
cDNA synthesis 
UTA, Measles N-&H-gene, illumps and Rubella RT-ICR 
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For measles RNA detection experiments, total RNA from SSPE autopsy 
material (described in the previous chapter) was used as a control to test the RT- 
nPCR methods ability to detect measles RNA in persistently infected tissue. 
Total RNA from measles-infected Vero cells (described in Chapter 5) was also 
used an a positive control. 
For mumps and rubella detection experiments, positive control mumps RNA 
was obtained by isolation of total RNA from the supernatant of Vero cells 
infected with the VR 106 strain of mumps virus and positive control rubella 
RNA was obtained by isolation of total RNA from Vero cells infected with the 
M33 strain of rubella virus (Table 4.2. ). 
. 
Aims. The aims of this study were to: 
1. Cocultivate PBMCs from patients with autistic enteropathy with Vero cells in 
order to propagate any measles, mumps and rubella viruses present, thereby 
increasing the level of viral RNA. 
2. Isolate total RNA from biopsies, PBMCs and Vero cell cocultures from 
patients with autistic enteropathy. 
3. Analyse RNA samples for the presence of measles, mumps and rubella RNA 
using RT-PCR. 
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10.2. RESULTS. 
10.2.1. Total RNA isolation and analysis of integrity. 
Vero cell cocultures. PBMCs from 10 affected and one control patient were 
isolated from 10 ml blood and used for cocultivation with Vero cells (section 
4.2.2. ). Subsequently, cocultures were pooled, coded and total RNA isolated 
(section 4.2.3. ). 
To assess the quality of RNA, 5 µl was used for RT (with random hexamers and 
MMLV reverse transcriptase) followed by PCR with Taq DNA polymerase and 
primers U1A1 and U1A2 (section 4.2.6. ). Reaction products were analysed by 
agarose gel electrophoresis and hybridisation with a radiolabelled probe (U1A3; 
section 4.2.9. ). In addition, 5 µl of total RNA was analysed by agarose gel 
electrophoresis (section 4.2.8. ). 
Biopsy samples. Coded, fresh-frozen biopsy samples from 10 affected patients 
were used for total RNA isolation (section 4.2.3. ). RNA integrity was assessed 
as described above. 
Blood samples. PBMCs were prepared from 10 ml of blood from 12 affected 
and 6 controls patients(section 4.2.3. ) and used for total RNA isolation (section 
4.2.3. ). RNA integrity was assessed as described above. 
Following agarose gel electrophoresis, 28S and 18S RNA band were clearly 
visible for all biopsy, PBMC and Vero cell coculure RNA samples. In addition, 
all samples yielded positive results following RT-PCR for U1A RNA. - 
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Figure 10.2: Analysis of RNA quality 
a. 
1t I r, x ýý ! ý1 M123450799M 
A 
. 
'S 
ýý C. 
(a. ) Representative agarose gel analysis (section 4.2.8. ) of total RNA from Vero 
cell cocultures (lanes I to 12). Lane M contains an RNA site marker (0.24- 
9.5 nt; described in Table 4.3. ). 
(b. ) Representative gel and (c. ) Southern blot analysis of UIA PCR products, 
using Taq DNA polymerase (section 4.2.5. ), from total RNA from biopsy 
samples (lanes 1 to 8). Lane 9 contains products from a negative control reaction 
with water. PCR products were probed with radiolabelled UI A3 (section 4.2.9. ). 
The arrows point to a 225 bp UIA PCR product. Lane M contains a 100 bp 
DNA size marker (Table 4.3. ). 
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10.2.2. Detection of measles, mumps and rubella RNA. 
RT-PCR reactions. cDNA was generated from 5 µl of each total RNA sample 
using MMLV reverse transcriptase and random hexamers (section 4.2.3. ) and 
1 µl of cDNA used for PCR detection (with Taq DNA polymerase) of measles, 
mumps or rubella cDNA templates (section 4.2.5). Reaction details are as 
follows 
1. Measles N-gene cDNA was detected in a nested reaction containing primer 
pairs MV I and MV2 (first round), then MV3 and MV4 (second round). 
Reaction products were analysed by gel electrophoresis (section 4.2.8. ). 
2. Measles H-gene cDNA was detected in a nested reaction containing primer 
pairs HH3 and H6 (first round), then H4A and H7 (second round). Reaction 
products were analysed by gel electrophoresis (section 4.2.8. ). 
3. Mumps phosphoprotein gene cDNA was detected using primer pairs MUP1 
and MUP2 based on a method described by Ni et al. (1997). Reaction 
products were analysed by gel electrophoresis (section 4.2.8. ) and 
hybridisation with a radiolabelled probe (MUP3; section 4.2.9. ). 
4. Rubella El gene eDNA was detected in a nested reaction containing primer 
pairs R2 and R7 (first round), then R11 and R8C (second round), based on a 
method described by Bosma et al. (1995). Reaction products were analysed 
by gel electrophoresis (section 4.2.8. ). 
Analysis of cDNA samples for measles N- and H -gene sequences by nPCR 
(Figure 10.3. ). Measles N-gene RNA was detected in the Vero coculture RNA 
derived from patients 2,3,16, and 21, and in. the biopsy RNA from patient 7. 
Sequence analysis of PCR products from these samples showed that they 
contained identical sequences to the laboratory strain (Hu2) virus. 
cDNA from 100 ng of total RNA from SSPE brain material gave positive PCR 
results for measles N- and H-gene analysis. Sequence analysis of these PCR 
products confirmed that they had not arisen as a result of PCR contamination. 
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Figure 10.3: Analysis of cDNA from autistic enteropathv and SSPF 
a. b. 
d. 
(a. ) Gel analysis of measles N-gene nPCR products (section 4 . 
2,5. ) using cDNA 
derived from 100 ng SSPE RNA (lanes I to 4). Negative control reaction 5 
contained water. The arrow points to a 253 hp PC'R product 
(b. ) Gel analysis of measles H-gene nPC'R products using cDNA derived from 
100 ng SSPE RNA (lanes I to 4). Lane 5 contains products Irony a negative 
control reaction with water. The arrow points to a 335 hp PC"R product. 
(c. ) Representative gel analysis of mneasles N-gene nPCR products from cDNA 
derived from total PBMC RNA samples I to 10 (lanes I to 10). Lane 
contains products from a negative control reaction with water and lane 12 
contains products from positive control reaction with I ng total RNA from 
measles-infected Vero cells. The arrow points to a 253 hp PCR product. 
(d. ) Representative gel analysis of measles H-gene nPCR products from cl. )NA 
derived from total PBMC RNA samples I to 10 (lanes I to I0). Lanes II and 12 
contains products from positive control reactions with 10 ng and I ng of' total 
RNA from measles-infected Vero cells, respectively. Lane 13 contains products 
from a negative control reaction with water. 
Lanes M contain a 100 bp DNA size marker (Table 4.3. ). 
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PCR for mumps and rubella cDNA (Figure 10.4. ). In all experiments, positive 
7 control mumps and rubella cDNA samples yielded 
the expected PCR products. 
Noe samples analysed gave positive results for either mumps or rubella cDNA. 
A full summary of measles, mumps and rubella RT-PCR results and the samples 
used is given in Table 10.1. 
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Figure 10.4: Analysis of cDNA from autistic enteropathy clinical samples 
for mumps and rubella RNA using NCR. 
M123456789 10 11 M 
a. 
C. 
(a. ) Representative gel and (h. ) Southern blot analysis of' mumps PCR products 
(section 4.2.5. ) from cDNA derived from Vero cell cocultures (lanes I to 10). 
Positive control reaction 10 contained cDNA derived from I ng of total RNA 
from mumps-infected cell cultures. Lane II contains products from it negative 
control reaction with water. PCR products were probed with radiolabelled 
MUP3 (section 4.2.9. ). The arrows point to a 223 hp PCR product. 
(c. ) Representative gel analysis of rubella nPCR products from cDNA derived 
from Vero cell cocultures (lanes I to 8). Lanes 9 and 10 contains products li-om 
positive control reactions with cDNA derived f ii I ng total RNA from rubclla- 
infected cell cultures. Lanes 11 and 12 contains products from negative control 
reactions with water. 
The arrow points to a 142 bp PCR product. Lanes M contain a 100 hp I)NA slic 
marker (Table 4.3. ). 
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Table 10.1: UTA, measles, mumps and rubella RT-PCR results using 
biopsies, PBMCs and Vero cell cocultures. Bx = biopsy. 
C= contaminant. 
Sample UTA MV-N MV-11 Rubella Mumps 
Affected patients 
1 Bx  x x x x 
2 Bx V x x x x 
Cultures  (C) x x x 
3 Bx  x x x x 
PBMCs  x x x x 
Cultures  (C) x x x 
4 Bx  x x x x 
PBMCs  x x x x 
Cultures  x x x x 
5 Bx  x x x x 
6 Cultures  x x x x 
7 Bx  (C') x x x 
PBMCs  x x x x 
8 Cultures  x x x x 
9 Bx  x x x x 
10 Cultures  x x x x 
11 Bx  x x x x 
PBMCs  x x x x 
12 Cultures  x x x x 
13 13x  x x x x 
PBMCs  x x x x 
Cultures  x x x x 
14 PBMCs  x x x x 
15 Bx  x x x x 
16 PBMCs  x x x x 
Cultures  (C) x x x 
17 PBMCs  x x x x 
18 PBMCs  x x x x 
19 PBMCs  x x x x 
20 PBMCs  x x x x 
21 Cultures  (C) x x x 
22 PBMCs  x x x x 
Control patients 
23 PBMCs  x x x x 
24 PBMCs  x x x x 
25 PBMCs  x x x x 
26 PBMCs  x x x x 
Cultures  x x x x 
27 PBMCs  x x x x 
28 PBMCs  x x x x 
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10.3. DISCUSSION 
Good quality RNA was isolated from biopsies, PBMCs and Vero cell cocultures 
as determined by agarose gel electrophoresis and RT-PCR for UIA RNA. 
SSPE RNA samples yielded positive results in both measles N- and I I-gene R'I'- 
nPCR experiments. Sequence analysis of PCR products confirmed that they had 
not arisen as a result of PCR contamination. Positive control mumps and rubella 
RNA samples yielded positive results for mumps R'l'-P('R and rubella R"I'- 
nPCR experiments, respectively. These results indicated that the methods 
employed were capable of detecting measles, mumps and rubella RNA within 
total RNA samples. 
In experiments to determine the presence of measles, mumps or rubella RNA in 
clinical samples, four Vero cell coculture samples and one biopsy sample tested 
positive for measles N-gene RNA. However, sequence analysis of these P('R 
products showed that they were identical to that of' the laboratory I Iu2-strain of 
measles virus. These results almost certainly arose from P('IZ contamination. No 
measles H-gene RNA, mumps RNA or rubella RNA was detected in any of the 
RNA sample from biopsies, blood or Vero cell cocultures. 
It is possible that persistent measles, mumps or rubella virus may he defective 
and this may prevent their efficient isolation and propagation. 'T'his is the case 
with SSPE (Carter and ter Meulen, 1990). Reasons for the luck of detectable 
measles, mumps and rubella RNA in these samples and the implications of these 
results are discussed in detail in Chapter II. 
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Chapter 11: GENERAL DISCUSSION 
11.1. MEASLES VIRUS RNA AND IBD 
The negative measles NASBA and RT-PCR results described in Chapters 6 and 
9, respectively, support the results of previously published work from our group 
and others (Smith, 1994; Lewey et al. 1995; Iizuka et al. 1995; Fan et al. 1996; 
Haga et al. 1996). Although there may have been problems with these studies in 
terms of detection assay sensitivity, the reproducible lack of detectable measles 
RNA in intestinal tissue is striking nonetheless. 
Given the two sets of results in Chapters 6 and 9, there are three clear 
possibilities as to why measles RNA was not detected in IBD clinical samples: 
measles virus is not present; measles antigens are present in the absence of 
measles RNA; measles RNA is present but not detectable using the methods 
described in this or other studies. 
11.1.1. Measles virus is not present 
Such an explanation would be in keeping with the results described here and 
also with previously published measles RT-PCR results for IBD samples (Smith, 
1994; Lewey et al. 1995; Iizuka et al. 1995; Fan et al. 1996; Haga et al. 1996). 
However, it is possible that early exposure to measles virus may lead to the later 
development of IBD without any need for viral persistence, therefore the 
positive epidemiological association is not dependent upon the presence of 
measles virus in IBD clinical samples. At least three mechanisms could account 
for this possibility: molecular mimicry leading to autoimmunity; 
immunosuppression leading to persistence of other infectious agents; and 
immune dysfunction. 
Autoimmunity. As discussed in Chapter 3, exposure to measles virus leads to 
lifelong immunity. Antibody cross-reactivity between measles antigens and self 
antigens may lead to the propagation of an autoimmune reaction. Self-antigens 
may be expressed later in life in response to a genetic or environmental trigger 
which are recognised by memory B-cells specific for measles antigens. If, for 
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example, these antigens are expressed on intestinal submucosal endothelial cells, 
an autoimmune reaction may occur leading to the generation of granulomatous 
vasculitis and chronic inflammation. Therefore it may be interesting to test the 
cross-reactivity of auto-antibodies detected in IBD patients with measles virus 
antigens. 
An autoimmune reaction against myelin basic protein, following measles virus 
infection has been described previously in Lewis rats (Liebert et al. 1988) and 
this reaction may be involved with the pathogenesis of diseases associated with 
persistent measles virus infection such as SSPE. Host cell myelin basic protein 
is believed to be involved with measles virus replication and is a component of 
viral particles which are recognised by the host immune system (Wirguin et al. 
1993). 
Interestingly, T cells reactive to, and B cells producing antibodies against (Link 
et al. 1992; Jingwu et al. 1991), both myelin basic protein and measles virus 
have been demonstrated in the cerebrospinal fluid of patients with multiple 
sclerosis. These observations raise the possibility that a measles virus infection 
of the CNS is cleared by the host immune system but later triggers an 
autoimmune reaction, leading to chronic inflammation. This would account for 
the lack of measles RNA in multiple sclerosis tissue as determined by RT-PCR 
(Godec et al. 1992). 
Early exposure to measles virus may be important in the generation of auto- 
antibodies and this could account for epidemiological associations between early 
measles virus exposure and IBD without a requirement for the presence of 
measles virus at the time of disease development. 
Immunosupression. As discussed in Chapter 3, a period of immune suppression 
follows both acute measles virus infection and measles vaccination. During this 
transient period of immunodeficiency, infectious agents in the gut lumen may be 
able to establish a persistent infection in intestinal submucosal endothelial cells 
without clearance by the host immune system. Such persistent agents may then 
trigger an abnormal immune response later in life, leading to the development of 
granulomatous vasculitis and chronic intestinal inflammation. 
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Immune dysfunction. Measles may be capable of disrupting the homeostasis of 
the gut immune system through the decreased production of IL-12 by follicular 
dendritic cells (Fugier-Vivier et al. 1998). IL-12 is known to induce the 
differentiation of ThO CD4+ T cells to Thl CD4+ T cells (Heufler et al. 1996) 
and therefore, disruption of IL-12 production may lead to chronic immune 
dysregulation which manifests itself as IBD many years after the original virus 
infection has been cleared. 
In susceptible individuals, early measles virus infection may lead to a chronic 
Thl/Th2 cytokine imbalance which may not become apparent until later in life 
when exposure to a particular environmental agent(s) leads to an abnormal 
immune response and the development of chronic inflammation. Such a 
mechanism would be in keeping with the epidemiological association between 
early exposure to measles virus and the development of IBD. 
Although these three explanations may account for the epidemiological 
association between early exposure to measles virus and IBD, significant 
discrepancies are introduced between the negative RT-PCR results of this and 
other studies, and the results of previous studies concerning the detection of 
paramyxovirus-like particles (Wakefield et al. 1993; Knibbs et al. 1993), 
measles antigens (Wakefield et al. 1993; Lewin et al. 1995; Miyamoto et al. 
1995; Ekbom et al. 1996; Daszak et al. 1997; Wakefield et al. 1997) and 
measles RNA (Wakefield et al. 1993) in IBD tissue. Such explanations would 
cast doubt on the validity of the results from previous studies: 
Electron microscopy. Two independent reports have been published concerning 
the detection of paramyxovirus-like particles in areas of granulomatous 
inflammation in Crohn's disease tissue using electron microscopy (Knibbs et al. 
1993; Wakefield et al. 1993). Both reports described the presence of intranuclear 
and intracytoplasmic inclusion bodies containing arrays of tubular structures 
morphologically consistent with paramyxovirus nucleocapsids. Such a 
description may apply to a range of viruses other than measles and it is possible 
that intracellular macromolecules may also form similar structures. The non- 
specificity of this technique prevents any definitive conclusion as to the presence 
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or absence of measles virus particles in IBD tissue, although these results 
justified further immunological studies. 
Measles nucleoprotein monoclonal antibody studies. A study at the Royal Free 
Hospital reported positive immunostaining for measles nucleoprotein in tissue 
samples from 13 of 15 patients with Crohn's disease but not in either two cases 
of intestinal tuberculosis, a granulomatous negative control (Wakefield et al. 
1993). The antibody used for this study was a commercially available 
monoclonal antibody directed against measles nucleoprotein (MAS 182r). Even 
though this antibody was shown to produce positive staining in positive control 
SSPE tissue sections, it is possible that it cross-reacted with cellular components 
within intestinal tissue leading to false-positive results. 
A recent study by Iizuka and Masamune (1997) has provided evidence 
supporting the possibility that MAS 182r cross-reacts with a cellular protein of 
human origin. Iizuka and Masamune replicated the immunohistochemistry 
results of Wakefield et al. (1993) using MAS 182r to show positive staining in 
Crohn's disease tissue. In order to confirm the specificity of antibody binding, 
cDNA from Crohn's disease tissue was used to construct a phage Xgt11- 
expression library. This library thus represented all the proteins encoded for by 
all the RNA molecules present in the Crohn's disease tissue. 
The expression library was screened using MAS 182r and one positive clone 
identified. The DNA from this positive clone was sequenced and compared with 
known sequences in databases. This revealed that the DNA sequence was 99% 
homologous with the 3' terminus of a human gene of unknown function 
(accession number AA449055) and did not share any sequence homology with 
the measles nucleoprotein gene. 
A second monoclonal antibody (4F 12) directed against the protein encoded by 
this human gene sequence was produced and used to stain Crohn's disease 
tissue, revealing a similar staining pattern to that of MAS 182r, providing further 
evidence that MAS 182r cross-reacts with a protein of human origin. Therefore 
it would appear that MAS 182r recognises epitopes present on both measles 
nucleoprotein and the human protein which are structurally related but have no 
amino acid sequence similarity. 
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This finding brings into doubt the validity of the original MAS 182r staining for 
measles nucleoprotein in Crohn's disease tissue. The fact that this antibody 
apparently recognises a protein specific for Crohn's disease granulomas is 
interesting in itself as this protein may be involved with the pathogenesis of 
Crohn's disease. 
The discovery of cross-reactivity between measles nucleoprotein and a human 
protein raises the possibility that "molecular mimicry" may occur, leading to the 
development of IBD later in life. Early exposure to measles virus leads to a 
polyclonal antibody response to measles virus, clearance of the virus and 
lifelong immunity. Within this polyclonal antibody population may be 
antibodies which cross-react with the human protein recognised by MAS 182r. 
Later in life, these antibodies may recognise the human protein expressed in the 
gut, leading to an autoimmune response and generating chronic inflammation. 
This possibility cannot be investigated until the human protein has been fully 
charcterized. 
Measles nucleoprotein polvclonal antibody studies. Following the monoclonal 
antibody study, a subsequent project used double staining to charrize the o 
immune response directed against cells staining positive for measles 
nucleoprotein in Crohn's disease tissue using a polyclonal antibody (Wakefield 
et al. 1997). Recombinant measles nucleoprotein was expressed in an E. coli 
vector and the bacterial cell lysate used to raise a measles nucleoprotein 
polyclonal antibody response in rabbits. The unpurified sera thus produced was 
used directly on positive control SSPE tissue, measles virus infected appendix 
tissue, and Crohn's disease tissue sections. Again, positive staining was observed 
in positive control tissue and also in areas of granulomatous inflammation in 
Crohn's disease tissue. 
The antibody used in this study was not affinity purified and it is therefore 
possible that antibodies directed against a range of antigens other than measles 
were present in the polyclonal sera. As recombinant Ecoli lysates were used as a 
source of measles nucleoprotein, the polyclonal sera probably contained 
antibodies directed against E. co1i antigens which are likely to be present in gut 
tissue, particularly in areas of active intestinal inflammation, as reviewed by 
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Burke (1997). 
The measles polyclonal ser"was found to give positive staining in E. coli- 
infected tissue and in cytospins of cultured E. coli, demonstrating the presence of 
, r+r` antibodies directed against E. coli within this se! However, staining measles 
antigen-positive Crohn's disease tissue, using an antibody specific for Ecoli 
generated different patterns of signal, indicating that specific measles antibody- 
antigen interactions were present in tissue sections analysed (unpublished data). 
Purification of recombinant measles nucleoprötein prior to immunisation (for 
instance, by immunoprecipitation) and affinity purification of this polyclonal 
antibody semay have reduced any problems regarding antibody specificity. 
In addition, the polyclonal antibody serrXdirected against measles nucleoprotein 
may contain antibodies which cross-react with the human protein recognised by 
MAS 182r, as discussed above. 
Using this same polyclonal antibody serf, Lui et al. (1995) described non- 
specific staining in all IBD and control tissues analysed. Although different 
methodologies may account for these strikingly different results, the presence of 
antibodies directed against non-measles antigens may be a significant factor in 
the result reported by Wakefield et al. (1997). 
Measles matrix protein study. In support of the findings of Wakefield et al. 
(1993), Miyamoto et al. (1995) described the identification of a monoclonal 
antibody (mAb 86) directed against the measles matrix protein which generated 
positive immunofluorescence signals in a significantly greater number of 
Crohn's disease tissue than ulcerative colitis or control tissues. mAb 86 was 
shown to react with a protein within wild-type measles-infected Vero cells of 
approximately the same size as the measles matrix protein by Western blot 
analysis. This antibody did not give any staining with uninfected cells, 
rinderpest-infected cells or canine distemper virus-infected cells, indicating that 
it does not cross-react with other morbilliviruses. 
The same antibody did not react with any antigens within HEL cells infected 
with an SSPE-strain of measles virus. As suggested by Miyamoto et al., mAb 86 
may have recognised wild-type measles matrix protein but not SSPE-strain of 
measles virus due to mutations accumulated during viral persistence affecting 
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the antigenicity of measles SSPE-strain matrix protein as described by Hirano et 
al. (1992). 
The antigen with which mAb 86 reacted in measles-infected Vero cells could 
have been isolated (for instance, by immunoprecipitation) and, if possible, 
sequenced to confirm the specificity of mAb 86. 
In the same study, a monoclonal antibody directed against measles nucleoprotein 
failed to generate any positive staining in Crohn's disease tissue. 
Immunogold electron microscopy. Three studies reported positive staining in 
Crohn's disease tissue using immunogold electron microscopy (Lewin et al. 
1995; Ekbom et al. 1996; Daszak et al. 1997). All these studies employed the 
same measles nucleoprotein polyclonal antibody used by Wakefield et al. (1997) 
and therefore the same problems concerning antibody specificity may have 
arisen, as discussed above. Positive signal was detected in the foci of a 
granuloma in one case of intestinal tuberculosis analysed, raising questions as to 
the specificity of the measles nucleoprotein polyclonal antibody ser V. 
Alternatively, this tissue may have been persistently coinfected with measles 
virus and tuberculosis. 
Epidemiology. Several studies have provided epidemiological evidence for the 
involvement of measles virus in the aetiology of IBD, particularly Crohn's 
disease (Ekbom et al. 1994; Thompson et al. 1995a; Ekbom et al. 1996). 
Although controversial, the results ugges f these studies that early exposure to 
measles virus is a significant risk factor for the development of IBD. As 
discussed above, early exposure to measles virus and molecular mimicry, 
without virus persistence, may be a risk factor for the development of IBD later 
in life, accounting for the observed epidemiological associations. 
11.1.2. Measles antigens are present in the absence of measles RNA 
It may be possible that measles antigens are present in IBD tissue in the absence 
of measles RNA. Such a phenomenon would be in keeping with the positive 
immunohistochemical results and the negative RT-PCR results. Three 
explanations may account for the presence of measles antigen but not measles 
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RNA in IBD tissue: retention of viral antigen by cells exposed to measles virus; 
degradation of viral RNA during chronic inflammation; and the interesting 
possibility that latent measles DNA may be present. 
Retention of viral antigens. As discussed later, even though the underlying 
mechanisms of antigen retention are not fully understood, antigens can be 
retained by cells for prolonged periods (Tew and Mandel, 1979). The life-span 
of a human endothelial cell is several years (Vanhoutte et al. 1995), therefore 
these cells may retain measles antigens for long periods of time following in 
utero or post natal measles virus infection. Several years later, an environmental 
or genetic trigger may give rise to MHC class I-restricted expression of these 
viral antigens (Dhib-Jalbut and Cowan, 1993), leading to monocyte adhesion 
and the development of granulomatous vasculitis. Therefore, upon analysis of 
IBD tissue, measles antigens may be detected in the absence of measles RNA. 
this explanation would be in keeping with the epidemiological association 
"_ 1 
between early measles virus infection and the development of IBD. 
Degradation of viral RNA. Early infection of intestinal submucosal endothelial 
cells with measles virus may lead to persistence of whole virus and trigger the 
development of granulomatous vasculitis later in life. The intestinal ischaemia, 
inflammation and infarction resulting from granulomatous vasculitis may lead to 
the degradation of labile RNA molecules but not more stable protein species. 
Therefore, by the time of intestinal tissue resection and analysis, only stable 
measles antigens may be present and detectable, whereas measles RNA 
molecules may have been degraded beyond the point where they are detectable 
by RT-PCR during chronic inflammatory processes. 
On the other hand, measles RNA is readily detectable in SSPE tissue where 
chronic inflammation is responsible for much of the disease pathology (Poser, 
1990), although the extent of inflammation is markedly different in IBD. 
Moreover, in this study measles RNA was detectable in SSPE autopsy material 
where the time between patient death and freezing of tissue was up to 24 hours, 
and during this time tissue autolysis may have been expected to degrade some of 
the RNA present. However, good quality RNA was isolated on the basis of gel 
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electrophoresis and housekeeping U1A RNA amplification. Moreover, measles 
RNA forms stable associations with measles nucleocapsids, rendering measles 
RNA highly resistant to nuclease digestion (Moyer et al. 1990). 
In highly metabolic tissues, such as gut, more degradative processes may occur 
during chronic inflammation and following tissue resection, and this may lead to 
the degradation of small amounts of any measles RNA present. 
Measles DNA. A recent publication by Klenerman et al. (1997) has identified 
lymphocytic choriomeningitis virus (LCMV) DNA in tissue from infected mice. 
This finding is highly significant with regard to measles virus since LCMV is a 
non-retroviral RNA virus. The authors decided to examine lymphoid tissue from 
infected mice for the presence of LCMV DNA since there was evidence of 
LCMV antigens in the absence of LCMV RNA following low-dose exposure to 
the virus. Moreover, infectious LCMV could not be isolated from tissue positive 
for LCMV antigens. The detection of LCMV DNA and antigens in the absence 
of LCMV RNA may be important in the context of the findings of measles 
nucleoprotein in Crohn's disease tissue in the apparent absence of measles RNA 
described in this study. 
The reverse transcriptase activity required to synthesise LCMV DNA in infected 
cells may have arisen from three sources: co-infection with a rctrovirus may 
have provided the necessary reverse transcriptase activity; endogenous reverse 
transcriptase activity may have arisen from retroviral DNA sequences present in 
the host genome; endogenous host enzymes capable of reverse transcriptase 
activity may have been responsible for the presence of LCMV DNA. 
The authors of this study suggested that latent LCMV DNA may play an 
important role in long term immunity to LCMV. Latent LCMV DNA may 
function as a natural DNA vaccine - periodically transcribed and translated to 
generate antigens which boost the immune response to LCMV. In this manner, 
persistent LCMV DNA may be present in association with only transient levels 
of LCMV RNA. In general, protein has a longer half life than RNA in vivo, 
therefore LCMV antigens may be detected in the absence of LCMV RNA. 
In 1975, a related study by Zhdanov (1975) reported the detection of integrated 
measles DNA in chronically-infected cell cultures, raising the possibility that 
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measles DNA may be a feature of measles virus persistence. However there are 
no published reports confirming these results using more sensitive molecular 
biology techniques now available. Moreover, there is no published data 
concerning measles DNA in persistent measles virus infections such as SSPE, 
although this lack of published data may indicate that measles DNA has not 
been sought in persistently infected tissue or cell cultures. 
Interestingly, reverse transcriptase activity has been identified in cultures of 
chick embryo fibroblasts associated with an endogenous avian retrovirus 
(Weissmahr et al. 1997). These cells are used to produce the live, attenuated, 
measles vaccine and such reverse transcriptase activity has also been detected `T% 
MMR preparations themselves (Boni et al. 1996). These findings raise the 
possibility that prior to, or following vaccination, regions of measles RNA may 
be reverse transcribed to measles DNA and become integrated within the host 
genome, or persist in the cell cytoplasm. Periodic transcription and translation of 
these measles DNA sequences may then lead to expression of measles antigen, 
stimulating the production of measles antibodies and leading to prolonged 
immunity to measles virus. In this manner, measles antigen may be more readily 
detectable than transiently expressed measles RNA. Studies underway in several 
laboratories may determine whether latent measles DNA is produced in cells 
following measles vaccination. 
If this phenomenon does occur, then it is possible that measles antigen expressed 
on host cells may be a target for the immune response, leading to chronic 
intestinal inflammation. The periodic expression of measles antigen would then 
account for the periods of remission and relapse observed in IBD. Transiently 
expressed measles RNA may be rapidly degraded and therefore measles RNA 
may not be present on examination of tissue samples in accordance with the 
results of this project. 
The studies described in Chapters 6 and 9 used total RNA from IBD clinical 
samples to test for the presence of measles RNA and therefore the presence of 
measles DNA was not determined. RNA test samples were not purified by 
DNAse digestion, therefore it is likely that these RNA samples were 
contaminated with cellular DNA. However, the small amount of cellular DNA 
contamination may have been insufficient to enable the detection of any measles 
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DNA present in the samples analysed. 
11.1.3. Measles virus RNA is present but not detectable 
Such an explanation would fit well with the positive immunohistochemical data 
and the epidemiological associations between measles virus and IBD. In 
previous studies to determine the presence of measles RNA in IBD tissue 
(Smith, 1994; Lewey et al. 1995; Iizuka et al. 1995; Fan et al. 1996; Haga et al. 
1996), accurate quantitation of the detection assay employed was not performed. 
Since hybrid capture has been shown to improve the sensitivity of measles RNA 
detection 100-fold, it is likely that the sensitivity limits of the measles RNA 
detection methods described in previous studies was in the region of 106 measles 
RNA molecules. Therefore, the methods used in these studies may not have 
been capable of detecting low copy-number measles RNA. The detection 
sensitivity of the method employed in Chapter 9 was quantified by adding 
known numbers of a measles RNA transcript to intestinal tissue or PBMC 
homogenates prior to RNA extraction, hybrid capture and RT-PCR for measles 
RNA. 
The efficiency of this method, and that of the NASBA method used in Chapter 
5, was further confirmed by performing RNA amplification on a variety of 
measles RNA templates: total RNA from Hu2 strain measles virus-infected 
Vero cells; total RNA from a Schwarz strain measles vaccine sample; synthetic 
wild-type measles RNA transcripts; and total RNA from autopsy material of 
four cases of SSPE. Amplification of measles RNA from SSPE autopsy material 
demonstrated the ability of the methods used in Chapters 6 and 9 to detect a 
persistent measles virus infection. Moreover, the detection of measles RNA by 
RT-PCR and NASBA in one case with negative immunohistochemical staining 
demonstrated the advantage of these methods over immunohistochemistry for 
the detection of persistent measles RNA. The detection of measles virus RNA 
but not antigens in SSPE tissue has been demonstrated previously by in situ 
hybridisation (Allen et al. 1996). It is therefore unlikely that a persistent measles 
virus infection is detectable by immunohistochemistry but not by more sensitive 
nucleic acid amplification techniques. 
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Detection sensitivity. As a positive control, RT-PCR and NASBA were used to 
amplify a housekeeping RNA species - comprising part of the spliceosome 
subunit, U1A - present in all eukaryotic cells. The detection of UTA RNA gives 
an indication of the integrity of RNA but does not necessarily mean that any 
measles RNA present should be detectable, since only a very small proportion 
of cells may be infected with measles virus. 
It is possible that measles RNA was present below the sensitivity limits of the 
measles RNA detection assays used in this study (as few as 104 measles N-gene 
RNA molecules). Measles virus may persist in only a very small number of 
intestinal microvascular endothelial cells, leading to focal granulomatous 
vasculitis and widespread chronic inflammation later in life. Immunogold 
electron microscopy data suggests a very low copy-number persistent measles 
virus infection in the foci of granulomatous inflammation in Crohn's disease 
tissue, in contrast to the relatively high copy-number infection observed in 
SSPE tissue (Lewin et al. 1995; Daszak et al. 1997). Such a focal, low-copy 
number infection may be difficult to detect even using highly sensitive 
molecular amplification methodologies. 
However, as described in Chapter 8,104 copies of a measles RNA transcript 
could be detected in tissue homogenates using hybrid capture followed by RT- 
PCR. In 1984, Lund et al. published the results of a study showing that up to 
13,000 measles nucleocapsids are present per measles virion. If each 
nucleocapsid contains a measles RNA genome, then approximately 103 measles 
RNA molecules are present per measles virion and so, in theory, the presence of 
very few functional virus particles (possibly as little as 10) can be detected by 
this method. Because of this high level of sensitivity, it would seem unlikely 
that every IBD sample analysed contained measles RNA at a level below that of 
the sensitivity of the detection method described. On the other hand, measles 
virus may be presentCrohn's disease tissue as low copy-number defective viral 
particles rather than functional replicative virus and may therefore be difficult to 
detect. 
Measles virus RNA isolation. The efficiency of measles RNA isolation may be 
below that of other RNA species, leading to an under-representation of measles 
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RNA in a total RNA sample. During total RNA isolation high concentrations of 
guanadinium thiocyanate salts are used for lysis, denaturation, and dissociation 
nucleoprotein/nucleic acid complexes prior to acid phenol-chloroform 
separation. Measles nucleoprotein forms very stable associations with measles 
RNA (Andzhaparidze et al. 1987) and it is possible that the high salt 
concentrations used for RNA isolation do not fully dissociate measles 
nucleoprotein from measles RNA. As a consequence, measles RNA may remain 
associated with measles nucleoprotein in the organic phase after acid phenol- 
chloroform separation and not detected in total RNA purified from the aqueous 
phase. Alternatively, measles nucleoprotein may remain associated to measles 
RNA in the aqueous phase following acid-phenol separation. Bound measles 
nucleoprotein may then inhibit reverse transcription of measles RNA, reducing 
the sensitivity of the measles RNA detection method. 
Measles RNA mutations. As discussed in Chapter 3, mutations accumulate in 
genomic measles RNA during persistent measles virus infection (Cattaneo et al. 
1989). Mutations in measles matrix (Hirano et al. 1992; Hirano et al. 1993) and 
fusion proteins (Schmid et al. 1992) are thought to be partly responsible for the 
establishment of viral persistence. As viral envelope proteins are not required for 
persistent measles infection, mutations also accumulate in the genes encoding 
these proteins. 
RNA amplification techniques require efficient hybridisation of oligonucleotide 
primers to target RNA sequences. In the case of highly mutated RNA targets, 
any mismatches occurring at the 3' end of the oligonucleotide primer may lead 
to inefficient primer extension, preventing optimal amplification of measles 
RNA sequences. 
As a consequence of the high mutation rate within the matrix, fusion and 
haemagglutinin genes of persistent measles virus, transcription of these genes is 
often restricted, leading to a characteristically steep gradient of measles mRNA 
expression (Sidhu et al. 1994). Therefore, the abundance of mRNA encoded by 
genes towards the 5' end of the measles genome (measles P, M, F, H, and L- 
genes) is significantly reduced, possibly below the sensitivity limit of a detection 
methodology. However, genomic (rather than messger) measles H-gene RNA el 
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was used as a target for amplification in experiments described in Chapter 8 and 
so the presence of a measles mRNA transcription gradient should not have 
interfered with measles genomic H-gene analysis. 
On the other hand, expression of measles N-gene mRNA is often normal in 
persistent infections (Sidhu et al. 1994). Moreover, measles nucleoprotein, 
phosphoprotein and large proteins are essential for measles RNA replication and 
packaging, therefore mutations rarely accumulate in these genes. Although 
mutations may affect the ability to detect measles M, F and H-gene RNA in 
persistently infected tissue, measles N-gene RNA should be detectable if enough 
infected cells are present in the samples analysed. 
Based on the results in Chapters 6 and 9, and those of other studies, various 
measles RNA species (including N and H-gene RNA) are detectable in 
persistently infected SSPE tissue using NASBA, RT-PCR (Godec et al. 1990; 
Katayama et al. 1995) and RT-PCR followed by in situ hybridisation (Esolen et 
al. 1995; Isaacson et al. 1996). It is therefore very unlikely that measles RNA is 
not detectable in clinical samples of patients with IBD purely because the 
measles RNA is highly mutated. 
11.1.4. Conclusion 
The results of this project (supported by results of other groups) offer no 
supportive evidence for the involvement of measles virus in the aetiology of 
IBD. However, it remains possible that a persistent measles virus infection is 
present in IBD tissue and that the measles RNA detection methods employed in 
this and other studies were of insufficient sensitivity to permit measles RNA 
detection. Further work may lead to the detection of measles RNA in IBD tissue 
via more sensitive methodologies. 
The presence of measles antigens in intestinal tissue of patients with Crohn's 
disease requires confirmation with an affinity-purified measles polyclonal 
antibody in order to reproduce the data of previous studies. A panel of measles 
monoclonal antibodies, directed against different measles antigens (or different 
epitopes of the same antigen), should also be used to try to obtain similar 
staining patterns which would provide convincing evidence for the presence of 
measles antigens in IBD tissue. Using a range of monoclonal antibodies would 
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reduce the possibility of obtaining false-positive results due to antibody cross- 
reactivity as suggested by the study by Iisuka and Masamune (1997). 
The specificity of polyclonal measles antibody sera used for 
immunohistochemical studies (Wakefield et al. 1989; Lewin et al. 1995; Ekbom 
et al. 1996; Daszak et al. 1997) should be determined by Western blot analysis 
with the human antigen expressed in the phage X library described by lisuka and 
Masamune (1997) and discussed above. This would determine whether these 
polyclonal cross-react with the same human antigen which MAS 182r appears 
to. In addition, double immunohistochemical staining of IBD tissue sections, 
using monoclonal antibody 4F12 (directed against the human protein discussed 
above), and each measles polyclonal antibody sera, would provide information 
concerning the specificity of the measles antigen staining in IBD tissue. 
The detection of measles antigen in IBD tissue may reflect long term retention 
of antigen-antibody complexes as a function of normal immunological memory, 
rather than showing a causal relationship between measles antigen and chronic 
inflammation. Therefore future immunohistochemical studies for measles 
antigens in IBD tissue should include large numbers of age-matched controls to 
determine the significance of any positive staining in IBD samples. 
Epidemiological data suggests that atypical exposure to measles virus is a risk 
factor for the later development of IBD. Persistence of measles virus may not be 
a prerequisite for the development of chronic intestinal inflammation. As 
discussed above, it is possible that molecular mimicry occurs between measles 
virus and a human protein leading to autoimmune-mediated chronic 
inflammation later in life. Therefore the possible absence of measles virus in 
IBD tissue does not reduce the significance of the measles virus and IBD 
epidemiological findings. 
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11.2. MEASLES, MUMPS AND RUBELLA RNA AND AUTISTIC 
ENTEROPATHY 
No measles, mumps or rubella RNA was detected in any of the clinical samples 
analysed in our laboratory from paediatric patients with autistic enteropathy. 
Immunohistochemical staining, using measles nucleoprotein polyclonal 
antibody sera (RAd 68), has indicated the presence of measles nucleoprotein in 
biopsy sections from these patients (Wakefield et al. 1998a). As is the case for 
the detection of measles virus in IBD, there are significant discrepancies 
between the positive immunohistochemical staining for measles antigen and the 
negative RT-PCR results for measles RNA. Three possibilities may explain this 
discrepancy: measles virus is not present; measles antigens are present in the 
absence of measles RNA; or measles RNA is present but not detectable using 
the methods described in this project. 
11.2.1. Measles virus is not present 
RAd 68 was derived from mice immunised with purified recombinant measles 
nucleoprotein expressed using an adenovirus vector. The purification of 
recombinant measles nucleoprotein prior to immunisation is important: a 
significant proportion of infantile gastroenteritis in the UK is caused by 
adenoviruses (Bryden, 1997), it was essential that no adenovirus antibodies were 
present in RAd 68 sera. 
However, the polyclonal antibody sera may have cross-reacted with a human 
protein, as described by Iisuka and Masamune (1997) for the monoclonal 
antibody MAS 182r discussed above. 
On the other hand, an adenovirus monoclonal antibody did not give any positive 
staining in tissues positive for RAd 68, indicating that this antibody did not 
recognise adenovirus antigens in the tissue samples analysed (Wakefield et al. 
1998a). The antibody sera specifically bound to recombinant measles 
nucleoprotein on Western blot analysis and stained SSPE and measles-virus 
infected Vero cells by immunohistochemistry, confirming the presence of 
specific measles nucleoprotein antibodies in this polyclonal sera. In addition, the 
antibody sera used specifically stained follicular dendritic cells in lymphoid 
214 
tissue, a common site of measles virus infection. 
These findings suggest that the immunohistochemical detection of measles 
nucleoprotein in biopsies from affected patients represents a real result and is 
not a result of non-specific antibody binding. 
11.2.2. Measles antigens are present in the absence of measles RNA 
Measles antigen retention. It has recently been postulated that a mechanism for 
the longevity of the immune response to measles virus could involve persistence 
of measles virus antigens but not measles RNA (Griffin et al. 1994). Follicular 
dendritic cells in lymphoid tissue may retain measles antigens for long periods 
following a measles virus infection and possibly measles vaccination. 
In 1979, Tew and Mandel demonstrated prolonged retention of 125I-labelled 
human serum albumin in lymphoid follicles of mice footpads after antigen had 
been degraded and cleared from other sites. Calculating the half-life We` 
antigen, it was shown that it may be able to persist for many years, possibly 
accounting for B-cell memory. Moreover, only a minority of dendritic cells 
retained antigen as shown by discrete staining of isolated cells in lymphoid 
tissue. 
Szakal et al. (1988) identified a mechanism of antigen retention in follicular 
dendritic cells involving antibody-antigen complexes. Such complexes are found 
in vesicles called iccosomes and these may be responsible for both antigen 
presentation to T and B cells in lymphoid tissue and antigen retention in the 
form of convoluted dendrites. At sites of measles virus infection, dendritic cells 
may endocytose viral antigens (or antibody-antigen complexes) or become 
infected. Migration of such cells to lymphoid tissue leads to exposure of viral 
antigens, either as immune complexes within iccosomes released from dendrites, 
or via MHC class I-restricted antigen presentation. Iccosomes released from 
dendritic cells are endocytosed by macrophage and B-cells leading to MHC 
class II-restricted expression of viral antigens and stimulating CD8+ cytotoxic 
lymphocytes. MHC class I-restricted expression of viral antigens on dendritic 
cells stimulates CD4+ T cells which recruit B cell help. In addition, some 
dendritic cells retain iccosomes within highly convoluted dendrites, leading to 
the persistence of viral antigens for many years. In this way, memory B cells 
215 
may be stimulated, conferring long-term immunity. Such a phenomenon has 
been observed with human immunodeficiency virus (Tacchetti et al. 1997), with 
viral antigens being trapped in follicular dendritic cells of lymphoid tissue. 
Tew et al. (1990) have postulated that, following exposure to an antigen, 
convoluted follicular dendritic cells retain antigen-antibody complexes for long 
periods of time. When antibody levels decline, a feedback mechanism exposes 
antigen, stimulating B cells to produce more antibody. In this manner, retained 
antigen levels are slowly exhausted over time to maintain antibody and memory 
B cell levels. The ratio of retained antigen: antibody in these complexes 
determines the immunogenicity of these complexes and it is possible that 
abnormally high levels of retained antigen lead to immunopathogenic events, 
stimulating chronic inflammation. 
This mechanism of antigen persistence may explain the phenomenon of lifelong 
immunity to measles virus and may also explain the detection of measles 
nucleoprotein in isolated dendritic cells of affected children, in the apparent 
absence of measles RNA. However, there is much debate as to whether antigen 
persistence is a requirement for long term immunological memory (Doherty et 
al. 1996) and the mechanisms of lifelong immunity to measles virus are 
currently under investigation in other laboratories. 
If retention of measles antigens as part of immune complexes in dendritic cells is 
a normal function of long term immunity to measles virus, then the detection of 
measles antigens in these cells may not be surprising and may even be unrelated 
to the chronic colitis observed in affected children. With this in mind, the best 
way to determine the significance of any positive measles antigen 
immunohistochemical staining in affected children would be to examine, in 
dý parallel, tissue from large numbersLnormal control children. It is essential that 
control children are age-matched with affected children as the amount of 
measles antigen retained in lymphoid tissue may decrease over time as 
suggested by the study of Tew and Mandel (1979). 
As discussed above, it is possible that measles DNA may be present in affected 
patients, leading to the expression of measles antigens. The transient expression 
of measles RNA may account for the difficulties encountered in its detection. 
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11.2.3. Measles RNA is present but not detectable 
As described above for IBD tissue, it is possible that measles RNA is present in 
clinical samples from patients with autistic enteropathy, but below the 
sensitivity of the detection methods employed. The sensitivities of the measles 
N- and H-gene RT-PCR detection methods used in this study were not 
accurately quantified although measles N- and H-gene RNA was detected in 
positive control SSPE tissue using, these methods. It remains possible therefore, 
that a persistent, low copy-number measles virus infection was present but not 
detectable in the samples analysed. 
11.2.4. Conclusion 
It is possible that a persistent measles virus infection is present in intestinal 
tissue of patients with autistic enteropathy, but below the sensitivity of the 
detection methods employed. However, the combined data from 
immunohistochemistry and RT-PCR studies raise the interesting possibility that 
measles antigens may be retained in isolated follicular dendritic cells within 
lymphoid tissue in the absence of measles RNA many years after exposure to 
wild-type or vaccine strain measles virus. 
Griffin and her co-workers are currently studying the mechanisms of the 
longevity of immunity to measles virus and such studies may help to determine 
whether i) the presence of measles antigens in lymphoid tissue is an integral part 
of this mechanism, or ii) measles antigens are involved with immunopathology, 
leading to chronic inflammation and regressive autism observed in these 
patients. 
Iisuka and Masamune (1997) and Lui et al. (1995) have raised doubts 
concerning the specificity of antibodies used to detect measles antigens in IBD 
tissue. Although a different polyclonal antibody was used in this study, it may 
be necessary to repeat the measles immunohistochemistry experiments on tissue 
from affected children using an affinity-purified measles polyclonal antibody. In 
addition, a panel of measles monoclonal antibodies, directed against different 
measles antigens (or different epitopes of the same antigen), should also be used 
to try to obtain similar staining patterns which would provide convincing 
evidence for the presence of measles antigens in affected children. Such work is 
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currently underway in our laboratory. 
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11.3. FUTURE WORK 
11.3.1. Measles virus and IBD 
Given the results of Iisuka and Masamune (1997), concerning measles antibody 
cross-reactivity, it is necessary to re-evaluate the original immunohistochemical 
findings concerning the presence of measles RNA in IBD tissue. If the original 
data are confirmed, these immunohistochemical studies have detected measles 
antigens in the intestine of non-1131) patients (Lewin et al. 1995; Daszak et al. 
1997), raising the possibility that the measles antigens detected are involved 
with long term immunological memory and unrelated to chronic intestinal 
inflammation. Therefore, studying many more non-IBD intestinal tissue may 
reveal the significance of detecting measles antigens in IBD tissue. 
If measles RNA is present in IBD tissue, then it is present below the sensitivity 
limits of the methods described in this and previous studies. Three 
methodologies may increase the detection sensitivity of measles RNA in IBD 
tissue: microdissection of Crohn's disease granulomas; isolation of human 
intestinal microvascular endothelial cells (HIMECs); and in situ RT-PCR. 
Microdissection of granulomas. Haematoxylin and eosin staining can be used to 
locate the position of granulomas in frozen or paraffin-embedded Crohn's 
disease tissue. These granulomas may then be isolated from measles antigen 
positive sections of tissue using a dissecting microscope and either used directly 
in a measles RT-PCR reaction, or used for total RNA isolation prior to measles 
RNA amplification. Such a method may significantly increase the ratio of 
measles: non-measles RNA present in the reaction mixture and may lead to the 
detection of measles RNA previously undetectable in whole tissue. 
Microdissection techniques have been described for the isolation of tumour cells 
prior to PCR studies to determine the presence of particular gene mutations 
(Hedrum et al. 1912; Wagner et al. 1995). In addition a microdissection 
technique, coupled with RT-PCR has been used for the detection of hepatitis C 
virus RNA in different liver cell types (Saito et al. 1997). Such a method may 
be adapted for the isolation of Crohn's disease granulomas prior to RT-PCR 
studies for measles RNA to improve the measles RNA detection sensitivity. 
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Isolation of HIMECs. Recently, HIMECs have been isolated and cultured from 
resection tissue of patients with IBD (Haraldsen et al. 1995). As measles 
antigens have been detected in these cells in IBD tissue, they may represent an 
enriched source of any measles RNA present and this enrichment may permit 
the detection of measles RNA previously not detectable in IBD tissue samples. 
However, persistently infected HIMECs may be less likely to survive isolation 
from diseased tissue and may therefore be under represented in cell culture. 
Experiments to isolate HIMECs from IBD tissue as a source of RNA for 
measles RT-PCR are currently underway. 
In situ PCR. If only several endothelial cells are infected with measles virus 
within a resection tissue sample, then total RNA from these samples may 
contain measles RNA below the sensitivity limits of conventional measles RNA 
amplification methods. In situ RT-PCR, followed by in situ hybridisation using 
a probe specific to the PCR product, may be used to identify very few infected 
cells within a tissue section and can also determine the infected cell type. An 
advantage of this technique is that it can be applied to formalin-fixed and 
paraffin embedded archival tissue. 
Both in situ PCR and in situ RT-PCR have been used to detect a number of 
DNA (Berger et al. 1997; Foreman et al. 1997) and RNA (Schmidtmayerova et 
al. 1996; Ramakrishnan et al. 1996) templates, respectively. Measles RNA has 
also been detected using in situ RT-PCR (Esolen et al, 1995; Ray et al. 1996; 
Isaacson et al. 1996) and two of these studies (Esolen et al. 1995; Isaacson et al. 
1996) have reported the identification of measles RNA in endothelial cells, 
previously undetectable by in situ hybridisation. Therefore this technique may 
help improve the detection of any measles RNA in sections of IBD tissue. 
Targeted in situ PCR. Pan et al. (1997) have recently developed a method of in 
situ PCR whereby tissue sections are cut onto glass coverslips, the tissue of 
interest is isolated using a diamond marker and the resulting sliver of glass 
(containing the tissue of interest) is used in a conventional RT-PCR reaction 
under mineral oil in an Eppendorf tube. Amplification products can be analysed 
by gel electrophoresis of the PCR reaction supernatant and the in situ location of 
220 
PCR products can be determined by in situ hybridisation on the tissue on the 
glass sliver. Preliminary work using a modified method for RNA detection has 
shown that this method is capable of detecting measles RNA in SSPE tissue 
sections. Work is currently underway using this method to detect any measles 
RNA present in Crohn's disease granulomas. In addition, this method should be 
capable of detecting any measles DNA present in Crohn's disease tissue as 
discussed above. 
11.3.2. Measles virus and autistic enteropathy. 
Measles RNA. As discussed above, the failure to detect measles RNA in 
intestinal tissue from these patients may be a result of inadequate measles RNA 
detection sensitivity. Even though the natural RNA transcripition gradient of the 
measles genome (Sidhu et al. 1994) would favour the detection of measles N- 
gene RNA over other measles RNA species, measles H-gene RNA may be a 
more appropriate target for measles RNA detection. For this reason, 
experiments are currently underway in our laboratory to optimise measles H- 
gene RT-PCR. Additionally, analysis of RNA from clinical samples of patients 
with autistic enteropathy for measles H-gene RNA work is currently underway 
in an independent laboratory (Dr H. Kawashima, Tokyo Medical School, Japan; 
personal communication). 
Targetted in situ RT-PCR for measles RNA in intestinal tissue (described 
above) may also permit the detection of previously undetectable measles RNA. 
Measles antigens. It remains a possibility that measles RNA is not present in the 
intestinal tissues analysed from these patients and therefore the detection of 
measles antigens in these tissues (Wakefield et al. 1998a) needs to be 
confirmed. Immunohistoehemistry using a range of monoclonal, or affinity 
purified polyclonal antibodies, specific to measles antigens, may be used to 
confirm the presence and location of measles antigens within lymphoid tissue. 
In addition, analysis of non-inflamed tissue from the same patients and tissue 
from non-inflammatory age-matched control patients may reveal the 
significance of any positive findings. 
Moreover, immunohistochemistry for other viral antigens (such as mumps or 
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rubella) may reveal if antigen retention by isolated follicular dendritic cells is a 
normal part of long term immunity to viruses in general. 
Measles DNA. As discussed previously, a study by Zhdanov (1975), supported 
by the results of a recent study (Klenerman et al. 1997), has raised the 
possibility that measles may exist in a persistent DNA form. Such latent measles 
DNA (possibly integrated into the host genome) may generate 
immunopathogenic amounts of measles antigen, leading to chronic colitis. 
Experiments are underway in our laboratory to determine whether measles DNA 
is generated in cell cultures persistently or acutely infected with either measles 
virus or measles, mumps and rubella viruses derived from MMR vaccine 
preparation. Depending on the results of these experiments, DNA may be 
isolated from clinical samples of affected children (and from JBD samples), 
purified and RNase-treated, and used as a template for measles PCR to 
determine the presence of measles DNA. 
Such experiments are interesting both in the context of mechanisms of measles 
virus replication and persistence, and in the context of the mechanism of long 
term immunological memory to measles virus. 
Although the results of this project offer no supportive evidence of an 
association between measles virus and chronic gastrointestinal inflammation, 
the future work deshibed here may provide further insights into the relationship. 
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CORRECTIONS 
PAGE LINE 
11. 30 "has been recently" instead of "have been recently" 
21. Fig.!. 1. "Livingstone" instead of "Livinstone" 
27. 6 "Gutensohn and Cole" instead of "Gutersohn and Cole" 
29. 8 "Disease pathogenesis. " instead of "diseased pathogenesis" 
42 18 "Mycobacterial" instead of "mycrobacterial" 
44 3,14 "Lysteria monocytogenes" instead of "Lysteria 
monocytogenese" 
44 9 "presence of Listeria" instead of "presence Listeria" 
44 21 "represents opportunistic... " instead of "represent 
opportunistic" 
46 5 "immunodeficient" instead of "immunodefficient" 
46 8 "and to the presence of pro-inflammatory cytokines" instead of 
"and pro-inflammatory cytokines" 
47 5 "a range of tissues" instead of "a range for tissues" 
47 16 "Koplik spots" instead of "Koplick spots" 
49 4 "Upsala" instead of "Upsalla" 
49 25 "has shown concurrent exposure to measles and mumps" 
instead of "has shown concurrent measles and mumps 
infections" 
51 9 "increased dramatically" instead of "increased was 
dramatically" 
51 10 "decided to study" instead of "decided the study" 
57 Fig. 2.1. Scale of bars: 
62 26 "involved with the" instead of "involve with the" 
66 20 "aphthoid ulcers" instead of "apthoid ulcers" 
70 2,3 Swap Bansil and Dhib-Jalbut references with Schulz reference 
71 13 "genomic RNA instead of "geneomic RNA" 
71 18 "vesicular stomatis virus" instead of "vesicular somatis virus" 
74 11 "syncytia formation" instead of syncitia formation" 
75 15 "characterised by" instead of "characterised my" 
81 12 "immunohistochemical" instead of "immmunohistochemical"' 
88 12 "and has a similar" instead of "and a similar" 
90 6 "RNA in PBMCs" instead of "RNA PBMCs" 
98 12 "electrophoresis" instead of "lectrophoresis" 
99 10 "phytohamagglutinin" instead of "phytohaemagluttinin" 
99 16,17,18, "medium" instead of "media" 
26,32,33 
100 2,5,8,9,13 "medium" instead of "media" 
24,26,31 
100 10 "cocultures mixed" instead of "cocultures. mixed" 
100 17 "Cells derived from" instead of "Cell derived from" 
100 25 "medium was replaced" instead of "medium media was 
replaced" 
102 24 "deproteinised" instead of "deprotienised" 
103 1 "resuspended in" instead of "resuspend in" 
107 16 "gel electrophoresis" instead of "gel electrophoresism" 
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107 24 "electrophoresis was carried out at" instead of "electrophoresis 
at" 
108 10 "Membranes were stored" instead of "Membranes stored" 
111 1,16 "deproteinised" instead of "deprotienised" 
111 12 "were phosphorylated" instead of "was phosphorylated" 
112 7,12 "deproteinised" instead of "deprotienised" 
119 2 "generated were used" instead of "generated was used" 
125 24 "detect as few as" instead of "detect as few as" 
132 14 "was analysed" instead of "was alalysed" 
133 1 "study were to" instead of "study was to" 
136 Fig. 6.2. "section 4.2.9. " instead of "section 4.2.8. " 
141 2 "characterize" instead of "charcterize" 
149 26 "products are used" instead of "products are are used" 
150 5 Delete sentence "In experiments to determine... " 
150 9 "guanidine" instead of "gaunidine" 
152 Title "competitive" instead of "competetive" 
152 5 "Oligonucleotide" instead of "oligonucleotide" 
153 3/4 "transcripts into" instead of "transcripts was spiked into" 
168 31 "messenger" instead of "messanger" 
169 6 "... mumps or rubella could be detected. " instead of "mumps or 
rubella. " 
173 8 "characterize" instead of "charcterize" 
174 7 "methods' general" instead of "methods general" 
174 11 "intestinal or SSPE tissue" instead of "intestinal of SSPE 
tissue" 
177 Fig. 9.2. "Lane 11 contains" instead of "Lane 11 conains" 
177 Fig. 9.2. "control reaction" instead of "control reactions" 
178 14 "to achieve" instead of "to achiev" 
180 Fig. 9.3. "respectively" instead of "receptively" 
184 17 "could have occurred" instead of "could have occurs" 
194 3 "No samples" instead of "None samples" 
203 17 "characterize" instead of "charcterize" 
204 1,3,9,10,13 "serum" instead of "sera" 
205 15 "serum" instead of "sera" 
205 21 "results of these studies suggest" instead of "results suggest of 
these studies" 
206 14 "This explanation" instead of "this explanation" 
208 10 "detected in MMR" instead of "detected MMR" 
210 28 "present in Crohn's" instead of "present Crohn's" 
211 2 "dissociation of nucleoprotein" instead of dissociation 
nucleoprotein" 
211 32 "messenger" instead of "messanger" 
215 12 "of this antigen" instead of "of these antigen" 
216 26 "numbers of normal" instead of "numbers normal" 
222 20 "described" instead of "desribed" 
ýýö ý 
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